Electrically Conducting Biofibers: Approaches to Overcome the Major Challenges in the Clinical Translation of a Tissue Engineered Cardiac Patch by Gershlak, Joshua R
Worcester Polytechnic Institute
Digital WPI
Doctoral Dissertations (All Dissertations, All Years) Electronic Theses and Dissertations
2018-06-19
Electrically Conducting Biofibers: Approaches to
Overcome the Major Challenges in the Clinical
Translation of a Tissue Engineered Cardiac Patch
Joshua R. Gershlak
Worcester Polytechnic Institute
Follow this and additional works at: https://digitalcommons.wpi.edu/etd-dissertations
This dissertation is brought to you for free and open access by Digital WPI. It has been accepted for inclusion in Doctoral Dissertations (All
Dissertations, All Years) by an authorized administrator of Digital WPI. For more information, please contact wpi-etd@wpi.edu.
Repository Citation
Gershlak, J. R. (2018). Electrically Conducting Biofibers: Approaches to Overcome the Major Challenges in the Clinical Translation of a
Tissue Engineered Cardiac Patch. Retrieved from https://digitalcommons.wpi.edu/etd-dissertations/499
 Decellularized Spinach Leaves and 
Electrically Conducting Biofibers: 
Approaches to Overcome the Major 
Challenges in the Clinical Translation of a 
Tissue Engineered Cardiac Patch  
A Di sserta tion  
Subm itted to the F aculty of  the 
W ORCESTER POLY TECHNIC INSTITUTE 
In partia l  f ulf il lment of the requi rements f or the Degree of  
Doctorate of  Phi losophy in Biom edical Eng ineering 
 
June 19t h 2018 
 
By 
 
____________________________ 
Joshua  R.  G ershlak 
 
 ___________________________ 
Glenn Gaudette, Ph.D. 
Professor, Advisor 
Department of Biomedical Engineering 
Worcester Polytechnic Institute 
___________________________ 
George Pins, Ph.D. 
Professor 
Department of Biomedical Engineering 
Worcester Polytechnic Institute 
___________________________ 
Tanja Dominko, D.V.M., Ph.D. 
Associate Professor 
Department of Biology and Biotechnology 
Worcester Polytechnic Institute 
___________________________ 
William Murphy, Ph.D. 
Professor 
Department of Biomedical Engineering 
University of Wisconsin- Madison 
___________________________ 
Pamela Weathers, Ph.D. 
Professor 
Department of Biology and Biotechnology 
Worcester Polytechnic Institute 
___________________________ 
Lior Gepstein, M.D., Ph.D. 
Professor 
Rappaport Faculty of Medicine and Research Institute 
Technion-Israel Institute of Technology 
 ii 
Acknowledgements 
There are a number of people that I want thank that have helped along the way while I have 
been working on the research associated with this dissertation.  Firstly, I want to thank my advisor 
Glenn Gaudette for his mentoring and support throughout the past 4 years.  Working with Glenn 
has opened up so many doors for me that wouldn’t have been there otherwise.  His mentorship 
and enthusiasm has helped me immensely.  His support in my project has been unwavering.  The 
experience that we both have undergone since our work became a worldwide viral story has 
been such a unique experience and I think we acted as a great team throughout this whole 
process.   
I would also like to thank the rest of my dissertation committee.  Pam Weathers has been such 
an amazing resource for her knowledge in plant biology.  Without her, this project would never 
have worked out.  Tanja Dominko was so helpful in some of the analytical aspects, experimental 
design, and writing.  George Pins had some great suggestions and expertise for the subcutaneous 
implantation project.  William Murphy and his lab were instrumental in the development of the 
RGD peptide used and were such great collaborators throughout the entirety of my project and 
they projects they are working on in conjunction with us.  Lastly, Lior Gepstein was so hospitable 
for hosting me twice in his lab at the Technion.  His knowledge and expertise in cardiac 
electrophysiology and molecular biology really were instrumental in the third specific aim and 
for introducing me to research on the electrical pathways of the heart.   
I would like to thank the Gaudette Lab at WPI for their unwavering support throughout the 
years.  It has been quite the journey working with each and every one of you.  You were so helpful 
during my time at WPI and were so useful whenever I needed help.  I would also like to thank the 
Gepstein Lab at the Technion for your hospitality during my stays in your lab.   
All of the graduate students at WPI, especially my fellow IGERT fellows, were so supportive 
during the time we have spent together at Gateway Park.  Thanks for all the great memories.   
Last and certainly not least, I would like to thank my friends and family for the support during 
the past 4 years at WPI and for the 7 years of grad school in general.  You were always there 
whenever I needed encouragement and were always available to help break-up the monotonous 
lab work.  Thanks to all, this dissertation would not have been finished without the love and 
support you gave.   
 
 
 
 
 
 
 
 
 
 iii 
Table of Contents 
Acknowledgements ......................................................................................................................... ii 
Table of Figures .............................................................................................................................. vi 
Abbreviations ............................................................................................................................... viii 
Abstract ........................................................................................................................................... x 
1. Overview ........................................................................................................................ 1 
1.1. Introduction ....................................................................................................................... 1 
1.2. Overall goal and hypothesis ............................................................................................... 3 
1.3. Specific Aim 1: Demonstrate the Use of Decellularized Leaves as a Perfusable Tissue 
Engineering Scaffold ........................................................................................................................... 4 
1.3.1. Objective 1a: Preparation and characterization of decellularized plant scaffold ...................... 5 
1.3.2. Objective 1b: Recellularization of leaf scaffold with human cells ............................................. 5 
1.4. Specific Aim 2: Investigate the Biocompatibility of Decellularized Leaf Scaffolds .............. 5 
1.4.1. Objective 2a: Optimization of decellularization process to limit cytotoxicity............................ 5 
1.4.2. Objective 2b: Determine the in vivo response to subcutaneously implanted leaf scaffold ....... 5 
1.5. Specific Aim 3: Creation of a Conducting Biofiber to Bridge Electrical Pathway in the Heart
 6 
1.5.1. Objective 3a: Creation of an electrically conducting biofiber ................................................... 6 
1.5.2. Objective 3b: In vivo investigation of bridging electrical signal in the heart ............................. 7 
2. Background ..................................................................................................................... 7 
2.1. Introduction ....................................................................................................................... 7 
2.1.1. Tissue engineering ................................................................................................................. 7 
2.1.2. Cell Sourcing and the Potential for Personalized Tissues and Organs .................................10 
2.1.3. Decellularization: Using Native Structures as Scaffolding for New Tissue ...........................12 
2.1.4. Cardiovascular system ...........................................................................................................15 
2.1.5. Cross Kingdom Similarities ................................................................................................16 
2.1.6. Leaf Tissue Phytotomy and Cell Wall Composition.............................................................17 
2.2. Cardiovascular Disease ............................................................................................. 20 
2.2.1. Myocardial infarction ............................................................................................................20 
2.2.2. Therapeutic interventions for myocardial infarction ..............................................................21 
2.2.3. Challenges to the clinical translation of engineered cardiac patch ..........................................22 
3. Objective 1a: Preparation and Characterization of Decellularized Plant Scaffold ........ 23 
3.1. Introduction ..................................................................................................................... 23 
3.2. Materials and Methods .................................................................................................... 26 
3.2.1. Perfusion Decellularization ....................................................................................................26 
3.2.2. Histological Analysis ..............................................................................................................27 
3.2.3. Scanning Electron Microscope Imaging ..................................................................................28 
3.2.4. DNA/Protein Quantification ..................................................................................................28 
3.2.5. Mechanical Testing ...............................................................................................................29 
3.2.6. Dye Perfusion........................................................................................................................29 
3.2.7. Microsphere Perfusion ..........................................................................................................29 
3.2.8. Statistical Analysis .................................................................................................................30 
3.3. Results ............................................................................................................................. 31 
3.3.1. Perfusion Decellularization Can Be Applied to Different Plant Species ....................................31 
3.3.2. Decellularized Leaf Vasculature Remains Patent After Decellularization .................................37 
3.4. Discussion ........................................................................................................................ 39 
4. Objective 1b: Recellularization of Leaf Scaffold with Human Cells ............................... 46 
 iv 
4.1. Introduction ..................................................................................................................... 46 
4.2. Materials and Methods .................................................................................................... 48 
4.2.1. Human Cell Culture and Seeding of Leaf Scaffold ...................................................................48 
4.2.2. Low Density Lipoprotein Uptake Assay ..................................................................................49 
4.2.3. hPS-CM Contraction and Fluorescent Analysis .......................................................................49 
4.2.4. Statistical Analysis .................................................................................................................50 
4.3. Results ............................................................................................................................. 50 
4.3.1. hMSCs Readily Adhere to the Surface of Decellularized Leaf Scaffolds ...................................50 
4.3.2. HUVECs Can Attach to the Inner Walls of the Leaf Vasculature and Remain Viable .................51 
4.3.3. hPS-CMs Function on the Surface of Decellularized Leaf Scaffolds for 21 Days .......................53 
4.4. Discussion ........................................................................................................................ 57 
5. Objective 2a: Modification of the Decellularization Process to Limit Cytotoxicity ....... 59 
5.1. Introduction ..................................................................................................................... 59 
5.2. Materials and Methods .................................................................................................... 60 
5.2.1. Modification of Decellularization Process ..............................................................................60 
5.2.2. DNA Quantification ...............................................................................................................60 
5.2.3. Fibroblast and Mesenchymal Stem Cell Culture .....................................................................61 
5.2.4. Live/Dead Assay ....................................................................................................................61 
5.2.5. MTT Metabolic Activity Assay ................................................................................................62 
5.2.6. SDS Quantification ................................................................................................................62 
5.2.7. Statistical Analysis .................................................................................................................63 
5.3. Results ............................................................................................................................. 63 
5.3.1. Leaf Decellularization Can Be Successfully Modified with Lower Concentration Detergents in 
Less Time 63 
5.3.2. Optimized decellularization process yields limited cytotoxic affects .......................................65 
5.4. Discussion ........................................................................................................................ 70 
6. Objective 2b: In Vivo Response to Subcutaneously Implanted Leaf Scaffold ................ 73 
6.1. Introduction ..................................................................................................................... 73 
6.2. Materials and Method ..................................................................................................... 75 
6.2.1. RGD Functionalization of decellularized leaf .................................................................... 75 
6.2.2. Subcutaneous implant surgery ..............................................................................................75 
6.2.3. Histological analysis ..............................................................................................................76 
6.2.4. Collagen Encapsulation and Deposition Measurements .........................................................76 
6.2.5. Statistical Analysis .................................................................................................................76 
6.3. Results ............................................................................................................................. 77 
6.3.1. Decellularized Leaves Illicit Little Immunological Response ....................................................77 
6.3.2. RGD-Functionalized Leaves are Fully Integrated into the Body at 1 Week ..............................81 
6.3.3. Comparison of Non-Functionalized and RGD-Functionalized Leaf Scaffold Integration into the 
Host Tissue 86 
6.4. Discussion ........................................................................................................................ 88 
7. Objective 3a: Developing an Electrically Conducting Biofiber ...................................... 91 
7.1. Introduction ..................................................................................................................... 91 
7.2. Materials and Methods .................................................................................................... 93 
7.2.1. Cell culture............................................................................................................................93 
7.2.2. Fibrin microthread formation ................................................................................................94 
7.2.3. Fibrin microthread seeding....................................................................................................94 
7.2.4. Microthread and hPS-CM coculture .......................................................................................95 
7.2.5. Immunohistochemical staining ..............................................................................................96 
7.2.6. Optical mapping ....................................................................................................................96 
 v 
7.2.7. Statistical analysis .................................................................................................................97 
7.3. Results ............................................................................................................................. 97 
7.3.1. HEK293-Seeded Biofibers Allow for Electrical Propagation Along Length of Thread ................97 
7.3.2. Biofibers can carry electrical signal generated from cardiomyocytes over extended distances99 
7.3.3. Seeded biofibers can bridge electrical propagation between multiple clusters of cardiomyocytes
 103 
7.4. Discussion ...................................................................................................................... 109 
8. Objective 3b: In Vivo Investigation of Bridging Electrical Signal in the Heart ............. 111 
8.1. Introduction ................................................................................................................... 111 
8.2. Materials and Methods .................................................................................................. 112 
8.2.1. Biofiber Implantation .......................................................................................................... 112 
8.2.2. Ex-Vivo Visualization of Electrical Activity in Heart Induced with Acute AV Conduction Block
 113 
8.2.3. Histological Analysis ............................................................................................................ 113 
8.3. Results ........................................................................................................................... 114 
8.3.1. Verification of AV-Block Heart Model .................................................................................. 114 
8.3.2. Unseeded Fibrin Microthreads Do No Affect the Electrical Pathway of the Heart ................. 116 
8.3.3. Implanted Conducting Biofiber Elicits Ventricular Feedback into Atria.................................. 117 
8.4. Discussion ...................................................................................................................... 120 
9. Conclusions and Future Work ..................................................................................... 124 
9.1. Conclusions .................................................................................................................... 124 
9.2. Future Work ................................................................................................................... 127 
10. References .............................................................................................................. 132 
11. Appendix ................................................................................................................. 152 
11.1. Reprint Permissions ....................................................................................................... 152 
11.2. Protocols ........................................................................................................................ 153 
11.2.1. Leaf Decellularization .......................................................................................................... 153 
11.2.2. Leaf Functionalization with RGD-Dopamine ......................................................................... 156 
11.2.3. Leaf Scaffold Rehydration .................................................................................................... 158 
11.2.4. Human Cell Recellularization of Leaf Scaffold....................................................................... 159 
11.2.5. Hematoxylin and Eosin Stain (Paraffin Embedded Tissue) .................................................... 161 
11.2.6. Hematoxylin and Eosin Stain (Frozen Tissue) ....................................................................... 162 
11.2.7. Masson’s Trichrome Stain ................................................................................................... 163 
 
 
 
  
 vi 
Table of Figures 
 
Figure 2-1 Plant Cell Wall and Xylem Structure…………………………………………………………………………19 
Figure 3-1 Comparison of animal and plant vascular network pattern branching and structure 25 
Figure 3-2 Cannulation of Spinach Leaf Petiole   ........................................................................ 31 
Figure 3-3 Time-lapse of spinach leaf decellularization ............................................................. 32 
Figure 3-4 Characterization of plant scaffolds before and after decellularization ...................... 33 
Figure 3-5 Assessment of decellularization by single solutions alone......................................... 34 
Figure 3-6 Quantification of DNA and Protein Content During Decellularization ....................... 35 
Figure 3-7 Mechanical Analysis of Decellularized Spinach Leaf .................................................. 36 
Figure 3-8 Decellularization of Other Plant Types ...................................................................... 36 
Figure 3-9 Spinach leaf vascular scaffolds retain patency and perfusion capabilities after 
decellularization ................................................................................................................ 39 
Figure 4-1 hMSCs can be used to recellularize different plant scaffolds..................................... 50 
Figure 4-2 HUVECs can adhere to the inner portions of the leaf vein and remain viable ............ 53 
Figure 4-3 Human pluripotent stem cell-derived cardiomyocytes (hPS-CMs) adhere and function 
on the surface of a leaf scaffold for 21 days ...................................................................... 57 
Figure 5-1 Workflow Diagrams of the Original and the Modified Decellularization Protocols. ... 63 
Figure 5-2 Comparison of Decellularized Leaves from the Two Processes ................................. 64 
Figure 5-3 Lyophilized Decellularized Leaves are able to be Rehydrated and its Vasculature 
Remains Patent ................................................................................................................. 65 
Figure 5-4 Measurement of Decellularized Leaf Cytotoxicity Through a Fibroblast Live/Dead 
Assay. ................................................................................................................................ 66 
Figure 5-5 Fibroblast metabolic activity and proliferation are unaffected by leaves decellularized 
in the optimized process ................................................................................................... 69 
Figure 6-1 Hematoxylin and Eosin staining of subcutaneously implanted decellularized leaf 
scaffolds ............................................................................................................................ 79 
Figure 6-2 Masson's Trichrome Staining of Implanted Decellularized Leaf Scaffolds .................. 81 
Figure 6-3 Histological Analysis of Implantation of RGD-Functionalized Leaf Scaffolds .............. 83 
Figure 6-4 Masson's Trichrome Staining of RGD-Functiolizaed Leaf Scaffold Implants ............... 86 
Figure 6-5 Comparison of Integration of Non-Functionalized and RGD-Functionalized Leaf 
Scaffold Implants. .............................................................................................................. 87 
Figure 7-1 HEK293 Cell Seeding and Co-culture System ............................................................. 95 
Figure 7-2 Transfected HEK293 cells seeded onto fibrin microthreads form gap junctions and 
allow for electrical propagation down the length of the microthread ................................ 98 
Figure 7-3 Transfected HEK293 cell seeded fibrin microthreads form gap junctions with iPS-CM 
monolayers and allow for electrical propagation from iPS-CM monolayer down the length 
of the seeded thread. ...................................................................................................... 100 
Figure 7-4 Different lengths of HEK293 seeded fibrin microthreads were used in coculture with 
iPS-CM monolayers to determine whether there is a length that would cause a conduction 
block. .............................................................................................................................. 102 
Figure 7-5 HEK293 seeded fibrin microthreads can be used to electrically connect two separate 
iPS-CM monolayers ......................................................................................................... 106 
 vii 
Figure 7-6 The synchronization of two separate iPS-CM monolayers that were electrically linked 
by HEK293 seeded microthreads was measured by cutting the biofiber .......................... 109 
Figure 8-1 Verification of AV-Block Heart Model ..................................................................... 115 
Figure 8-2 Electrical Activity Is Unaffected by Implanted Unseeded Fibrin Microthread. ......... 116 
Figure 8-3 Electrical Activity in Heart Implanted with Conducting Biofiber Results in Ventricular 
Feedback Into The Atria .................................................................................................. 119 
Figure 8-4 Histological Analysis of Implanted Biofiber ............................................................. 120 
 
  
 viii 
Abbreviations 
3-D Three Dimensional  
ANOVA Analysis of Variance 
AV Node Atrioventricular Node 
Ca Calcium 
cm Centimeter 
Cnx43 Connexin 43 
Cnx45 Connexin 45 
diH2O Deionized Water 
DMEM Dulbeco’s Modfied Eagle Medium 
DNA Deoxyribonucleic Acid 
ECM Extracellular Matrix 
ESC Embryonic Stem Cell 
EtO Ethylene Oxide 
FPS Frames Per Second 
GAP Good Agricultural Practices 
GCaMP Genetically Encoded Calcium Sensor 
GFP Green Fluorescent Protein 
H&E Hematoxylin and Eosin 
HDM High Density Mapping  
HEK293 Human Embryonic Kidney Cells 293 
hMSC Human Mesenchymal Stem Cells 
hPS-CM Human Pluripotent Stem Cell Derived Cardiomyocytes 
HUVEC Human Umbilical Vein Endothelial Cells 
iPS Induced Pluripotent Stem Cells 
iPS-CM Induced Pluripotent Stem Cell Derived Cardiomyocytes 
K Potassium 
kg Kilogram 
Kir2.1v Inward Rectifier Potassium Ion Channel 
LA Left Atria 
LDL Low Density Lipoprotein 
LV Left Ventricle 
MI Myocardial Infarction 
mM Millimolar 
ms Millisecond 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
Na Sodium 
nm Nanometer 
PBS Phosphate Buffered Saline 
PDMS Polydimethylsiloxane 
 ix 
Qdot Quantum Dot 
RGD Arginine-Glycine-Aspartic Acid 
RPMI Roswell Park Memorial Institute Medium 
SA Node Sinoatrial Node 
SCN5A Sodium Channel Protein Type 5 
SDS Sodium Dodecyl Sulfate 
SEM Scanning Electron Microscope 
U Units 
μg Micrograms 
μL Microliters 
μm Micrometers, microns 
μM Micromolar 
 
  
 x 
Abstract 
Cardiovascular disease is the leading cause of death in the United States, accounting for 
approximately 25% of total deaths. Myocardial infarction (MI) is an extreme case of 
cardiovascular disease where ischemia leads to irreversible tissue necrosis. As the heart lacks the 
capacity to endogenously regenerate, the infarcted region is negatively remodeled, reducing 
cardiac function. Current therapies are not able to regenerate cardiac function post-MI, requiring 
novel approaches such as tissue engineering. However, there are three major pitfalls that are 
currently limiting the clinical translation of a tissue engineered cardiac patch: lack of proper 
vascularization within the tissues; biocompatible material; and lack of electrical integration 
between engineered tissue and host. The research within this dissertation aimed to engineer 
solutions to overcome these three pitfalls.   
Plants and animals exploit fundamentally different approaches to transporting fluids, yet there 
are surprising structural similarities. To take advantage of these similarities, we looked across 
different kingdoms and investigated whether plants and their innate vasculature could serve as 
perfusable scaffolds for tissue engineering. Standard perfusion decellularization techniques were 
adapted and applied to spinach leaves, which were found to be fully devoid of DNA following 
processing. Leaf vasculature remained patent post-decellularization and supported transport of 
various sized microparticles. Human cells successfully seeded onto and inside the plant scaffolds. 
Decellularized leaves were found to be nearly void of any cytotoxic affects. Leaf biocompatibility 
was then investigated in vivo through subcutaneous implantation in a rat model. Leaf scaffolds 
were found to be biocompatible after 4 weeks of implantation.  Furthermore, leaves that were 
pre-functionalized with an RGD-dopamine peptide were fully integrated into the host tissue 
within one week. This shows the leaf scaffold’s potential to be an immuno-modulatory material, 
depending upon the intended application.   
Electrically conducting biofibers were engineered through the combination of fibrin 
microthreads and engineered conductive HEK293 cells.  Biofibers could act as a modular platform 
to allow for electrical integration between the host tissue and any engineered cardiac patch. 
Biofibers directionally carried electrical current and were found capable of bridging electrical 
signal between two separate clusters of cardiomyocytes. In vivo investigation bridging a biofiber 
from the left atria to the left ventricle was accomplished in a rat model. Electrical maps 
demonstrated a visible accessory pathway that created a feedback electrical signal from the 
ventricle to the atria through the implanted biofiber. These results demonstrate electrical 
integration in vivo between host myocardium and the engineered biofiber.  
Overview 1 
 
1. Overview 
1.1. Introduction 
Cardiovascular disease is the leading cause of death in the United States, accounting for 
approximately 25% of total fatalities 1. Pre-existing cardiovascular disease such as coronary artery 
disease 2 can lead to acute myocardial infarction (MI). MI is caused by a blockage in the cardiac 
vasculature that decreases blood flow, causing a lack of oxygen and nutrient transport to the 
affected area. As the heart lacks the capacity to endogenously regenerate, the necrotic region is 
remodeled into collagen-rich non-contractile scar tissue 3. This non-compliant scar diminishes 
cardiac function and output, which can lead to end stage heart failure. Current gold standard 
treatments to treat the blockage in cardiac vasculature are angioplasty 4 and coronary artery 
bypass surgery 5; these treatments resume blood flow to the affected region, but do not address 
the long-term issue of the necrotic scar 6. The only real cure for end stage heart failure is whole 
organ transplantation using a donor heart. However, this is not an ideal option due to the 
extremely limited availability of donor hearts and the potential for transplant rejection. In fact, 
only a reported 4% of people who need a heart transplant receive one that successfully saves 
their life 7. Furthermore, there is an expected economic burden that is associated with such a 
prevalent and severe disease.  Heart failure prevalence has increased from 5.7 million patients 
between 2009-2012 to 6.5 million patients between 2011-2014 8 and it is predicted that greater 
than 8 million people or 1 in every 33 people in the United States would be living with heart 
failure by 2030 9.  This many patients dealing with heart failure would result in direct care costs 
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upwards of $160 billion.  Therefore, there is a need to find a long-term sustainable treatment 
that addresses the effects of the long-term tissue necrosis. 
One such treatment that is being extensively investigated is the use of a patch made from 
engineered cardiac tissue 10-14.   Research into the generation of a cardiac patch is one of the 
most readily investigated subjects in the field of tissue engineering.  An engineered cardiac patch 
would be required to be implemented surgically to replace the scarred region of the heart, post-
infarction.  This patch would need to be able to regain the functionality that was lost as a result 
of the MI. Tissue engineered patches are generated by combining cells and biomaterials with 
specific stimulation to drive functionality.  Over the course of the past 20 years, there have been 
great strides made in the science of engineering cardiac tissue.  Engineered cardiac patches have 
been shown to improve cardiac function upon implantation after MI in a wide variety of animal 
models.  This scientific success, however, has not been successfully translated into clinically-
relevant cardiac patch. There are a wide variety of pitfalls that have limited the clinical translation 
of a cardiac patch.  The leading investigators in the field have identified three main challenges 
that are currently limiting translation into the clinic 15.  These challenges are: 
1. Vascularization of the patch 
2. Immunological response to the patch, and 
3. Electromechanical integration between the patch and the host tissue. 
These challenges must be met in order to engineer a cardiac patch that could be translated into 
a clinical intervention.   
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1.2. Overall goal and hypothesis 
This dissertation aims to address the three challenges limiting the clinical translation of 
engineered cardiac patches:  
1. Develop a pre-vascularized material able to support cardiomyocyte contraction   
2. Determine the biocompatibility of this pre-vascularized material   
3. Develop a method to electrically connect isolated cardiac constructs 
When searching for an appropriate material to act as a pre-vascularized scaffold, it is 
important to assess the availability, vascular network formation, and ability to grow tissue upon 
it.  A material that is highly available and has an inherent vascular network is a plant’s leaf.  Leaf 
vasculature is reminiscent of the structure seen in the human cardiovascular system.  
Modification of the leaf such that it is void of any immunological issues could potentially be a 
highly sustainable solution.  Leaves could be modified through decellularization,  a process that 
removes all of the cellular material from a tissue, leaving the tissue immunologically-blank, as 
previously demonstrated in whole organ decellularization 16.  I hypothesize that perfusion 
decellularization could be adapted for use with leaves.  The established decellularized leaf could 
then act as a pre-vascularized scaffold for engineered cardiac tissue.  Leaves are mainly composed 
of cellulose, a well-studied biomaterial that is known to be biocompatible with human tissues. I 
therefore hypothesize that the decellularized leaf would be immunologically blank to the 
mammalian body.  
Finally, an electrical connection needs to be established between the native heart tissue and 
the engineered leaf patch.  This connection needs to be based on a modular design that could 
carry electrical signal over long distances.  Fibrin microthreads 17 have been previously been 
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shown to serve as a highly adaptable platform useful for cellular delivery into the myocardium.  
Within the heart tissue, certain cells act as pacemaker cells that carry electrical current.  There 
have been successful attempts to engineer large number of cells that could act as pacemaker 
cells in order to provide a possible cellular therapy for patients affected by arrhythmias 18.  I posit 
that a modular biofiber could be engineered by combining fibrin microthreads with the 
engineered pacemaker cells which would allow for directionalized electrical signal over long 
distances.   
The biofiber could act to electrically integrate the engineered cardiac leaf patch with the 
native electrical pathway system of the heart, alleviating any potential electrical mismatch.  The 
combination of a decellularized leaf cardiac patch with an electrically conducting biofiber could 
address the current shortfalls limiting the clinical translation of cardiac patches.  This dissertation 
will aim to investigate these new potential technologies in order to address the feasibility of this 
proposed new approach.   
 
1.3. Specific Aim 1: Demonstrate the Use of Decellularized Leaves as a Perfusable Tissue 
Engineering Scaffold 
Establishing a sustainable, pre-vascularized material for use as a scaffold for cardiac tissue 
engineering could help push the field into the clinic.  Decellularization could be adapted for use 
in leaves, which in turn could be seeded with cardiomyocytes to yield a functional cardiac patch.  
In this aim, the efficacy of using perfusion-based decellularization on plant tissues to generate 
pre-vascularized scaffolds suitable for tissue engineering will be investigated.  This specific aim 
had two different objectives.   
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1.3.1. Objective 1a: Preparation and characterization of decellularized plant scaffold 
In this objective, perfusion decellularization was modified to work on leaf and other plant 
structures.  Decellularized spinach leaves were studied as a model plant type due to their 
advantageous geometry and availability.  Decellularized leaves were assessed and characterized 
for their DNA content, protein content, and their vascular patency.   
1.3.2. Objective 1b: Recellularization of leaf scaffold with human cells 
In this objective, the decellularized spinach leaves established in objective 1a were 
recellularized with different human cells in order to test their ability to act as a tissue engineering 
scaffold.  Cells used included mesenchymal stem cells (MSCs), human umbilical vein endothelial 
cells (HUVECs), and human pluripotent stem cell derived cardiomyocytes (hPS-CMs).   
1.4. Specific Aim 2: Investigate the Biocompatibility of Decellularized Leaf Scaffolds 
In this aim, the biocompatibility of the decellularized leaf scaffolds was investigated.  If these 
leaves are to be used in a clinical setting, they must be compatible with the native body and not 
illicit a massive immunological response.  This aim had two sub-objectives.   
1.4.1. Objective 2a: Optimization of decellularization process to limit cytotoxicity 
Optimization of the decellularization process is needed in order to lessen the use of detergent 
solutions in the decellularization process, as established in objective 1a.  Lowered detergent 
concentrations allowed for increased cellular viability, as measured through cytotoxicity assays.  
1.4.2. Objective 2b: Determine the in vivo response to subcutaneously implanted leaf 
scaffold 
In this objective, in vivo response to the decellularized leaf scaffolds was studied. Leaf 
biocompatibility was assessed through subcutaneous implantation of decellularized leaves in a 
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rat model.  The native immunological response is a complex cascade of events ranging from days 
to weeks. Thusly, the native immunological response was measured over the course of 4-weeks.  
Decellularized leaves were found to be non-immunogenic and inert to the body after the 4-
weeks.  Furthermore, prior functionalization of leaves with an RGD-Dopamine peptide increased 
integration into the host tissue which led to active remodeling of the foreign body.  These results 
showed that leaf has the capability to be immuno-modulatory through prior modification to the 
leaf surface prior to implantation.    
 
1.5. Specific Aim 3: Creation of a Conducting Biofiber to Bridge Electrical Pathway in the 
Heart 
In this aim, a conducting biofiber capable of bridging an ionic/electrical signal was engineered.  
This biofiber was created solely out of biological materials.  This aim had two objectives.   
1.5.1. Objective 3a: Creation of an electrically conducting biofiber 
In this objective, I hypothesized that an electrically conducting biofiber could be engineered 
by combining an excitable cell type with fibrin microthreads.  Fibrin microthreads were previously 
been used to delivery stem cells into the heart.  This platform could be used in conjunction with 
an excitable cell type to direct an electrical signal that could be used to bridge long distances.  
This hypothesis was tested using in vitro cell coculture assays.  Engineered conducting biofibers 
were able to directionally carry electrical current over long gaps.  These biofibers were able to 
actively act as an electrical bridge between two distant, separate clusters of cardiomyocytes.   
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1.5.2. Objective 3b: In vivo investigation of bridging electrical signal in the heart 
In this objective, in vivo electrical integration of the biofiber was investigated.  Biofibers were 
implanted in rats, bridging the left atria with the left ventricle.  After implantation, the biofibers 
were given time to form gap junctions with the native myocardium.  Hearts were excised and 
atrio-ventricular conduction block was achieved through pharmacological intervention.  The 
electrical activity resulting from this conduction block were measured using optical mapping. 
There was electrical conduction bridging seen from the biofiber in a majority of the hearts tested, 
demonstrating proof-of-principle of a biological electrical bridge.     
2. Background  
2.1. Introduction 
2.1.1. Tissue engineering 
There is a massive organ transplant availability shortage that is plaguing the United States.  
There are consistently more than 100,000 patients on the organ waiting list 19. The number of 
patients on the waiting list has rapidly increased over the past 15 years whereas the number of 
available transplants has remained the roughly the same.  For instance, in 1991 there were 
around 24,000 patients on the waiting list and 16,000 transplants had occurred whereas in 2015 
there were approximately 118,000 patients on the waiting list, but only 31,000 transplants had 
occurred.  The number of donors and transplants performed over time has roughly doubled but 
this is not nearly enough to bridge the large gap in numbers of patients on the waiting list. As a 
result of this, researchers have embarked on the very ambitious quest to engineer new organs 
and tissues.  This field, known as tissue engineering, has shown great promise in potentially 
alleviating the future organ shortage.  The concept of engineering new tissues and organs is not 
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a new one, however.  Throughout time, doctors have aimed to use different materials to help 
repair damaged tissues and organs.  For instance, the practice of skin grafting for wound and 
burn healing can be dated back to 3000 B.C.E. India 20.  As understanding of human anatomy and 
physiology improved with scientific study, so too did the efforts to engineer new tissues and 
organs.  During the 1500s, the pioneering surgeon Tagliacozzi was the first to describe the use of 
a forearm skin flap to be used as a nasal replacement 21.  Improvements in sterile conditions and 
anesthesia advanced surgical techniques and interest in building new tissues and organs.  As this 
interest peaked, so did the understanding of different materials and their potential use in the 
body.   
A lot of the development around materials for tissue engineering occurred as the result of 
World War II.  As an example, paratroopers routinely had to use their parachutes as a means to 
help stop bleeding and noticed no ill-effects from this material.  British surgeon Harold Ridley 
found that pilots had irritants from their Plexiglas windshields in their eyes, but the pilots had no 
rejection or pain complications.  This discovery led Ridley to use Plexiglas as the basis for new 
intraocular lenses 22.  Further development of materials and tissue culture techniques following 
WWII and throughout the Cold War era led us to the possibility of using these materials and 
techniques to build new tissues and organs.  
 Tissue engineering as a term was officially proposed in 1988 at a National Science Foundation 
meeting 23 and was formally defined in 1993 by Chemical Engineering Professor Robert Langer 
and Surgeon Joseph Vacanti.  They defined tissue engineering as “an interdisciplinary field that 
applies the principles of engineering and life sciences toward the development of biological 
substitutes that restore, maintain, or improve tissue function” 24.  The interdisciplinary aspect of 
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the field is important to emphasize.  The field is built around the combined efforts of engineers, 
scientists, and doctors to build, study, and implement new tissues and organs.  These combined 
efforts have produced mixed results, with some great successes but also untimely failures.  
The field was initially met with a great promise, especially commercially, and tissue 
engineering startup companies were well-funded and showed great promise in the mid to late 
90s 25.  This promise was so vast that Time Magazine named the tissue engineer as the top job 
for the new millennium.  However, in the early 2000s, blowback from the dot-com financial bust 
and high operating costs caused most of these initial companies to go bankrupt 26.  This was 
devastating for the prospect of widespread commercialization of tissue engineering and the field 
faced a paradigm shift in its approach. The field was able to successfully reform in the mid 2000s 
through the current day and have started to advance some tissue engineered products into the 
clinic.  Coupling this change of practice along with some of the advances in stem cell biology, 
tissue engineering is at an even more advanced stage than it was in the late 90s 27.  There are still 
some major hurdles to be cleared before a whole organ or large scale complex tissues could be 
engineered, but that hurdle is shrinking with each passing day.  
 The general approach to tissue engineering typically follows what is known as the “tissue 
engineering triad” 23.  There are three different components needed to engineer a tissue.   The 
three components are cells, a scaffold, and stimulation.  Cells are the functional part of the tissue 
as they are the basis for tissue and organ function, growth, turnover, and integration into the 
body.  The scaffold is a biomaterial that has appropriate properties (such as cellular binding 
motifs, mechanical properties, or hierarchical structure), which provides three dimensionality 
and structure for the engineered tissue.  Last, different forms of stimulation are provided in order 
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to focus the cells on conditions and functionalities specific to tissue and organ type.  When the 
three are properly combined, an engineered tissue can act like its intended biological target in 
the body.   
2.1.2. Cell Sourcing and the Potential for Personalized Tissues and Organs 
Engineered tissues have progressed with improved understanding and study of cellular and 
molecular biology.  Scientists have been able to identify and isolate specific cell and subcell types 
that comprise the tissues that they are actively trying to engineer.  This improved understanding 
of the role of different cells within a tissue has allowed tissue engineers to better mimic the native 
tissue.  Furthermore, the knowledge gained has also improved cell sourcing.  Cell sourcing is 
important to understand as there needs to be ample amounts of cells produced and the cells 
used would ideally not illicit a transplanted engineered tissue to be rejected.  Because of this, 
tissue engineers typically look towards the use of a stem cell for the basis of the engineered 
tissue.  Stem cells are cells within the body that can transition into other cell types.  The adult 
body has residential stem cells found within bone marrow and fat.  These cells can easily be 
isolated and turned into a small portion of more specialized cells such as skin, muscle, bone, and 
nerve cells. They, however, cannot be turned into every cell type, which would be necessary to 
engineer proper tissue.  Because of this, there has been a strong focus on the development and 
use of pluripotent stem cells.   
Pluripotent stem cells are stem cells that can be turned into any somatic cell in the body. A 
somatic cell is any cell in the body other than a sperm or egg.  Because of this potential, 
pluripotent stem cell biology has been one of the most widely studied fields but also one of the 
most controversial.  There are two main forms of pluripotent stem cells: embryonic stem cells 
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and induced pluripotent stem cells (iPS cells).  Embryonic stem cells are isolated from an embryo 
as the embryo goes through normal development from fertilized egg into a neonate 28.  Because 
of the sourcing, there are many ethical, religious, and political factors questioning the use and 
research on embryonic stem cells. There are also some other drawbacks to the use of embryonic 
stem cells outside of these issues.  The major drawback is that the cell used, especially if 
eventually used for a transplanted engineered tissue, still retains the genetic makeup of the 
donor, so that transplant rejection is a possibility. The use of immunosuppressant drugs may be 
needed to be used in conjunction with any tissue engineered from embryonic stem cells.  Because 
of these issues and many others, there needs to be a better solution.  A powerful solution was 
successfully demonstrated in 2006 by Shinya Yamanaka and colleagues in Japan where they were 
able to induce adult cells into a pluripotent state 29.  The researchers were awarded the Nobel 
Prize in Physiology in 2012 for this work.  These iPS cells, are able to act like embryonic stem cells 
but are void of the ethical, religious, and political questions.  Also, similar to the embryonic stem 
cells, iPS cells retain the genetic makeup of the donor.  This is advantageous as it opens up the 
possibility of using a patient’s own cells as the basis for an engineered tissue. Potentially, a biopsy 
could be taken from a patient waiting for a transplant.  Cells could be isolated from the biopsy 
and then induced back into a pluripotent state.  Once in the pluripotent state, the cells could be 
further differentiated into the specific cell type needed for an engineered tissue or organ.  The 
cells could then be cultured on an appropriate scaffold and given proper stimulation thereby 
resulting in a patient-specific engineered tissue or organ.  Using a patient’s own cells also obviates 
issues of rejection and the need for immunosuppressant drugs.  A personalized engineered tissue 
or organ is still far from being implemented in the clinic, but in theory it seems a strong future 
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possibility, although there are still limitations.  These limitations include concerns over the 
genetic modification undergone by the iPS cells 30, the possibility of teratoma formation 31, the 
need for improved differentiation protocols 32, and the upscaling needed to generate clinically-
relevant cell numbers 33.  By focusing on biomimetic approaches, there are seemingly new and 
interesting potential solutions that one day could advance such an engineered tissue or organ 
into the clinic.   
2.1.3. Decellularization: Using Native Structures as Scaffolding for New Tissue 
As tissue engineering has progressed, there has been emphasis on using cells, scaffolds, and 
stimulations as close to possible as to what would be seen in the body.  The biomimetic nature 
of tissue engineering has been an important paradigm shift.  The idea of looking to the body and 
nature as inspiration or the basis for the foundations of tissue engineering has provided 
opportunities for new developments and improved engineered tissues.  A great example of body 
inspired improvements can be seen in the design and selection of materials for use as scaffolding 
for tissue engineering.  Within the body, tissue is comprised of cells embedded within a complex 
mixture of proteins, carbohydrates, and glycoproteins called the extracellular matrix (ECM) 34,35.  
ECM was thought to be merely just the supporting framework for the cells in a tissue or organ.  
More recent research has found that the ECM is more than just a framework and is in fact 
important in directing cellular, tissue, and organ function 36,37.  ECM composition is unique to the 
tissue type and can be affected by age and health status 3,38.  Because of these considerations, 
there has been a strong push to use the beneficial properties of the ECM when engineering new 
tissues.   
Background 13 
Not only does the composition of the ECM affect the overall tissue function, but so does its 
hierarchical structure 39.  Structures, such as blood vessels, that are found in tissues and organs 
in the body must be considered when designing scaffolds for engineered tissues and organs 40.  
In fact, one of the greatest hurdles currently affecting clinical translation is the density of and 
lack of properly vasculature.  Vasculature is critical as it allows for blood and nutrient delivery to 
the cells within the tissue.  Blood carries oxygen, which is necessary for cells to survive and 
function.  Oxygen needs to be delivered within 100-200 microns of cells within the tissue due to 
limitations in the diffusion of oxygen from blood into the cell 41.  Without adequate blood 
delivery, engineered tissues will die when grown to clinically-relevant sizes 42, thereby limiting 
our ability to engineer both smaller pieces of tissue and whole organs. This limitation must be 
addressed as the field aims to solve the organ shortage problem.  Techniques such as 3D printing 
43 have opened up new possibilities when designing new scaffolds, but they cannot currently 
create viable vasculature at the proper size and density needed to build whole organs. 
Researchers have looked towards the native structure found in tissues and organs in the body 
and have tried to harness that structure directly.  One such approach, which has shown great 
promise is through decellularization 16.  Decellularization is a technique where researchers can 
wash cells from a tissue or organ, leaving behind just the ECM of the tissue.  The ECM can then 
be studied 44, used by itself as a therapeutic 45, or could be used as a tissue engineering scaffold 
46,47.  Using decellularization opens up new scaffolding that could potentially lead engineered 
tissues and organs to be successfully translated into the clinic.   
Decellularization is performed by treating tissues or organs with solutions that wash away 
the cells living in the tissue; leaving a substrate completely void of cellular material 48.  Because 
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the tissue or organ would be completely void of cellular material, if it were to be used in an 
implant there should be minimal to no rejection 49.  This technique is commonly performed using 
different detergents, which work to disrupt the cell membrane thereby destroying the cells.  
These detergents can be perfused through the vasculature of the organ being decellularized 
which allows for the hierarchical structure of the organ to be retained 16,50.  Decellularization is 
powerful because the overall structure and ECM composition of an organ is retained while the 
donor’s cellular material is eliminated.  Using perfusion decellularization to engineer whole 
organs was established in 2008.  Harald Ott and colleagues were able to decellularize a whole rat 
heart by perfusing detergents through the heart’s vasculature 16.  The heart was left blank and 
this “ghost heart” was subsequently competent to accept and sustain cardiomyocytes.  The newly 
engineered heart showed some heart mechanical and electrical function.  This study inspired 
many other researchers to use the technique of whole organ perfusion decellularization with 
virtually every organ type within the body.   
There is immense prospect in engineering whole organs using perfused decellularized organs 
as the scaffolding.  Combining iPS cell technology with decellularized organs could lead to the 
potential of generating a patient specific organ transplant.  As previously discussed, iPS cells could 
be generated from a biopsy of a patient and then could be used with a donated decellularized 
organ to generate the transplant.  With this potentially powerful combination, there could be 
major headway made to eliminate the organ shortage.  A newer study by Ott and colleagues 
showed this potential, using cadaveric hearts and human iPS cells to generate an engineered 
whole organ which should some heart function 47.  There is considerable amount of research and 
development that needs to be performed before this is a possibility in the clinic but all things are 
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pointing towards this being a reality. However, the lack of donor heart availability is still an issue.  
While some hearts rejected for transplantation, such as those not transplanted in time, may be 
used, it is unlikely that enough hearts will be available to address the number of organs needed.   
2.1.4. Cardiovascular system 
The cardiovascular system is one of the major organ and tissue systems that comprise the 
body.  The main function of the cardiovascular system is to provide oxygen and nutrients to the 
rest of the body.  This is accomplished through the transport of oxygenated blood through 
arteries and capillaries.  After the blood is brought into close contact with the area being provided 
with the oxygen and nutrients, it becomes deoxygenated and is removed through flow in veins.  
The flow of blood is controlled by the pumping action of the heart.  The heart both pumps 
oxygenated blood to the rest of the body and brings deoxygenated blood back to the heart. The 
blood is also pumped to the lungs, where the blood is re-saturated with oxygen and the process 
begins anew.   
Deoxygenated blood flows into the right atria of the heart, down through the tricuspid valve 
and into the right ventricle where the pumping action pushes the blood out of the heart and into 
the pulmonary artery.  Once inside the pulmonary artery, deoxygenated blood is brought into 
close contact with the alveolar of the lung where oxygen is exchanged with carbon dioxide. Newly 
oxygenated blood returns into the heart through the pulmonary veins, into the left atria and 
through the mitral valve.  The blood is then brought into the left ventricle where the major 
pumping action of the heart occurs and pushes the blood out of the heart through the aorta and 
back to the rest of the body.   
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Cardiac pumping is a mechanical function initiated by a precisely timed electrical signal in the 
heart originating from the sinoatrial node, which is located in the right atria.  Signal propagates 
down into the atrioventricular node, also located in the right atria, where the signal is slowed in 
order to properly activate mechanical function in the ventricles.  Electrical signal then propagates 
through the bundle of His, located in the ventricular wall between the right and left ventricles, 
and eventually passes into the Purkinje Fibers where electrical signal initiates mechanical action 
in the ventricles.  The timing of the electrical system is important, as improper timing could result 
in inefficient pumping and eventual systemic pathologies.  
2.1.5. Cross Kingdom Similarities  
Despite the apparent differences between plant and animal tissue, there are many similarities 
in overall tissue composition and architecture.  These similarities open up the possibility of 
cross kingdom contributions, where structures from the plant kingdom could be applied to the 
animal kingdom or vice versa.  Plants can broadly be categorized as being vascular or non-
vascular, with the majority of plants being vascular 51,52.  Similar to the human body, vascular 
plants are comprised of organ systems; the root system and the shoot system.  The root system 
is found mostly underground and works to absorb water and nutrients from the soil.  The shoot 
system includes the stem, petioles, and leaves of the plant and is above ground and works to 
both transport the water and nutrients from the roots and also acts to receive sunlight for the 
generation of energy from photosynthesis 53.   
Xylem and phloem act as the transport vessels for the water and nutrients, similarly to the 
arteries and veins within the cardiovascular system.  Specifically, xylem transports water from 
the roots through the shoot to the leaves whereas the phloem transports the nutrients 
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generated from photosynthesis from the leaves to all the different plant tissues when needed.  
The patterning of these vascular structures can affect the hierarchical structures of the plant 
and leaves. A monocot is a plant where the vascular structures are aligned whereas a dicot has 
a branched vascular pattern.  The branching pattern of a dicot closely matches the branching 
pattern seen in the human cardiovascular system 54.   
Leaf tissue also has some similarities to structures seen within the human body.  Leaf tissue 
is a multi-layered system reminiscent of skin.  The outer-most layer of the leaf is the cuticle, 
which is a waxy layer that acts to protect the leaf.  Underneath the cuticle there are layers of 
plant cells that make up the majority of the leaf structure and composition.  Plant cells walls 
give mechanical strength to the leaf and are comprised of a variety of polysaccharides such as 
cellulose, hemicellulose, and pectin 55 as well as a variety of proteins 56.  The main protein within 
the plant cell wall is extensin 57.  Extensin is a protein that is comprised of a repeating sequence 
of the amino acid hydroxyproline 58, which is also seen in the structure of collagen type I 59.   
The structure and composition of the human extracellular matrix has been shaped and formed 
by evolution 60 and this might explain the potential analog of extensin and collagen.   
2.1.6.  Leaf Tissue Phytotomy and Cell Wall Composition 
Hierarchal structures of a leaf are comprised of different compositional and geometric 
structures similar to the ECM that constitutes the hierarchical structure of human tissue.  Leaf 
tissues are encased in a cuticle, a waxy outer layer, which works to protect the leaf from invading 
pathogens and helps retain water in the leaf 61.  Beneath the cuticle layer, there is the leaf 
epidermis, usually a single cell layer containing multiple cell types including guard cells that act 
to regulate opening and closing of the stomatal pores on the leaf surfaces 62.  Beneath the 
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epidermis is the mesophyll tissue that makes up the bulk of the internal leaf structure. Mesophyll 
includes cells that are responsible for photosynthesis. Last is leaf vascular system, including 
phloem and xylem.  Photosynthetic mesophyll cells contain the most chloroplasts of any plant 
cell types 63.     
Unlike animal cells, plant cells have a primary wall that is mainly composed of the linear 
polymer cellulose, which is the most abundant polymer found on earth 64.  Dozens of the 
polymeric chains of cellulose form together and extend throughout the wall forming cellulose 
microfibrils.  In response to phytohormones and environmental cues, these microfibrils are laid 
down in all directions within the wall forming a well-knit laminate within which are also 
integrated extensin proteins and the polysaccharides, hemicellulose and pectin.  Hemicelluloses 
are highly branched structures that crosslink the cellulosic microfibrils thereby providing great 
strength to the wall 55.  Pectins act to bind positively charged ions into the network and form a 
gel-like structure especially between plant cells, “gluing” them together while also protecting the 
cellulose microfibrils 65.  As the plant cell matures, it lays down multiple cell wall layers in different 
laminar directions to provide strength and support for the cell.  The outermost cell wall layer is 
thin and flexible and is known as the primary cell wall.  Because of this flexibility, the primary cell 
wall allows for the plant cell to expand when water transport is achieved 66.  The primary cell wall 
also acts to give the shape and size of the plant cell and also provides protection from invading 
microbials 67.   The inner most layer of the cell wall is known as the secondary cell wall that is laid 
down after the primary wall is formed.  The secondary wall provides the mechanical strength to 
the cell wall and contains large amounts of the organic biopolymer, lignin 68. Lignin is the second 
most abundant biopolymer and is comprised of three alcohol monomers that are polymerized 
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together, which results in a very strong and complex molecule 69.  Lignified cell walls are 
commonly seen in the cell walls that surround the xylem vessels within leaves.  The strength of 
lignin allows for the xylem to withstand large amounts of negative pressure, for example xylem 
within the great sequoia tree must withstand a pressure gradient of »1 MPa 70.  Altogether, the 
cell walls of the mesophyll cells act together and creating the bulk of the leaf and surround the 
vascular tissues.   
 
Figure 2-1 Plant Cell Wall and Xylem Structure.  (A) Overview of the layering of the plant cell wall and the 
molecules found within each layer.  (B) Overview of the structure and lignification of xylem.  Note: both images are not 
drawn to scale and this figure is merely a schematic. 
Transport of fluids and solutes into (xylem) and from (phloem) the mesophyll cells involves 
both passive and active mechanisms depending on the molecule being transported 71.  Xylem is 
created by long-lignified dead cells that act together to create long open vessel structures 72.  
These vessels bring water from the roots in the plant up into the mesophyll of the leaf through 
capillary action 73.  Water transport occurs when there is a loss of water within the mesophyll, 
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typically due to the opening of stomata for uptake of carbon dioxide for photosynthesis 74.  When 
open, water is also lost through the stomata via the process of transpiration thereby creating a 
negative pressure.  Xylem needs to transport water throughout the entirety of the mesophyll of 
the leaf to allow for proper plant growth and optimal photosynthesis.  Once photosynthesis 
occurs, the synthesized sugars are then transported from the mesophyll cells via the phloem of 
the vasculature to provide fixed carbon nutrients to tissues throughout the plant.   
 
2.2. Cardiovascular Disease 
The dynamic electromechanical function of the heart is incredibly important to the overall 
health and wellbeing of a person.  Considering that the heart beats over 100,000 times a day and 
over 2 billion times in a lifetime 75, any type of disease that affects this beating capacity would be 
devastating. Unfortunately, cardiovascular disease is an epidemic in the United States where over 
33% of the population suffers from some form of it 76.  One of the more severe forms of 
cardiovascular disease is myocardial infarction (MI) and approximately 7% of those who suffer 
from cardiovascular disease will experience an MI.  MI could develop into heart failure, a 
condition where the heart is unable to pump enough blood to meet the needs of the rest of the 
body 77.   
2.2.1. Myocardial infarction 
Myocardial infarction mainly occurs when there is a blockage in the cardiac vasculature 
resulting in diminished blood flow.  Diminished blood flow results in an ischemic environment 
that results in tissue necrosis in an adjoining region.  As the heart lacks the capacity to 
endogenously regenerate, the necrotic region is negatively remodeled into collagen rich non-
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contractile scar tissue 3. This non-compliant scar diminishes cardiac function and output.  During 
this process, an estimated 1 billion cardiomyocytes die 78, which further causes lack of function.  
As the MI primarily occurs in the left ventricle, this loss of compliance and function can be 
devastating and eventually could lead to end stage heart failure without interventions. 
2.2.2. Therapeutic interventions for myocardial infarction 
Current surgical interventions for treating MI are not directed at treating the infarcted tissue 
but rather treating the occluded vasculature. These treatments include angioplasty 4, stenting of 
the blocked arteries 79, coronary artery bypass surgery 80 , or whole organ replacement. 
Angioplasty and stenting work to reintroduce blood flow to the infarcted region by opening up 
the blocked arteries.  Bypass surgery introduces a new artery graft that bypasses the blocked 
region, again reintroducing blood into the infarcted region.  These techniques work well in 
restoring blood flow in the region but this alone will not regain the necessary function in the left 
ventricle.  The only option, and thus the gold standard of care that regains function in the infarct 
is through whole organ transplant.  However, whole organ transplant is not the most sustainable 
option as there is an inadequate supply of hearts for transplant.  Furthermore, patients given a 
transplant have to be permanently placed on immunosuppressant drugs, which in turn leads to 
a low quality of life.   
Tissue engineering offers a potential solution to this problem through the prospect of 
engineering a functional myocardium that could be used to replace the scarred region of the 
heart.  Furthermore, as described previously 47, these engineered tissues have the possibility of 
being patient-specific, eliminating the need for immunosuppressants.  Engineering cardiac tissue 
is one of the more well studied subjects within the field of tissue engineering.  There are 
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established demonstrations 14,81,82 of functional engineered cardiac tissue in vitro.  Implantation 
of engineered cardiac tissues in animal models have also been successful in regenerating cardiac 
function after MI.  Despite this success, there are still challenges in getting engineered cardiac 
tissue into the clinic.   
2.2.3. Challenges to the clinical translation of engineered cardiac patch 
In a recent publication, 13 of the leading investigators in the field of cardiac tissue engineering 
provided a perspective of the field and its future 15.  These investigators identified three major 
challenges that must be met when considering the clinical prospects of using engineered cardiac 
tissue to treat MI.  These challenges include vascularization of the engineered tissue, eliminating 
the immunological response to the implanted graft, and integrating electromechanical linkage 
between the graft and host.   Without proper vascularization, the necessary amounts of oxygen 
cannot be provided to the engineered tissue.  Oxygen has a diffusion limit of 100-200 µm 83, 
which makes the pre-establishment of micron-sized vasculature crucial.  A negative immune 
response to the implanted graft would result in rejection and a return to loss of cardiac function.  
Finally, without electromechanical integration between the graft and host, there will be a 
mismatch of the electrical signals, resulting in establishing lethal arrhythmias.   
In this dissertation, I aim to address these three challenges and offer viable solutions towards 
the creation of a clinically relevant engineered cardiac patch.  A prevascularized scaffold will be 
established and studied for its in vivo immunological response.  Finally, a modular system that 
could induce electrical signal into the graft will be generated.   
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3. Objective 1a: Preparation and Characterization of Decellularized Plant Scaffold 
The introduction (starting with section 3.1), methods, results, and discussion presented in this 
objective have previously been published in Biomaterials 84, Vol. 125 pgs. 13-22, Joshua R. 
Gershlak, Sarah Hernandez, Gianluca Fontana, Luke R. Perreault, Katrina J. Hansen, Sara A. 
Larson, Bernard Y.K. Binder, David M. Dolivo, Tianhong Yang, Tanja Dominko, Marsha W. Rolle, 
Pamela J. Weathers, Fabricio Medina-Bolivar, Carole L. Cramer, William L. Murphy, Glenn R. 
Gaudette, “Crossing Kingdoms: Using Decellularized plants as perfusable tissue engineering 
scaffolds”, Copyright 2017, with permission from Elsevier (See Appendix A) 
3.1. Introduction 
One of the major factors currently limiting clinical applicability of tissue engineered solutions 
is the lack of a functional vascular network 85. Without a viable vascular network, the 100-200 
μm oxygen diffusion limit within tissues cannot be overcome, consequently restricting the size of 
graft that can be engineered and retain viability. Most current bioengineering techniques are 
unable to create patent perfusion vessels. Techniques such as the loading of scaffolds with pro-
angiogenic factors 86, cellular-guided vascular network formation 87, and microfabricated designs 
88 have demonstrated limited success in fully recapitulating native vasculature.  Furthermore, 
microvasculature (<10 μm in diameter) cannot be functionally fabricated with current 
biofabrication techniques, such as 3-D printing due to current constraints in printing resolution 
89.  Even as these biofabrication approaches have improved over time, the availability and time 
needed to create such a densely vascularized tissue would be a difficult problem to overcome.  
Furthermore, there is a concern that 3-D printed microvasculature could collapse upon 
themselves due to the surrounding scaffolding weight.   
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Instead of attempting to engineer a vascular network, current focus has shifted towards bio-
inspired approaches, further driven by the advent of perfusion-based techniques for 
decellularization 16.  Decellularization removes cellular material from a tissue or organ leaving 
behind an acellular scaffold consisting of extracellular matrix (ECM), the composition of which 
depends on the tissue or organ from which it was derived 35, while preserving an intact vascular 
network 47.  By removing the cellular material of a donor’s tissue, a decellularized graft would be 
rendered non-immunogenic while retaining gross organ structure 39. Decellularized tissues and 
organs can then be recellularized with a patient’s own cells to create an autologous graft 47.  
Native biochemical composition and hierarchical tissue structure of a potential decellularized 
graft are derived from the donor of the tissue or organ. This inherently leads to inconsistency 
among tissues or organs derived from different patients, or decellularized using different 
methods, due to confounding variables such as age, organismal or tissue pathology, and the 
specifics of the decellularization protocol 3,35,48. In particular, protein compositional analysis 
through mass spectrometry has shown drastic differences in the composition of decellularized 
tissues between different patients 90,91.  Decellularized mammalian tissues are also in short 
supply and, even when available, are expensive. Furthermore, a considerable amount of 
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additional research needs to be conducted before entire decellularized organs can be considered 
as a practical clinical option 46. Consequently, a more consistent, cost-effective and readily 
available tissue source for decellularization would improve prospects by increasing viable 
numbers of grafts at a significantly lower cost.   
Most current bioengineering approaches are limited by the physical and intellectual isolation 
of basic research in different organisms to their respective biological kingdoms. This critical 
challenge can be overcome by exploiting cross-kingdom contributions within the same 
bioengineered platform. Plants and animals exploit fundamentally different approaches to 
transporting fluids, chemicals, and macromolecules, yet there are surprising similarities in their 
vascular network structures (Figure 3-1). Plant vasculature follows Murray’s Law 54, which is the 
physiological law describing the tapered, branching network design of the human cardiovascular 
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Figure 3-1 Comparison of animal and plant vascular network pattern branching and structures. A rat heart 
was decellularized, as previously described (10,33), and was perfused with a Ponceau Red stain to visualize 
the vasculature. A Buddleja davidii leaf was perfused with fluorescein-labeled PEGDA to visualize the leaf 
vasculature. 
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system 92. Structures within plant tissue 93, like human tissue 94, exhibit varied mechanical 
properties, enabling varied functions. Plant cell walls are composed of a variety of 
polysaccharides, the most prominent of which are cellulose, pectin, and hemicellulose 95. 
Cellulose, which is the most abundant component of plant cell walls, is a well-studied biomaterial 
for a variety of clinical applications 96. Cellulose is biocompatible and has been shown to promote 
wound healing 97. Furthermore, cellulosic tissue engineering scaffolds derived from 
decellularized apple slices have shown the ability for mammalian cell attachment and 
proliferation 98 and were found to be biocompatible when implanted subcutaneously in vivo 99.  
Pectin 100 and hemicellulose 101 have also been studied as biomaterials for bone tissue 
engineering and wound healing, respectively. The innate similarities and apparent 
biocompatibility of plant ECM spurred us to look across kingdoms and investigate whether plants 
and their innate vasculatures could serve as perfusable scaffolds for engineering human tissue. 
In this objective, decellularization techniques were applied to different plant species and tissues 
in order to generate acellular, pre-vascularized tissue engineering scaffolds. The abundance and 
rapid growth of many plant species also provides for a less costly, more plentiful and sustainable 
scaffold material.   
3.2. Materials and Methods 
3.2.1. Perfusion Decellularization 
Spinach and parsley were acquired from a local market. Artemisia annua leaves (SAM 
cultivar, specimen voucher MASS 00317314) were harvested from soil-grown plants. Peanut 
hairy roots were generated through Agrobacterium rhizogenes-mediated genetic transformation 
102,103. Decellularization for the different plant types was adapted from whole organ perfusion 
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decellularization techniques 16,35,47.  Spinach leaves were cannulated through the petiole and 
parsley stems were cannulated via the basipetal end of the stem segment. A 10% sodium dodecyl 
sulfate (SDS) in deionized water solution was perfused through the cannulas for 5 days, after 
which they were perfused in with a 0.1% Triton-X-100 in a 10% sodium chlorite bleach (Aqua-
Tab, Beckart Environmental, Kenosha, WI) in deionized water solution for 48 hours.  Sterile 
deionized water was then perfused for an additional 48 hours.  Perfusion was accomplished from 
a constant pressure head of 152 mmHg and flow was initiated by gravity.  A. annua and peanut 
hairy roots were decellularized using the same technique but instead of cannulation and 
perfusion, they were soaked in the solutions.  Cuticles were removed from the plants via serial 
treatment with hexanes (98%, Mixed Isomers, Alfa Aesar, Haverhill, MA) and 1x PBS. After 
decellularization was complete, tissues were stored in sterile deionized water at 4°C until needed 
for up to two weeks.  
3.2.2. Histological Analysis 
Leaf samples were cut into ~1cm squares, preferentially cut with the main vascular 
channel of the leaf down the middle of the square. Roots and stems were cut into approximately 
~1cm length pieces. Tissue samples were fixed overnight in an ATP-1 automatic tissue processor 
(Triangle Biomedical Sciences, North Carolina) and then embedded in paraffin. Paraffin blocks 
were sectioned at 14 μm. Samples that were stained using Sass’s Safranin and Fast Green 
protocol for plant staining were done as previously reported 104.  In short, sections were stained 
for 1 hour in aqueous 1% (w/v) Safranin-O, and then rinsed in deionized water for approximately 
5 minutes, or until all residual dye was removed from the sections. Sections were dehydrated in 
70%, then 95% ethanol and dipped for 10 seconds in Fast Green FCF (0.1% w/v in 95% ethanol). 
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Sections were washed in two changes of 100% ethanol (2 minutes/step) and cleared in two 
changes of xylene (2 minutes/step). Samples were stained for lignin for 10 min in a saturated 
solution of phloroglucinol in 20% hydrochloride, as previously reported 105.  Samples were 
visualized through use of a DMLB2 upright microscope (Leica Microsystems, Buffalo Grove, IL).  
3.2.3. Scanning Electron Microscope Imaging 
The preparation of samples for Scanning Electron Microscopy (SEM) analysis consisted of 
fixation with 1.5% glutaraldehyde in freshly prepared 0.07 M sodium cacodylate buffer for 2 
hours. The samples were then rinsed in 0.07 M sodium cacodylate with the addition of 2.5% 
sucrose and dehydrated by serial immersion in a graduated series of ethanol in H2O, in the 
following concentrations: 30, 50, 80, and 95%. Then samples where immersed in 
hexamethyldisilazane (HDMS) in ethanol solutions in the following concentrations: 30, 50, 80, 
and 95%. The samples were left to dry on the sample holder and then gold sputter coated prior 
imaging in SEM.  
3.2.4. DNA/Protein Quantification 
 Both native and decellularized leaves were put in centrifuge tubes in a liquid nitrogen 
bath and ground with a pestle. Fragments were further processed by pulling through a 25-gauge 
syringe needle and by sonication with 5 pulses performed 3 times to reduce leaf fragment size. 
DNA was then measured using a CyQUANT Direct Cell Proliferation Assay (Thermo Fisher, 
Waltham, MA) and protein was measured using a Coomassie (Bradford) Protein Assay Kit 
(Thermo Fisher). Concentrations were determined using a Victor3 spectrophotometer (Perkin 
Elmer, Waltham, MA).  
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3.2.5. Mechanical Testing 
Native and decellularized spinach leaves were cut into a 1x2 cm dogbone shape. Leaves 
were loaded into the grips of the mechanical tester with the apical end of the leaf being upright.  
An ElectroPulse E1000 tester (Instron Corp., Norwood, MA) was used to uniaxially stretch the 
leaves.  Leaves were stretched at a constant strain of 10 mm/mm until failure.  Maximum tangent 
modulus, ultimate tensile strength, and strain at failure were calculated.  Maximum tangent 
modulus was established by fitting a line to the maximal sloped linear region of the stress-strain 
graph.  Ultimate tensile strength and strain at failure were calculated from the generated stress-
strain graphs.   
3.2.6. Dye Perfusion 
 Decellularized spinach leaves were removed from refrigerated storage and were dried 
with Kimwipes prior to the start of the different perfusion studies.  A 0.1% Ponceau Red (Sigma 
Aldrich, Saint Louis, MO) in 1% acetic acid solution was perfused through the cannula attached 
to the petiole of each decellularized spinach leaf.  Ponceau red was perfused from a constant 
pressure of 152 mmHg via gravity driven flow. Images were taken before and after cannulation 
to investigate the remaining patency of the decellularized leaf vasculature.   
3.2.7. Microsphere Perfusion 
Microspheres (1, 10, 50, and 100 μm sized) (Phosphorex Inc., Hopkinton, MA) were used 
to determine the inner diameter flow limitations of the leaf vasculature.  Perfusion was 
accomplished through a syringe-pump with a flow rate of 200 µl/min. Prior to the microsphere 
perfusion, blank fluid was perfused through the leaf to measure any autofluorescence from the 
perfusate.  A serial perfusion of different singular fluorescent microsphere sizes was conducted 
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beginning with smallest to largest diameters.  After perfusion was completed, the runoff of each 
individually sized microsphere was collected and analyzed using a Victor3 microplate reader 
(Perkin Elmer) against a known standard curve for each individually sized microsphere.  There 
was some fluid loss experienced when collecting the runoffs from the perfusion.  This fluid loss 
can be attributed to the porous structures of the leaves causing small volumes of liquid to collect 
in the leaf. For the high-speed videos, a HiSpec4 high-speed camera (FastTec, San Diego, CA) was 
attached to a DMIL inverted microscope (Leica Microsystems, Buffalo Grove, IL) and high-speed 
videos were taken at 60 frames per second.  A mixture of the different microspheres was 
perfused for the videos.  Microspheres flowing through the vasculature were false colored white 
to heighten the contrast between sphere and background.  Confocal images of leaves verified 
microsphere entrapment.  Images were acquired using a SP5 Point Scanning Confocal (Leica 
Microsystems).   
3.2.8. Statistical Analysis 
All results are presented as mean ± standard error.  Statistical comparisons were made 
through either the use of a Student’s t-test or a one-way ANOVA with a Tukey’s post-hoc test.  
Both statistical tests were performed within SigmaPlot (Systat Software Inc., San Jose, CA).  
Statistical significance was determined to be p<0.05. There was a minimum of 3 biological 
replicates used for all statistical measures presented within this chapter.   
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3.3. Results 
3.3.1. Perfusion Decellularization Can Be Applied to Different Plant Species  
The natural structure of higher plants allows for the transport of nutrients via xylem and 
phloem to distal cells, e.g. from roots to leaves and leaves to roots or other leaves. To explore 
the potential for a plant-based tissue engineered scaffold, perfusion decellularization 16 was 
adapted for use with Spinacia oleracea (spinach) leaves. Spinach leaves were used as a model 
species due to their ready availability, their vascular network pattern and density, and their wide 
diameter petiole. Spinach leaf petioles were cannulated (Figure 3-2) with a syringe needle, which 
was held in place by a suture knot.  The spinach leaves were then perfused with decellularization 
solution (10% sodium dodecyl sulfate (SDS) in deionized water) for 5 days, followed by 2 days of 
Figure 3-2 Cannulation of Spinach Leaf Petiole. (A) Identification of the petiole of 
the spinach leaf.  The petiole is then cannulated using a 27-gauge needle that has 
been covered by silicon tubing.  (B) Image of a fully cannulated spinach leaf, (C) 
with a zoom in on the cannulated stem.   
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perfusion with clearing solution (0.1% TritonX-100, 10% sodium chlorite in deionized water). One 
day after initiation of the decellularization process, the leaves began to lose their green color 
(Figure 3-3, A and B). Leaves became translucent with a green hue by Day 5 (Figure 3-3C). The 
addition of sodium chlorite sterilized the tissue while also removing any residual chlorophyll, 
resulting in a colorless and translucent leaf by Day 7 (Figure 3-3D). Histological analysis identified 
cells with nuclei and chloroplasts in native leaves (Figure 3-4, A and C), neither of which was seen 
in their decellularized counterparts (Figure 3-4, B and D). When imaged by scanning electron 
microscopy (SEM), decellularized spinach leaves maintained the same pattern and density of 
vascular networks seen in native leaves (Figure 3-4, E and F) indicating that the decellularization 
process did not affect the topographical properties of the surface of the leaf. Furthermore, lignin, 
which is a major biopolymeric component of the leaf vasculature, was present before and after 
decellularization as shown by additional histological staining (Figure 3-4, G and H).  
Figure 3-3 Time-lapse of spinach leaf decellularization. (A) Leaf is dark green and opaque prior to 
decellularization at Day 0. (B) At Day 1, the leaf loses some of its dark color and begins to appear translucent. (C) By 
Day 5, the leaf is completely translucent while maintaining a light green hue. (D) After being treated and sterilized 
with sodium chlorite, the leaf loses the remainder of its color and becomes completely decellularized on Day 7.  
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Figure 3-4 Characterization of plant scaffolds before and after decellularization. Spinach leaf (A) before and (B) 
after decellularization; (C) Native and (D) decellularized leaf stained with Safranin and Fast Green. Safranin-O (red) 
stains for chromosomes and nuclei. Fast Green (bluish-green) stains for cytoplasm and cellulosic cell walls. The blue 
dark spheres are chloroplasts, which are abundant in leaves. Scale bars: 250 mm and 50 mm (insert). Scanning 
Electron Microscope image of surface topography for both (E) native and (F) decellularized spinach leaves with 
inserts at higher magnification. Scale bars: 100 mm. (G) and (H) Lignin was present before and after 
decellularization in the leaf vasculature. Lignin was stained with phloroglucinol.  Scale bars: 50 µm.   
 
Neither decellularization nor clearing solution alone was able to completely decellularize the 
leaves (Figure 3-5), indicating that both anionic and non-ionic detergents were needed for 
complete removal of plant cellular material. 
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Decellularized leaves contained significantly less DNA (9.4 ± 1.3 vs. 1,129 ± 217.3 ng DNA/mg 
tissue, Figure 3-6A) and significantly less protein when compared to native leaves (2.4 ± 0.6 vs. 
19.1 ± 1.9 µg protein/mg, Figure 3-6B). These data demonstrated that the plant decellularization 
process removed nearly all of the DNA and protein. The remaining DNA satisfied the minimal 
requirement determined to classify a tissue as decellularized (< 50 ng DNA per mg tissue) 106. The 
kinetics of protein removal demonstrated a rapid and significant decrease of protein content 
during the first 10 minutes. The protein levels decreased further during the subsequent days and 
reached their lowest concentration after 3 days of decellularization (Figure 3-6C). After 5 days of 
perfusion, there was no significant decrease difference between protein levels in different 
samples and were determined negligible.  Thus, 5 days of perfusion with the decellularization 
solution was chosen as the standard time.   
Spinach, Decellularization Solution Only (10% SDS)
Spinach, Clearing Solution Only (0.1% Triton-X-100 in 10% bleach)
A
B
100 μm
100 μm
50 μm
50 μm
Figure 3-5 Assessment of decellularization by single solutions alone. 
Neither (A) SDS nor (B) TritonX-100 solutions alone could fully decellularize 
the leaf, as indicated by histological staining.  Scale bars 100 µm. 
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For robust characterization of a tissue scaffold, it is imperative to examine the mechanical 
properties of the scaffold material, as these properties govern the ability of the tissue to function. 
When compared to native leaves, decellularized leaves displayed significantly lower ultimate 
tensile strength (p=0.00925) and strain at failure (p=0.000287) during uniaxial tensile mechanical 
analysis (Figure 3-7).  Despite the apparent loss of mechanical integrity, maximum tangent 
modulus for decellularized spinach leaves (0.3 MPa) was within the range of normal  
decellularized human cardiac tissue (0.2-0.5 MPa) 47.   
Figure 3-6 Quantification of DNA and Protein Content During Decellularization. (A) DNA content was 
quantified through a CyQuant assay (p=0.00002; n=4). (B) Total protein before and after leaf 
decellularization was quantified by Bradford assay (p=0.0000007; n=3). (C) Protein loss was quantified 
as a function of time to best determine decellularization time needed.   
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**
A B
C D
Figure 3-7 Mechanical Analysis of Decellularized Spinach Leaf.  (A) Spinach scaffolds were cut into 
dogbone shapes to localize forces to the middle of the sample.  (B) Maximum tangent modulus, (C) 
ultimate tensile strength, and (D) strain at failure were measured.    
Figure 3-8 Decellul rization of Other Plant Types. P rsley stem, pea ut airy 
root , nd Artemesia annua were all also shown to decellularize; which 
highlights th  widespread application of this method.   
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We also explored the applicability of this technique to other plant species and tissues. 
Petroselinum crispum (parsley) stems, Arachis hypogaea (peanut) hairy roots, and Artemisia 
annua leaves were also successfully decellularized (Figure 3-8) thereby suggesting widespread 
potential for using a variety of plant species and tissues for decellularization. 
 
3.3.2. Decellularized Leaf Vasculature Remains Patent After Decellularization 
A major advantage of using the decellularized leaf as a scaffold for tissue engineering is its 
innate vasculature. We thus sought to determine whether the leaf vasculature remained intact 
and patent after the decellularization process. Ponceau Red was perfused through the cannula 
of decellularized spinach leaves. The Ponceau Red perfused throughout the entirety of the leaf 
vasculature, with some minor leakage observed (Figure 3-9A). The perfusate also flowed into and 
through the smaller branches of the leaf vein (Figure 3-9B) indicating that the microvasculature 
of the leaf remained fairly intact.  
For a vascularized tissue engineered scaffold to be clinically relevant, the inner diameter of 
any mimetic vessels must allow for blood flow.  Human capillaries have vessel diameters between 
5 and 10 μm 107 that support the flow of the 6-8 μm diameter red blood cells 108.  To predict 
whether the vascular network of a decellularized leaf would support flow of such cells, leaf 
vasculature was perfused with medium containing fluorescent microspheres of various sized 
diameters. This method allows for evaluation of both the diameter and patency of any given 
vessel.  Videos were acquired at 60 frames per second to visualize the microsphere flow (Figure 
3-9C; To increase contrast, the bead was false-colored white in these videos). The medium that 
perfused through the leaf (flow through) was collected and used to calculate the percentage of 
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microspheres recovered by measuring fluorescence intensity.  While essentially all of the 1 and 
10 μm beads were recovered after perfusion, transport of larger beads became progressively 
more restricted; only 46% of the 50 μm and 10% of the 100 μm microspheres were collected 
(Figure 3-9D).  Additionally, analysis of blank fluid being perfused through the system showed 
some noise generated by autofluorescence, and the 100 μm microsphere collection was within 
this noise region.  Collection of the 1 and 10 μm microspheres was statistically greater than both 
the 100 μm microsphere collection (p=0.01 for 1 μm and 10 μm microspheres) and the blank fluid 
noise (p=0.009 for 1 μm and p=0.01 for 10 μm microspheres).  Visualization of the entrapped 
beads within plant vascular networks yielded complementary results (Figure 3-9, E and F); i.e. 
only 50 and 100 μm diameter microspheres were found to be trapped within the plant tissue.  
Taken together, these results demonstrated that the leaf vasculature supports the flow of 
particles within the size range of a red blood cell.  
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Figure 3-9 Spinach leaf vascular scaffolds retain patency and perfusion capabilities after decellularization. 
Decellularized leaf (A) before and (B) after perfusion of Ponceau Red. Fluorescent microspheres of various 
diameters (1, 10, 50, and 100 mm) and blank fluid were perfused through a decellularized leaf. Statistical 
differences were found between the percentage collected between both 1 and 10 mm and the collection of 100 mm 
and blank fluid. (* indicates p < 0.05, # indicated p < 0.01). (C) Video frames capturing microsphere location within a 
leaf vein over time, with the arrow tracking an individual microsphere. (D) Microspheres that traversed vascular 
walls were collected and their fluorescence quantified (n 1⁄4 3). (E, F) Fluorescence images of leaf vasculature 
perfused with beads. Images show 50 and 100 mm spheres retained within the vasculature. Scale Bars: 100 mm (E), 
500 mm (F).  
3.4. Discussion 
Exploring biological "orthogonality" between kingdoms provides a unique opportunity to 
interface multiple biological kingdoms, as well as to mimic biological features from other 
kingdoms.  This novel approach can be exploited in order to utilize paradigms that have evolved 
in one biological kingdom in order to provide solutions to problems that another kingdom faces, 
through a common interface. By searching for interfaces between the plant and animal systems, 
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new solutions may be effectively engineered for a wide variety of disciplines, such as regenerative 
medicine.  
For example, the major limiting factor affecting the clinical translation of tissue engineering is 
the lack of viable vascular networks in engineered tissues.  Current fabrication techniques, such 
as 3-D printing, cannot accurately and effectively create microvasculature, such as that seen in 
capillary beds.  Even as these technologies improve over time, there is concern that the time and 
resources needed to fabricate a full-thickness scaffold suitable for a clinical approach would be 
unsustainable.  With all of that in mind, we looked for inspiration from the plant kingdom to 
address this challenge.  Plant vasculature, like mammalian vasculature, supports flow of fluid and 
transport of important biomolecules. This transport is accomplished through a different 
mechanism in the plant than in mammalian vessels, but the structures are similar, especially the 
microvascular architecture.  Furthermore, cellulose which is the main component of plant cell 
walls is a well-studied polysaccharide and biomaterial.  Cellulose has been used in a wide variety 
of regenerative medicine applications, such as cartilage tissue engineering 109,110, bone tissue 
engineering 111,112, and wound healing 96,97.  For those studies, cellulose was usually derived from 
bacteria in order to control the fiber geometries and chemical properties.  More recently, 
however, cellulose was isolated from decellularized apple hypanthium tissue and was used to 
support cellular attachment and proliferation in a 3D scaffold 98.  That material was found to be 
biocompatible when implanted subcutaneously in vivo 99 . Coupling the similarities seen between 
mammalian and plant vasculature with the apparent biocompatibility and regenerative 
properties of the plant tissue, I sought to cross kingdoms and study whether decellularized plants 
could serve as a perfusable scaffold for tissue engineering.  
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Perfusion decellularization techniques were successfully adapted for use with plant tissues. 
Multiple plant types, all with different hierarchical geometries, were able to be decellularized 
including, spinach and A. annua leaves, parsley stems, and peanut hairy roots.  Spinach was 
chosen as the model leaf through the rest of the study due to its ready availability and its high 
vascular density.  Other plant species were chosen to highlight the widespread potential of the 
technique.  Decellularization was verified through histological staining, as well as quantification 
of DNA and protein content.  Histological staining showed the loss of nucleic materials from the 
plant tissue while maintaining both the structure and the differing native composition of the 
tissue, as noted when lignin was stained before and after decellularization.  The vasculature 
remained patent after decellularization, as demonstrated by microsphere perfusion.  Using the 
microspheres, the vessel diameter of perfusable vasculature within the spinach leaves could be 
approximated, which was found to support flow of particles the size of human blood cells.   
By utilizing the natural architecture of plant tissue, we could effectively engineer a multiplicity 
of mammalian tissue depending upon the plant template. Matching native mechanical properties 
have shown to be a crucial aspect when engineering tissue.  Since a wide variety of anatomical 
structures exist within the plant kingdom 93, finding structures with mechanical properties 
emulating those needed for a human tissue engineered scaffold, even after decellularization, 
should be feasible.   This is advantageous due to the diversity in architecture of different plants 
and their structures, in the hopes that they may be able to recapitulate some of the complexity 
seen within mammalian tissues and thus lead to future clinical applications. Further optimization 
and investigation would be necessary to understand which plant tissue would be appropriate for 
different tissue engineering applications. A highly vascularized plant tissue, such as the spinach 
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leaf, might be better suited for a highly vascularized tissue, like cardiac tissue, whereas the 
cylindrical hollow structure of the stem of Impatiens capensis might better suit an arterial graft. 
Conversely, the vascular columns of wood might be useful in bone engineering due to their 
relative strength and geometries.  
Plant based tissue engineered solutions need to be further elucidated and explored before 
translation into medical applications.  The decellularization solutions used in this study contain 
high concentrations of detergents that were chosen after an initial investigation that accounted 
for the time needed for decellularization.  Residual detergents present after decellularization 
have been shown to affect cellular viability 113 and thus could become problematic with use of 
high detergent concentrations.  There were at best only limited viability issues in this study, 
nevertheless, this and other potential concerns should be addressed with further refinement of 
the decellularization techniques.   
Further exploration into the residual composition of plant cell walls would also be important 
because ECM composition has an effect on cellular functionalities 35,38,44.  The plant cell wall 
contains cellulose microfibrils that are crosslinked with hemicellulose and pectins 95 further 
interwoven and strengthened with extensin proteins and lignins 56.  Understanding the effect 
that the decellularization process has on the composition of the plant cell wall is important.  This 
is also crucial to understanding whether the lignified cell walls of the xylem are also affected; 
lignin is crucial to the function of xylem in carrying fluid and allows the vasculature to withstand 
pressure gradients of upwards of 1 MPa 70.  Considering that the decellularization process has 
been shown to be highly effective in retaining protein composition in mammalian organ 
decellularization 16,114, extensin protein found within the cell wall should be minimally disturbed 
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by the decellularization process.  Detergent based decellularization, specifically using SDS and 
Triton-X-100, showed varying degrees in retained glycosaminoglycans (GAGs) found within the 
mammalian ECM 91,106.  This is an important consideration because the GAGs found within the 
mammalian ECM are the molecular component most similar to the predominantly 
polysaccharide-based plant cell wall and lignified vascular structures.   Whereas the plant cell wall 
polysaccharide network is highly crosslinked with hemicellulose, GAGs contain long linear 
polysaccharides that are unbranched 115.  Because of this hemicellulose crosslinking, the plant 
cell wall should survive the decellularization process to a greater degree than the GAGs in the 
human ECM.  Although extension is expected to remain, the remaining polysaccharide structures 
within the decellularized leaf should predominately be cellulose, hemicellulose, pectin, and 
lignin, all of which have been shown to be biocompatible 100,101,109,116.  Based upon this 
hypothesis, I am able to predict the remaining biochemical structures within the leaf after 
decellularization occurs.  Further testing to remove or degrade specific compounds also would 
be beneficial from a regulatory standpoint as well as adoption of controlled growth 
environments.    
Currently, it is as yet unclear how the plant vasculature would be integrated into the native 
human vasculature and whether there would be an immune response.  Decellularized cellulose 
is biocompatible and biodegradable 85, but it is unclear the in vivo response to whole 
decellularized plant tissue.  Future investigation will need be made into the native immune 
response to more complex compositional plant scaffolds.  One final aspect of our plant scaffolds 
that need to be further developed in order to improve the medical translation, is the question 
about out flow in the plant vasculature.  Plant vasculature does not have a separate outflow 
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system, such as the venous system.  A potential tissue engineered graft based upon the plant 
scaffolds could use multiple leaves where some act as arterial support and some act as venous 
return.  
The use of plants as the foundation for tissue engineering scaffolds has many benefits outside 
their innate vascular networks. There is a current push in technology development to become 
more “green” and environmentally friendly due to concerns over anthropogenic climate change 
and dwindling supplies of natural resources. Tissue engineering scaffolds are typically produced 
either from animal-derived or synthetic biomaterials, both of which have a large cost and large 
environmental impact. Animal-derived biomaterials used extensively as scaffold materials for 
tissue engineering include native ECM proteins such as collagen I or fibronectin and whole animal 
tissues and organs.  Annually, 115 million animals 100 are estimated to be used in research.  Due 
to this large number, a lot of energy is necessary for the upkeep and feeding of such animals as 
well as to dispose of the large amount of waste that is generated.  Along with this environmental 
impact, animal research also has a plethora of ethical considerations, which could be alleviated 
by forgoing animal models in favor of more biologically relevant in vitro human tissue models. 
Synthetic biomaterials are commonly generated from chemical processing of nonrenewable 
resources, such as petroleum, and their production often yields toxic byproducts.  An example of 
a biomaterial negatively affecting the environment can be found from polytetrafluoroethylene 
(Teflon), a widely used synthetic biomaterial in cardiovascular applications such as tissue 
engineered vascular grafts 101. During high temperature degradation of Teflon, large amounts of 
ozone-depleting gases such as trifluroacetic acid and chlorodifluoroacetate 102 are generated. 
While this is not an issue in the body when Teflon is used as a graft, manufacturing byproducts 
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are a major concern for the production and storage of the material. Recently, more eco-friendly 
sources for biomaterial production have been explored, such as syntheses from vegetable oils 103 
and polymerization of natural bio-polymers like cellulose 104. By exploiting the benign chemistry 
of plant tissue scaffolds, we could address the many limitations and high costs of synthetic, 
complex composite materials.  Furthermore, there are many issues in the mass production of 
materials that could be overcome from using plant tissue. Plants can be easily grown using good 
agricultural practices (GAP) and under controlled environments. By combining environmentally 
friendly plant tissue with perfusion-based decellularization, we have shown that there can be a 
sustainable solution for pre-vascularized tissue engineering scaffolds.   
In this chapter, I demonstrated the feasibility of using decellularized plants to provide 
sustainably produced scaffolding for tissue engineering.  By applying paradigms from one 
kingdom to another, I devised a method for addressing the limitation of perfusion that exists in 
traditional approaches to tissue engineering and regenerative medicine. My investigation 
provided promising results, but many questions still remain before decellularized plants become 
clinically relevant. The development of decellularized plants for scaffolding opens up the 
potential for a new branch of science that investigates the mimicry between kingdoms, e.g. 
between plant and animal.  Although further investigation is needed to understand future 
applications of this new technology, I believe it has the potential to develop into a “green” 
solution pertinent to a myriad of regenerative medicine applications. 
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4. Objective 1b: Recellularization of Leaf Scaffold with Human Cells 
Sections of the introduction (starting with section 4.1), methods, results, and discussion 
presented in this objective have previously been published in Biomaterials 70, Vol. 125 pgs. 13-
22, Joshua R. Gershlak, Sarah Hernandez, Gianluca Fontana, Luke R. Perreault, Katrina J. Hansen, 
Sara A. Larson, Bernard Y.K. Binder, David M. Dolivo, Tianhong Yang, Tanja Dominko, Marsha W. 
Rolle, Pamela J. Weathers, Fabricio Medina-Bolivar, Carole L. Cramer, William L. Murphy, Glenn 
R. Gaudette, “Crossing Kingdoms: Using Decellularized plants as perfusable tissue engineering 
scaffolds”, Copyright 2017, with permission from Elsevier (See Appendix A) 
4.1. Introduction 
In objective 1a, the feasibility of transforming a leaf into a tissue engineering scaffold 
through decellularization was demonstrated. The decellularized leaf was left as a “blank” 
scaffolding on which new cells could be grown yielding a cross-kingdom tissue.  To engineer new 
tissue using the leaf scaffold, human cells need to be seeded onto its surface.  Combining cells 
and scaffolds are the main foundation in which tissue engineering operates 23.  Previous efforts 
recellularizing a decellularized scaffold have shown the efficacy of such an approach.  For 
example, decellularized human heart tissue 47, lung tissue 77, and skin tissue 105 have been 
successfully recellularized with the respective cell type unique to the tissue.  By recellularizing 
the decellularized tissue with new cells, this newly engineered tissue could function and integrate 
as a potential implant.  The advances in induced pluripotent stem cell (iPS) technology open up 
the possibility of engineering a patient-specific implant.  iPS cells 29 retain the patient’s genetic 
makeup, opening up the possibility of generating tissue that would not illicit an immune 
response.  
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To further elucidate the feasibility of using a decellularized leaf as a scaffold for tissue 
engineering, the leaf must be recellularized with proper human cells.  There are a variety of cells 
within each tissue in vivo, so many different cell types were tested in relevant seeding locations 
on decellularized leaves.  For example, endothelial cells are the cell type that line the inner 
portions of blood vessels 106.  Endothelial cells are important as they act as a barrier to limit the 
formation of blood clots.  Therefore, it is important to investigate whether endothelial cells can 
be seeded onto the lumen wall of the leaf vasculature.  Furthermore, cells provide the function 
within a tissue so it is important to study whether cellular functionality is retained when seeded 
onto the leaf scaffold.  For example, a cardiomyocyte has a mechanical contraction that is timed 
by an electrical signal. Cardiomyocytes work together to propagate this signal into larger gross 
cardiac function.  In order for a decellularized leaf to be a suitable scaffold to be used to engineer 
a cardiac patch, cardiomyocyte functionality needs to be retained when seeded onto the leaf 
over long periods of time.   
The aim of objective 1b is to investigate whether human cells can be used to recellularize 
the decellularized leaf scaffold.  Cellular attachment to the surface of the leaf scaffold was first 
investigated through recellularization with human mesenchymal stem cells (hMSCs).  Human 
umbilical vein endothelial cells (HUVECs) were seeded to the inner portions of the leaf 
vasculature and their viability was measured.  Finally, human pluripotent stem cell derived 
cardiomyocytes (hPS-CMs) were seeded onto the surface of the leaf and their contractile and 
electrical function was measured over time.   
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4.2. Materials and Methods 
4.2.1. Human Cell Culture and Seeding of Leaf Scaffold 
For only HUVEC and hPS-CM attachment experiments, leaf scaffold stems were coated 
with fibronectin. For HUVEC seeding, fibronectin (from bovine plasma, Sigma Aldrich) was 
injected through the cannula of the leaf scaffolds at a concentration of 10 µg/mL and allowed to 
coat for 24 hours in a standard incubator. Prior to HUVEC seeding, leaves were injected with 
sterile PBS to wash away any non-coated fibronectin from the leaf.  For hPS-CM seeding, 
fibronectin was applied to the surface of the leaf at the same concentration and incubation time.  
Prior to hPS-CM seeding, leaves were washed in sterile PBS.   
HUVECs (CRL-1730, American Type Culture Collection (ATCC), Manassas, Virginia) were 
maintained using an Endothelial Cell Growth Kit –VEGF (ATCC) according to the manufacturer’s 
instructions.  HUVECs were fluorescently labeled through uptake of acetylated low-density 
lipoprotein (Dil-Ac-LDL) (Thermo Fisher).  Labeling occurred by incubating HUVECs for 4 hours at 
37°C in medium containing 10 μL/mL Dil-Ac-LDL.  A 500 μL aliquot containing 375,000 labeled 
HUVECs was injected into the cannulated stem of a decellularized spinach leaf.  HUVECs were 
allowed 24 hours for adherence and were then subsequently washed with PBS.  Adherent 
HUVECs were visualized using a Rhodamine filter on a SP5 Point Scanning Confocal (Leica 
Microsystems).  
P4-P8 hMSCs (Lonza, Walkersville, Maryland) were maintained in MSCGM growth 
medium (Lonza) until they reached 70-80% confluence.  The hMSCs were treated for 24 hours 
with MSCGM medium supplemented with 8.2 nM QDot 655 ITK carboxyl Quantum Dots (Thermo 
Fisher). After the 24-hour treatment, the quantum dot-loaded hMSCs were gently washed with 
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PBS and maintained in growth medium until use.  Loaded hMSCs were seeded on the surface of 
the decellularized spinach leaves for 24 hours to allow for attachment.  Adherent hMSCs were 
visualized using QDot 655 filter settings on the SP5 Point Scanning Confocal. 
  Embryonic stem cell derived cardiomyocytes (hPS-CMs) (provided by Dr. Michael 
LaFlamme, University of Toronto, Toronto, Ontario) 107 were maintained in RPMI medium 
containing 2% B27, 1% Pen/Strep, and 1% L-Glutamine (Thermo Fisher). The hPS-CMs were 
thawed and immediately seeded onto the surface of spinach leaves.  Cells were given 24 hours 
of seeding before medium was replaced and were subsequently replaced every 48 hours for the 
duration of 21 days.   
4.2.2. Low Density Lipoprotein Uptake Assay 
Viability of HUVECs after recellularization was measured using a LDL uptake assay.  
Unlabeled HUVECs were injected into the cannulated stem as previously described; 24 hours 
after seeding, HUVEC seeded stems and unseeded stems were moved into medium containing 
10 μL/mL Dil-Ac-LDL for 4 hours at 37°C.  Images of stems were acquired prior to LDL incubation, 
24 hours after the end of incubation, and 48 hours after the end of incubation using a Rhodamine 
filter on a DMIL inverted microscope (Leica Microsystems).   
4.2.3. hPS-CM Contraction and Fluorescent Analysis 
A HiSpec4 high speed camera (FastTec, San Diego, CA) was attached to a DMIL inverted 
microscope (Leica Microsystems, Buffalo Grove, IL) and videos of contracting hPS-CM clusters 
were taken at 60 frames per second.  A speckle-based tracking algorithm, high density mapping 
108, was applied to the contraction videos.  The algorithm measures subpixel level displacement 
of a random light intensity object.  From these subpixel displacements, the contractile strain can 
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be calculated over a region of interest.  Fluorescent videos were recorded at 71 frames per 
second and were analyzed through a custom MATLAB code, which measured the relative change 
in intensity overtime.  
4.2.4. Statistical Analysis 
 All results are presented as mean ± standard error.  Statistical comparisons were made 
through the use of a one-way ANOVA with a Tukey’s post-hoc test.  The statistical tests were 
performed within SigmaPlot (Systat Software Inc., San Jose, CA).  Statistical significance was 
defined as p<0.05.   
4.3. Results 
4.3.1. hMSCs Readily Adhere to the Surface of Decellularized Leaf Scaffolds 
Human mesenchymal stem cells (hMSC) were used for seeding onto the outside surface 
of a decellularized leaf (Figure 4-1A). To overcome autofluorescence generated within the plant 
tissue, mostly seen in the shorter wavelengths of the visible spectrum 109, hMSCs were labeled 
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Figure 4-1 hMSCs can be used to recellularize different plant scaffolds. The image of the leaf in the upper left corner of the 
image and the stem in the lower left corner gives the relative position from which images A, B, and C are derived. (A) hMSCs 
were labeled with quantum dots and seeded onto the surface of a decellularized spinach leaf. Scale bars: 250 μm for main 
image, and 50 μm for insert. (B, C) Quantum dot-loaded hMSCs were seeded onto the outside surface of a decellularized parsley 
stem.  The hMSCs were seeded via a rotation bioreactor for 24 hours and formed monolayers along the outside of the stem.  
Scale Bars 250 μm and 50 μm.  
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with quantum dots prior to the seeding, as previously described 17. The hMSCs readily adhered 
to the entire surface of the leaf 24 hours after seeding.  Cell attachment was also observed on  
the outside surface of decellularized parsley stems (Figure 4-1, B and C), indicating that three-
dimensional plant surfaces could be used as scaffolds, from a variety of plant species or macro-
scale structures.  This allows for larger and more intricate tissue to be formed on these larger and 
more three-dimensional scaffolds. 
 
4.3.2. HUVECs Can Attach to the Inner Walls of the Leaf Vasculature and Remain Viable 
To endothelialize the leaf vasculature, human umbilical vein endothelial cells (HUVECs) 
were seeded into the lumen of the leaf scaffold vasculature. Leaf vasculature was first coated 
with fibronectin to promote cellular attachment to the lignified walls of the leaf vasculature.  
HUVECs labeled with acetylated low-density lipoprotein (Dil-Ac-LDL) were delivered through the 
cannula. After 24 hours, HUVEC attachment to the inner surface of leaf vasculature was 
confirmed with confocal microscopy (Figure 4-2A). HUVEC viability after recellularization was 
evaluated using a LDL uptake assay.  Unlabeled HUVECs were injected through the cannula and 
allowed 24 hours to attach to the inner surfaces of the leaf’s petiole.  Seeded and unseeded 
petioles were incubated in Dil-Ac-LDL medium and fluorescent signal was assessed 24 and 48 
hours after incubation.  At both time points, there was a positive fluorescent signal present for 
seeded petioles and no signal for unseeded petioles, indicating that the HUVECs remained viable 
after recellularization (Figure 4-2, B-G). Although HUVECs attached and remained viable after 
recellularization, improvements in functionalizing the leaf vasculature and use of perfusion 
bioreactors will be needed before complete endothelialization of the entire leaf can occur.   
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Figure 4-2 HUVECs can adhere to the inner portions of the leaf vein and remain viable. The image of the leaf in 
the upper left corner of the image gives the relative position from which image A are derived. (A) Dil-Ac-LDL-labeled 
human umbilical vein endothelial cells (HUVECs) were seeded within a vein of a decellularized spinach leaf by 
perfusion. Scale bar: 250 μm. (B-G) Unlabeled HUVECs were seeded in petioles for 24 hours prior to being incubated 
in medium containing Dil-Ac-LDL. (B, C) Images of seeded petioles and unseeded petioles prior to incubation in LDL 
showed no presence of fluorescent signal.  At (D, E) 24 and (F, G) 48 hours after the incubation, seeded petioles 
exhibited fluorescent signal whereas unseeded petioles remained void of signal after the incubation.  Fluorescent 
signal indicates that there was uptake of the labeled LDL demonstrating that the HUVECs seeded in the petioles 
remain viable after recellularization and that the signal is not a measure of auto fluorescence.  Scale bars 250 μm. 
4.3.3. hPS-CMs Function on the Surface of Decellularized Leaf Scaffolds for 21 Days 
 To investigate whether cells could adhere and maintain functionality, human pluripotent 
stem cell derived cardiomyocytes (hPS-CM) were seeded onto the surface of leaf scaffolds. hPS-
CMs attached to the surface and formed cell clusters (Figure 4-3A) within three days of seeding.  
Five days after the initial seeding, hPS-CMs began to spontaneously contract while seeded on the 
leaf scaffold while control hPS-CM seeded on tissue culture plastic (TCPS) began contraction on 
Day 3.   
Contractile analysis (Figure 4-3B), based on sub-pixel level change in the random light 
intensity of the hPS-CM cluster 125, demonstrated approximately 1% contractile strain at a 
contractile rate of 0.8 Hz in the myocytes seeded on leaf scaffolds. Spatial strain maps revealed 
contraction present throughout the entire hPS-CM cluster whereas the surface of the scaffold 
displayed little to no strain signal (Figure 4-3C). Contractile strain increased from Day 5 to Day 
10.  At Day 10, the contraction peaked and plateaued for 7 days, until Day 17.  There was a 
decrease in contraction from Day 17 to Day 21 (Figure 4-3D).  On Day 21 (Figure 4-3E), hPS-CM 
contraction decreased to 0.6% at a contractile rate of 0.5 Hz. The control hPS-CM clusters seeded 
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onto TCPS had a higher magnitude of contractile strain on all days of analysis and these measures 
statistically increased on days 7 (p=0.04) and 17 (p=0.04).  There was no statistical difference 
between the hPS-CM clusters on the leaf scaffolds and TCPS control for all other time points.  
Contractile analysis on day 10 (the peak value for the hPS-CMs seeded onto the leaf scaffold) 
yielded similar strain values for the cells seeded on the TCPS with contractile strains near 1.0% 
with a frequency of 0.37 Hz. 
Due to the decrease in contraction at Day 21, we investigated whether the calcium 
handling capability of these cells was maintained using GCaMP3 reported transfected hPS-CM 
cells 124, providing a fluorescent signal corresponding to the intracellular calcium signal. 
Fluorescence videos detected GCaMP3 fluorescence (Figure 4-3F), corresponding to calcium flux 
during contraction.  On Day 21, the change in fluorescent signal intensity in hPS-CM clusters was 
measured over several contractile cycles and compared to the signal from the surface of the leaf 
(Figure 4-3, G and H). The calcium signal originating from the hPS-CM cluster was more intense 
than the signal from the leaf’s surface, suggesting that the hPS-CMs retained calcium-handling 
capabilities when seeded onto the leaf scaffolds and was not an artifact of autofluorescence. 
Furthermore, the calcium signal also followed a similar frequency, 0.5 Hz, as seen with the 
contraction at Day 21 suggested that the two were interrelated and the cardiomyocytes were 
functioning normally on the leaf.  The calcium signal from the hPS-CMs that were seeded on the 
leaf scaffolds were also compared to hPS-CMs that were seeded on TCPS at day 21.  Calcium 
signals had similar fluorescent intensities with the hPS-CMs having a higher calcium handling 
frequency.  This difference in frequency is probably due to the difference in the size of the 
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different clusters analyzed as the clusters of hPS-CMs formed on the TCPS were larger than the 
clusters formed on the leaf scaffolds.   
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Figure 4-3 Human pluripotent stem cell-derived cardiomyocytes (hPS-CMs) adhere and function on the surface of 
a leaf scaffold for 21 days. (A) hPS-CMs adhere and form cell clusters. Scale bar: 50 μm. (B) Contractile strain of hPS-
CMs was quantified through subpixel level displacement of the cell clusters.  Contraction was graphed over the time 
of recorded videos and, on Day 10, the cluster was found to contract at nearly 1% strain. (C) Contractile strain can 
be visualized through a heatmap. (D) Contractile strain was measured over 21 days for a cluster of cells. Contractile 
strain was compared to a control of hPS-CMs cultured on tissue culture plastic (TCPS). Strains calculated on days 7 
and 17 were found to be statistically greater on cells seeded on the TCPS as opposed to cells seeded on the leaf 
scaffolds (* indicates p<0.05).  There were no statistical differences calculated in any of the other time points.  (E) 
Day 21 strain values showing the lowered contractile strain magnitude. (F) hPS-CMs were modified with a GCaMP3 
reporter 124, providing a fluorescent signal corresponding to the intracellular flux of calcium ions. (G, H) The relative 
change of fluorescent signal was visualized and compared relative to the leaf surface on Day 21.   
 
4.4. Discussion 
 Traditionally, tissue engineering aims to bring together a biomaterial scaffold with cells 
that act concurrently to create a functional tissue.  In objective 1a, I demonstrated that whole 
organ perfusion decellularized could be adapted to successfully decellularize plant tissue such a 
spinach leaf.  The decellularized leaf was found void of any cellular material and its vasculature 
remained patent and able to support the transport of microparticles on the size of red blood cells 
(»10µm).  This blank structure could possibly act as a pre-vascularized scaffold for tissue 
engineering.  To further explore this, it was imperative to recellularize the leaf with a variety of 
human cells.  Cells are the functional aspect of the tissue, usually providing the intended 
physiological activities of the engineered tissues.  For instance, engineered cardiac tissue would 
need to be comprised mainly of cardiomyocytes 127,128.  The cardiomyocytes mechanically 
contract and form gap junctions between cells in order to pass the proper electrical signals 
throughout the tissue.  Without these proper cellular activities, any engineered cardiac tissue 
would not function in a physiologically relevant manner 13,129,130.   
Integration of a tissue-engineered, decellularized leaf construct into a potential host 
would be mediated with cells adherent upon the surface of the leaf.  One such important cell 
type is endothelial cells.  Endothelial cells line the inner portions of the blood vessels of the body 
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and thereby are the major cell type that interacts with blood in the body 131.  Their main function 
is regulating formation of blood clots 132.  Thus, it is important to consider when engineering a 
vascular tissue how best to integrate endothelial cells.  Previous investigations have successfully 
engineered endothelialized tissues through layer-by-layer biofabrication 133, RGD 
functionalization 134, or electrospun collagen nanofibers 135. Furthermore, decellularized tissues 
have been successfully re-endothelialized through perfusion of endothelial cells into the vacant 
vascular structures 16,46,122 .  Because the decellularized leaf scaffold is void of any cellular 
materials and the inner portion of the leaf vasculature is comprised of foreign proteins to the 
body, endothelialization of the leaf vasculature is paramount for increasing the likelihood of 
successful integration into the body.  
In this objective, I investigated whether the decellularized leaf scaffold developed in 
objective 1a could be recellularized with different types of human cells.  Three different human 
cells were studied as examples of the widespread potential of the leaf scaffold.  These cells were 
mesenchymal stem cells (MSCs), human umbilical vein endothelial cells (HUVECs), and human 
pluripotent stem cell derived cardiomyocytes (hPS-CMs).  MSCs were shown to attach readily to 
the surface of the leaf and align and adhere to the outer portions of the cylindrical parsley stem.  
MSCs are an important cell type to investigate as they could be further differentiated into a wide 
variety of cell phenotypes including osteoblasts, chondrocytes, skeletal muscle cells, and neurons 
136-138.  Next, HUVECs were used due to their importance as the vascular liner. HUVECs were 
injected, became adherent to the inner lumen layer of the leaf vasculature.  Two days after 
seeding, HUVECs were shown to be functional through a lipoprotein uptake assay.  The final cell 
type used were hPS-CMs. These cardiac muscle cells were derived from pluripotent stem cells.  
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The hPS-CMs attached and functionally contracted on the surface of the leaf scaffold for 21 days, 
and electrical signaling properties of the hPS-CMs were conserved at least 21 days after seeding.    
 
5. Objective 2a: Modification of the Decellularization Process to Limit Cytotoxicity 
5.1. Introduction 
 The process of decellularization is a relatively harsh technique that aims to remove all of 
the cellular material of a tissue.  Decellularization can be performed with different detergents, 
acids and bases, hypotonic solutions, enzymes, and by physical means 106.  The most common 
methods include use of detergents due to their effectiveness, ease of use, availability, and cost.  
Different detergents can be used in combination to maximize the decellularization.  For instance, 
sodium dodecyl sulfate (SDS) and TritonX-100 are usually used together.  SDS is an anionic 
detergent that has been shown to be highly effective in removing nuclei from dense tissues 139 
whereas TritonX-100 is a nonionic surfactant that is effective in dilapidation and removal of other 
detergents 140.  Thereby SDS and TritonX-100 are often used serially when decellularizing tissue 
16,47.  The timing of treatment and the concentrations of the solutions can affect the final 
decellularized tissue.  Higher concentration solutions can lessen the amount of time necessary 
for decellularization, but there is concern that residual detergents could cause cytotoxic effects 
141,142.  Likewise, lower concentration solutions take longer to fully decellularize the tissue but 
result in the tissue being in contact with these cytotoxic detergents for longer than necessary.  
Because of this, modification of decellularization protocols is important to perform to maximize 
decellularization in the shortest amount of time while using the lowest possible detergent 
concentrations 143-145.  Before a leaf scaffold can be used in vivo, the cytotoxicity needs to be both 
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studied and eliminated.  In objective 2a, I aim to modify the leaf decellularization process to limit 
any potential cytotoxic affects.   Furthermore, I aim to investigate the cytotoxicity of leaves that 
underwent both the original decellularization protocol and the modified protocol.  I hypothesize 
that residual SDS in the original protocol will be cytotoxic whereas the lowered SDS levels in the 
modified decellularized leaf will be benign.   
5.2. Materials and Methods 
5.2.1. Modification of Decellularization Process 
 Spinach leaves were acquired from a local market.  Their petioles were cannulated as 
described in objective 1a.  Prior to the perfusion of the different detergent solutions, the leaves 
were treated to remove their cuticles.  Leaf cuticles were removed through three one minute 
long serial washes of hexanes (98%, Mixed Isomers, Alfa Aesar, Haverhill, MA) and 1x PBS.  1% 
Sodium dodecyl sulfate in deionized water was perfused through the leaf for 1 day followed by 1 
day perfusion of 0.1% TritonX-100 in 10% bleach solution and followed by 1 day perfusion of 
deionized water.  After decellularization was complete, some leaves were washed in 10 mM, pH 
9.0 tris-HCl buffer (Sigma Aldrich, Saint Louis, MO) for 12 hours.  Some of the leaves were frozen 
overnight prior being lyophilized for 24 hours.  Lyophilized leaves were rehydrated in the same 
tris buffer solution for 3 hours prior to two washes with 1x PBS.  Leaves were further sterilized 
with UV light exposure for 20 minutes.   
5.2.2. DNA Quantification  
 Leaves were processed using either the original decellularization process, as described in 
objective 1a, or the newer modified protocol.  DNA was extracted and measured in native and 
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both types decellularized leaves as described in objective 1a to measure whether the modified 
protocol decellularizes the tissue to the same extent as the original protocol.   
5.2.3. Fibroblast and Mesenchymal Stem Cell Culture  
 P5-P12 Human dermal fibroblasts (CRL-2352, American Type Culture Collection, 
Manassas, VA) were cultured in fibroblast maintenance media (Isocove’s Modified Dulbelcco’s 
Medium supplemented with 10% fetal bovine serum, 2% glutamax, and 1% pen-strep), as 
previously described 146.  When fibroblasts were ready for use in the cytotoxicity assays, they 
were plated in 24-well plates at a seeding density of 25,000 cells/cm2 for 12 hours prior to 
initiation of assays.  Plating medium was removed and replaced with 1 mL of fibroblast media.  
Equal weights of either the original decellularized leaves or the modified decellularized leaves 
were cut up and placed in the media of different respective wells.  A control was established 
where no leaves was placed in the respective wells. The cells were cultured in these different 
conditions for up to 7 days for use in the different assays described in 5.2.5 and 5.2.6.   
5.2.4. Live/Dead Assay 
 The different cells were incubated in the different material supplemented media for 24 
hours.  After 24 hours, a live/dead cell viability assay (L-3224, Thermo Fisher, Waltham, MA) was 
run.  Dead control wells were treated with ethanol for 30 minutes prior to staining of wells.  Cells 
were incubated in 8	µM ethidium homodimer and 4 µM calcein AM in DMEM for 30 minutes.  
Cell nuclei were counterstained with Hoechst for 5 minutes prior to fixation in 4% 
paraformaldehyde.  Ethidium homodimer stains a dead nucleus red, calcein AM stains a live cell’s 
cytoplasm green, and the Hoechst counterstain stains the nucleus blue.  Fluorescent images were 
acquired on a DMIL inverted microscope (Leica Microsystems, Buffalo Grove, IL).   
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5.2.5. MTT Metabolic Activity Assay 
The metabolic activity of the cells cultured for the different conditions were measured 6 
hrs, 24 hrs, 3 days, and 7 days after the medium was supplemented with the different types of 
decellularized leaves.  The metabolic activity is measured using a MTT assay 147.  A stock 10 mg/mL 
solution of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide), M6494, Thermo 
Fisher) in PBS was made.  0.5 mL of the MTT stock solution was added to 4.5 mL of media and 
sterile filtered.  This working solution was added to each of the wells of cells at the appropriate 
time points and allowed to incubate for 2 hours at 37°C.  After incubation, the unreacted solution 
was aspirated to waste.  The activated MTT was solubilized in dimethyl sulfoxide for 10 minutes.  
The solubilized MTT was loaded onto a 96-well plate and its absorbance was read on a Molecular 
Devices SpectraMax250 plate reader at 540 nm with a premix for 5 seconds.  The metabolic 
activity was measured over time.  Metabolic activity of the different conditions was compared to 
a control where there was no supplementation into the media of the well.   
5.2.6. SDS Quantification  
 Decellularized leaves from either the original or the modified decellularization protocols 
were put in 1.5 mL centrifuge tubes that were then dropped into a liquid nitrogen bath and 
ground with a pestle. Fragments were suspended in 0.5 mL of diH20 and further processed by 
pulling through a 25-gauge syringe needle and by sonication with 5 pulses performed 3 times to 
reduce leaf fragment size.  Four samples from each leaf were taken and analyzed by treatment 
with a Stains-All dye reagent (1-Ethyl-2-[3-(1-ethylnaphtho[1,2-d]thiazolin-2-ylidene)-2-
methylpropenyl]naphtho[1,2-d]thiazoliumbromide,3,3ʹ-Diethyl-9-methyl-4,5,4ʹ,5ʹ-
dibenzothiacarbocyanine, E9379, Sigma Aldrich)  148.  Samples taken from the 10x SDS 
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decellularization were diluted 5x in diH20.  The samples were quantified using a standard curve 
of known SDS amounts ranging from 0-2000 µg.  Samples were read on a Molecular Devices 
SpectraMax250 plate reader at absorbance of 438 nm with a premix for 5 seconds.   
5.2.7. Statistical Analysis 
All results are presented as mean ± standard error.  Statistical comparisons were made 
through the use of either a t-test or a one-way ANOVA with a Tukey’s post-hoc test.  The statistical 
tests were performed within SigmaPlot (Systat Software Inc., San Jose, CA).  Statistical 
significance was determined to be p<0.05.  
5.3. Results 
5.3.1. Leaf Decellularization Can Be Successfully Modified with Lower Concentration 
Detergents in Less Time  
 
The modified decellularization protocol decellularized the spinach tissue to the same degree 
as the original protocol.   The modified protocol resulted in a lyophilized decellularized leaf 5 days 
from the start whereas the original protocol took 9 days just to decellularize the leaf (
Figure 5-1 Workflow Diagrams of the Original and the Optimized Decellularization Protocols. 
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Figure 
5-1).  This was verified through both DNA analysis and through qualitative measures.  DNA 
analysis showed that both the original decellularization and optimized decellularized were fully 
decellularized and had significantly (p<0.05) lower amounts of DNA per milligram of tissue when 
compared to non-decellularized spinach leaves (Figure 5-2A).  Qualitative measures showed that 
prior to the lyophilization steps both protocols left similarly transparent leaves (Figure 5-2, B and 
C).   
 
 
 
Figure 5-2 Comparison of Decellularized Leaves from the Two Processes. (A) DNA analysis showed that both the 
1x and 10x decellularization protocols yielded similar levels of nanograms of DNA per milligram of tissue.  Both 
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were found to be significantly lower than the DNA content of a native spinach leaf.  Qualitative measures of leaves 
decellularized via the (B) 10x SDS decellularization and the (C) 1x SDS decellularization yielded no differences 
between the two processes.   
 
The newer protocol results in lyophilized leaf scaffolds (Figure 5-3A).  Lyophilization allows for 
better long-term storage as the tissue should not degrade once it has been freeze-dried.  Leaf 
scaffolds, as described in objective 1a, addresses the major problem limiting the clinical 
translation of tissue engineered grafts, the lack of a viable vascular network.  Because of the extra 
processing performed on the leaf scaffolds as a part of lyophilization, it was important to 
investigate the properties of the leaf vasculature after rehydration from lyophilization.  
Lyophilized leaves can be easily rehydrated and retain the same properties as leaves prior to 
lyophilization (Figure 5-3B).  Red dye perfusion through the rehydrated leaves showed that the 
vasculature within the leaf remains patent after the processing (Figure 5-3C).   
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Figure 5-3 Lyophilized Decellularized Leaves are able to be Rehydrated and its Vasculature Remains Patent. (A,B) 
Decellularized leaves after lyophilization can be rehydrated to reform its original properties.  (C) Red dye perfusion 
through a rehydrated lyophilized leaf shows that the vasculature remains patent after processing and 
lyophilization.  
5.3.2. Optimized decellularization process yields limited cytotoxic affects 
Optimization of the decellularization process aimed to not only shorten the amount of time 
necessary to perform the process but also to limit the amount of SDS used.  Lower amounts of 
SDS at shorter times should lessen any cytotoxic affects.  To measure cytotoxicity, fibroblasts 
were cultured in standard polystyrene tissue culture wells.  Equal amounts of leaves were diced 
and added into the medium in which the fibroblasts were being cultured in.  The leaves were left 
floating in the medium to measure whether there would be cytotoxic agents that would leach 
out from the leaf (Figure 5-4A).   
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Figure 5-4 Measurement of Decellularized Leaf Cytotoxicity Through a Fibroblast Live/Dead Assay. (A) Fibroblasts 
were cultured in the bottom of a culture well. Pieces of the different treated decellularized leaves were introduced 
into the medium of the well plate and cytotoxicity was measured 24 hours later.  (B) There was no visible 
cytotoxicity seen when no leaf was implanted in the medium.  (C) When leaves that had been decellularized with 
the original 10% SDS decellularization process, there was widespread cell death.  (D) There was no apparent toxicity 
of leaves from the modified 1% SDS process.  These cells appeared to be normally growing and had a phenotype 
similar to the no leaf condition.   
A live-dead assay was run after 24 hours of fibroblasts being cultured with the leaves floating 
in their media.  There were equal weights used for each leaf in each well.  When no leaf was 
introduced into the medium (Figure 5-4B), fibroblasts appeared normal phenotypes with limited 
cytotoxicity.  When there were pieces of the 10% SDS leaves (Figure 5-4C), there were high levels 
of cytotoxicity.  There were large areas where cells had detached from the culture plate indicating 
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cell death occurred prior to the 24-hour time point.  Cells that remained attached to the culture 
plate were round and did not show the normal spindle-like phenotype of fibroblasts.  Moreover, 
the majority of remaining cells were positively stained red by the ethidium homodimer for the 
dead marker in their nuclei.  Fibroblasts that were subjected to the 1% SDS leaves (Figure 5-4D) 
had limited to no cytotoxicity.  There were some small gaps of non-adherent areas indicating 
some cell death but this was not widespread.  Cells had the normal phenotype and were 
considered to be nearly the same as those that had no leaf in their medium.  Furthermore, there 
was limited positive red dead stain found in the adherent cells.   
Cytotoxicity was quantified by measuring the metabolic activity of fibroblasts using an MTT 
assay.  Metabolic activity was measured at 6 hrs, 24 hrs, 3 days, and 7 days after introducing the 
leaf pieces into the medium.  Metabolic activities were normalized to wells that contained no 
leaf pieces at each time point (Figure 5-5A).  At all four time points, fibroblasts subjected to the 
10% SDS decellularized leaves had significantly lower levels of metabolic activity than the controls 
where fibroblasts were culture without leaves.  In contrast, fibroblasts cultured with the 1% SDS 
leaves showed no significant difference in metabolic activity compared to wells with no leaves, 
indicating no significant cytotoxic affects from these leaves.  Furthermore, all of the culture wells 
that without leaves or the 1% SDS leaves could also be used for the MTT assay at all the time 
points.  Only 21% of the wells that contained pieces of the 10% SDS leaves were viable for the 
MTT assay (Figure 5-5B).  This indicated that 79% of the wells were unusable for this assay 
because of many non-adherent cells at the four time points.  Comparing the fibroblast non-
normalized metabolic activity over time also gave insight into the growth of the fibroblasts.  The 
fibroblasts that were subjected to no leaves have very similar growth patterns when compared 
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to the fibroblasts supplemented with the 1% SDS leaves.  There was a sharp decrease in metabolic 
activity in both conditions going from the 6 to 24-hour time point which is probably an artifact of 
the seeding of the cells.  Going from 24-hour to 3 days and subsequently to 7 days, the metabolic 
activity changed to a very similar degree.  The slopes of the growth curves between the 1% SDS 
leaves and when there was no leaf introduced were similar.  Whereas the fibroblasts that were 
subjected to the 10% SDS leaves had lowered metabolic activities starting at 6 hours and these 
metabolic activity levels remained relatively unchanged throughout the study, indicating limited 
to no growth of these fibroblasts (Figure 5-5C).  To fully elucidate difference between the two 
conditions, residual SDS was measured (Figure 5-5D).  10% SDS leaves had statistically 
significantly greater amounts of SDS over the leaves processed in the modified 1% SDS process.  
These results validate my hypothesis that although residual SDS caused cytotoxicity, it could be 
limited by modifying the decellularization protocol.    
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Figure 5-5 Fibroblast metabolic activity and proliferation are unaffected by leaves decellularized in the optimized 
process. (A) Fibroblast metabolic activity was measured using an MTT assay for fibroblasts grown in the culture 
shown in Figure 5-4A.  The activity was measured over 4 time points and was normalized to activity measured in 
conditions where no leaf was introduced into the medium.  Leaves treated with the 10% SDS process elicited 
significant cytotoxicity and fibroblasts showed limited and significantly lowered (p<0.05) metabolic activity.  There 
was no difference between the no leaf and the 1% SDS condition.  (B) The percentage of viable wells was measured 
for these assays.  Only 21% of the wells that had the 10% SDS leaves introduced into them were usable, indicating 
large scale cell death.  (C) Non-normalized metabolic activity for the different conditions was compared over time.  
The fibroblasts that were subjected to no leaves or to the modified 1% SDS followed very similar growth patterns.  
Fibroblasts that were treated with the 10% SDS leaves had lowered metabolic activities that remained relatively 
the same over the time-course of the study. (D) Residual SDS was measured in both 10% and 1% SDS processed.  
There were significantly greater amounts of residual SDS found in the 10% SDS treated leaves and there were 
negligible amounts seen in the 1% SDS condition.   
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5.4. Discussion 
One consideration that must be made whenever working with decellularized tissues is 
understanding whether the decellularized tissues would illicit a cytotoxic response. This is due to 
the fact that the processing of decellularizing a tissue requires exposing the tissues to harsh 
conditions in order to remove their cellular components.  One such condition that is commonly 
employed as a decellularization process is the perfusion of different detergent solutions.  These 
solutions work to lyse the cells in the tissues by destroying their cellular and nuclear membranes.  
Residual detergents, especially SDS, have been shown to be highly cytotoxic 141,142,144.  SDS also 
can cause hierarchal structural changes to tissues, which can also result in cytotoxic affects 149.  
Because of this, a decellularization process should aim to limit the amount of detergents used.  
Upon review of the original plant decellularization process that was described in objective 1a, it 
was found that the detergent concentration and time required for decellularization was on the 
higher end when compared to other processes 39,106.  Even though there was successful human 
recelluarization in objective 1b, the potential cytotoxic effects of such highly concentrated 
detergents was worrisome, especially when thinking towards future clinical translation.   In 
objective 2a, I aimed to limit the cytotoxicity of the decellularized leaf scaffold by modifying the 
decellularization process.   
In objective 1a, plant tissue was decellularized using a serial perfusion of 10% SDS for 5 
days followed by 2 days of perfusing a 0.1% TritonX-100 in 10% bleach solution.  This process was 
originally modified by previously used protocols to decellularize heart tissues 16,35,44, which used 
1% SDS followed by a 0.1% TritonX-100 solutions.  The SDS solution used for the plant 
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decellularization was set at a higher concentration than the previously used protocols in order to 
break up the tougher plant cell structures.  Furthermore, bleach was incorporated in order to 
remove chloroplasts and sterilize the tissue 150.  The use of 10% SDS at the time seemed necessary 
but since working with plant tissue and understanding its phytotomy it became apparent that 
this concentration could be lowered through some prior modifications to the leaf.  The leaf has 
an outer waxy coating known as the cuticle 151 which acts as a protective coating for the epidermis 
of the leaf.  The cuticle acts to limit fluid loss from within the leaf which causes an increase in the 
vascular resistance of the leaf.  Previously, the cuticle was removed by treatment with hexanes 
152 before recellularization with human cells in objective 1b.  The cuticle’s hydrophobic properties 
make it a non-ideal surface for the attachment of human cells 153.  Removal of the cuticle prior to 
the decellularization should allow for increased fluid flow by reducing the vascular resistance.  
Increased fluid flow would open up the possibility of lowering the detergent concentrations and 
the time needed for decellularization.  Considering this, I hypothesized that by removing the 
cuticle prior to the decellularization, the decellularization process could be accomplished with 
lower concentrations of SDS in shorter amounts of time.  By lowering the time to decellularization 
and the SDS concentration, the likelihood that the leaf scaffold would illicit cytotoxic affects 
should be diminished.  Furthermore, instead of two-day perfusion cycles of both the TritonX-
100/bleach solution and water, the increased fluid flow allowed for only one day perfusions of 
both.  In order to further rid the decellularized tissue of any residual detergents, a 12-hour wash 
in 10mM tris buffer was added after the decellularization was complete.  Residual SDS has been 
shown to bind to proteins via lysine groups within decellularized tissue, this binding can be 
disrupted through altering the pH of the tissue 149.  With this in mind, the tris buffer wash was 
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added to the procedure in order to change the pH of the tissue to disrupt any bound residual SDS 
within the tissues.  Finally, the spinach leaves were then lyophilized in order to have a more stable 
long-term storage as opposed to the original method which stored the leaves in sterile deionized 
water at 4°C.  Lyophilization should also remove any residual bleach that may be left on the tissue.  
Bleach is comprised of a salt and chlorine, lyophilization should remove any of the gaseous 
chlorine and leave behind just the salt on the surface which could be easily washed away when 
rehydrated the leaf 154.   
The modified decellularization process was found to decellularize spinach leaves to the same 
degree as the original process.  Both had significantly lower levels of DNA when compared to 
native spinach leaves and the residual levels of DNA in both decellularized samples was 
considered fully decellularized when compared to proposed standards 106.  The modified 
decellularized leaves were stored lyophilized which should increase their shelf-life and improve 
any potential storage degradation.  Lyophilized leaves were rehydrated and the rehydrated 
leaves still had patent vasculature, demonstrating the efficacy of these leaves.  Aligning with my 
hypothesis, the leaves that underwent the original process caused high levels of death and 
limited proliferation of cultured fibroblasts.  The leaves that underwent the modified process had 
limited cytotoxic affects and allowed for proliferation that matched the controls.  I had 
hypothesized that residual SDS would cause this cytotoxic effect and this was verified through 
measurement of residual SDS in both leaf types.  There was a significant difference between the 
residual SDS in both leaves with the 1% SDS optimized protocol leaving behind miniscule amounts 
of SDS.  In this objective, I demonstrated that the leaf decellularization protocol can be modified 
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to limit cytotoxicity.  Therefore, as we continue with this research, the decellularization method 
used will be the newer optimized protocol.   
 
6. Objective 2b: In Vivo Response to Subcutaneously Implanted Leaf Scaffold 
6.1. Introduction 
The body has a complex response to a foreign body implantation, which cannot be simulated 
in vitro.  When a biomaterial is implanted into the body, there is an injury that occurs to the 
region of the implant.  This injury elicits an inflammatory and wound healing response 155 which 
range from normal 156 to abnormal 157 depending upon the material that is being implanted. In 
short, neutrophils in the blood recognize the material and start to absorb proteins onto its 
surface.  The proteins cause activation of macrophages and in turn macrophages fuse together 
to form foreign body giant cells.  These cells work to encapsulate the foreign body isolating it 
from the rest of the body 158.  Immunological response to any foreign body is inevitable but can 
be modulated to allow for proper integration into the body.  Immunosuppressive drugs 159 can 
effectively subdue the immune system to allow for material integration but there are many 
complications 160 that can occur due to this therapy such as infection 161.  Newer techniques have 
looked to altering the surface of the material such that it is seen as more favorable by the body 
162.  Establishing an immunomodulatory biomaterial 163 has been a promising approach as it 
allows for a finely-tuned immunological response that is favorable given the intended application 
164.  Whenever a new biomaterial is established it is important to investigate this innate host 
response and whether the material could be altered to give a favorable response.     
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 In objective 2a, the concentration of SDS used in the decellularization of the leaf scaffolds 
was lessened to limit any cytotoxic response to the material.  Lowering the SDS concentration is 
not only important for limiting cytotoxicity but also for improving the response when the material 
is implanted into the body.  Residual SDS has been shown to illicit a foreign body response in vivo 
141.  Modification of the decellularization process resulted in limited residual SDS in the 
decellularized leaves.  Cellulose, a major component of the leaf has been a widely studied 
biomaterial, used in countless biomedical applications.  It has been used in a wide variety of 
regenerative medicine applications, such as cartilage tissue engineering 110,165, bone tissue 
engineering 111,112, and wound healing 96,97.  For those studies, cellulose was derived from bacteria 
in order to control the fiber geometries and chemical properties.  More recently, however, 
cellulose was isolated from decellularized apple hypanthium tissue and was used to support 
cellular attachment and proliferation in a 3D scaffold 98.  That material was found to be 
biocompatible when implanted subcutaneously in vivo 99.  That investigation demonstrated that 
native cellulose is a biocompatible material.  Considering that apple hypanthium tissue is entirely 
comprised of cellulose and spinach leaves are comprised of a multitude of plant polysaccharides 
and proteins such as lignin, pectin, and hemicellulose, it is imperative to study the in vivo 
response to a decellularized spinach leaf. Furthermore, we have previously been able to 
functionalize the surface of decellularized leaves and stem with an RGD-Dopamine peptide 166.  
Biofunctionlized leaves could potentially offer an immunomodulatory material that could be 
tuned for an intended response.  In objective 2b, I aimed to investigate the body’s response to 
decellularized leaf scaffolds.  I will also investigate whether biofunctionalization of the leaves 
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with a peptide could alter the body’s response and allow fine-tuning of the response depending 
upon the potential application of the tissue engineered graft grown on the leaf scaffold.   
 
6.2. Materials and Method 
6.2.1. RGD Functionalization of decellularized leaf 
Decellularized spinach leaves were functionalized with a synthesized RGD-Dopamine peptide, 
as previously reported 166.  Decellularized leaves were washed in a 10mM tris buffer solution (pH 
9.0) for 30 minutes.  Leaves were then placed in a 1 mg/mL RGD-Dopamine solution in 10 mM 
tris buffer for 24 hours under light agitation. After the 24 hours, leaves were again rinsed in tris 
buffer to remove any unbound solution.  Leaves were then frozen overnight and lyophilized for 
24 hours.  Functionalized leaves were stored lyophilized at 4°C indefinitely.   
6.2.2. Subcutaneous implant surgery 
Lyophilized leaves were cut into 1 cm x 1 cm square pieces, both non-functionalized and RGD-
functionalized, and are then rehydrated in sterile 1x PBS for 20 minutes and placed under UV 
light for 20 minutes for sterilization.  Leaves were then washed again in sterile PBS and placed in 
a 37°C incubator until surgeries are performed.   
All animal experiments were performed under the guidance of and approved by the 
Institutional Animal Care and Use Committee at Worcester Polytechnic Institute. Female Sprague 
Dawley rats weighing between 350-500 grams were used in the study.  An approximately 3-cm 
long incision was made in the rat abdominal skin along its midline. The abdominal skin was then 
bluntly dissected from the underlying tissue for 3-cm lateral to the end incision on both sides, 
creating 2 skin pockets. Two pieces of leaf were then implanted in one of the created pockets, 
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with one leaf being placed on the cranial side of the pocket and another leaf being placed in the 
caudal side. The other created pocket was used as a control sham operation.  Skin was then 
closed up using 5-0 nylon suture.  Animals were sacrificed ethically at the different reported time 
points (1 week, 2 weeks, and 4 weeks) post implantation and the tissues were then excised.  
Excised tissue was then fixed in 4% paraformaldehyde prior to histological processing.   
6.2.3. Histological analysis 
Fixed excised tissues were processed in alcohol, xylene, and paraffin in a Tissue-Tek Vip 6AI 
tissue processor (Sakura, Torrance, CA) in a 14-hour processing cycle.  After processing was 
complete tissues were embedded in paraffin blocks.  10 µm sections of the tissue were cut using 
a Leica RM 2235 microtome (Leica Microsystems, Buffalo Grove, Il).  Sectioned tissues were 
stained using either a Hematoxylin and Eosin (H&E) 167 or a Masson’s Trichrome stain 168.   
6.2.4. Collagen Encapsulation and Deposition Measurements 
Images of Masson’s Trichrome stained sections of implants were used to quantify collagen 
encapsulation thickness and deposition within leaf implants.  All measurements were performed 
using ImageJ Software.  Collagen encapsulation thickness was measured in 7 different random 
regions along the entirety of the implant to account for any irregularities found 169.  Deposition 
area was measured and compared as a percentage of the total area of the leaf implant.   
6.2.5. Statistical Analysis 
All results are presented as mean ± standard error.  Statistical comparisons were made 
through the use of two-way ANOVA with a Tukey’s post-hoc test.  The statistical tests were 
performed within SigmaPlot (Systat Software Inc., San Jose, CA).  Statistical significance was 
determined to be p<0.05. n=5-6 with 3 biological replicates.   
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6.3. Results  
6.3.1. Decellularized Leaves Illicit Little Immunological Response   
 Decellularized leaves were implanted subcutaneously for 1, 2, and 4 weeks prior to the 
tissue being excised and embedded in paraffin for histological analysis.  After implantation, no 
rats experienced any systemic health issues as a result of the implants.  At the respective end 
time points, the animals were ethically sacrificed.  The abdomen of the animal was excised 
around the regions where the implants were made.  These excised samples were cut to include 
all layers of skin, fat, and muscle layer in order to grossly study the impact that the host system 
had on the leaf implant.  Excised tissue was prepared for histological analysis.   
H&E staining of excised tissue sections (Figure 6-1) showed limited gross systemic 
immunological and inflammatory response to the leaf implant at all three time points (1, 2, and 
4 weeks).  At 1 week (Figure 6-1, A and D), there was a hematoma that had begun to form and 
encapsulate around the leaf scaffold and there was some cellular infiltration into the leaf implant.  
This is considered a limited initial inflammatory response suggesting the leaf could be viewed as 
an inert material.  At 2 weeks (Figure 6-1, B and E), the encapsulation grew larger while also the 
cellular infiltration was greater with some remodeling seen.  At week 4 (Figure 6-1, C and F), 
there was a higher level of cell infiltration into the implant while also the encapsulation was seen 
to have subsided at this time.  There were cellular components found within the phloem and 
xylem cross-sections of the leaf implant.   
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Figure 6-1 Hematoxylin and Eosin staining of subcutaneously implanted decellularized leaf scaffolds. (A, D) 1 
week after implantation, leaves were seen to have a limited immunological response.  There was apparent 
hematoma formed surrounding the leaves.  (B, E) After 2 weeks of implantation, there was some cellular infiltration 
seen and the formation of some encapsulation around the leaf implant.  (C, F) 4 week after implantation, the leaves 
were infiltrated with more cells and there was some remodeling occurring.  Scale bars: (A, B, C)- 0.5 mm, (D, E, F)- 
100 µm. 
Masson’s Trichrome staining which stains collagen blue, muscle fibers red, and nuclei black 
(Figure 6-2) showed the remodeling of the leaf by the body, as indicated by the deposition of 
collagen into the leaf scaffold.  There was some collagenous encapsulation seen surrounding the 
different implants.  At 1 week (Figure 6-2, A and D), there was limited collagen deposition seen 
within both the leaf scaffold and the surrounding tissue that was the beginning of the 
encapsulation.  The encapsulation was remodeled into collagen by week 2 (Figure 6-2, B and E).  
There were also small isolated areas of collagen deposition at the 2-week excision.  By week 4 
(Figure 6-2, C and F), the surrounding collagen capsule had shrunk in size and there were greater 
amounts of collagen deposition within the main sections of the leaf implant.   
Objective 2b: In Vivo Response to Subcutaneously Implanted Leaf Scaffold 81 
 
Objective 2b: In Vivo Response to Subcutaneously Implanted Leaf Scaffold 82 
Figure 6-2 Masson's Trichrome Staining of Implanted Decellularized Leaf Scaffolds. (A, D) 1 week after 
implantation, there was limited collagen deposition found.  (B, E) After 2 weeks, there was some collagen being 
deposited into the leaf scaffold indicating remodeling.  There was also a thin collagen capsule being formed around 
the outside of the leaf.  (C, F) After 4 weeks, there was greater amounts of collagen being deposited within the leaf 
and the collagen capsule began to shrink.  Scale bars: (A, B, C)- 0.5 mm, (D, E, F)- 100 µm. 
6.3.2. RGD-Functionalized Leaves are Fully Integrated into the Body at 1 Week  
Decellularized leaves were functionalized with an RGD-Dopamine peptide to stimulate 
increased integration into the host tissue.  Previous investigation into the effects of 
biofunctionalization of decellularized plants showed increased cellular attachment, alignment, 
and proliferation on plant tissues that were functionalized as opposed to non-functionalized 166.  
RGD functionalized leaves were implanted subcutaneously and analyzed through histological 
staining in the same manner as the non-functionalized leaves.  Implanted functionalized leaves 
are seen to be integrated to a greater degree than non-functionalized leaves after just one week 
( 
Figure 6-3).  H&E staining shows a limited negative immunological response.  Leaf phloem 
and xylem (black arrows) are found being completely surrounded and assimilated by the native 
host’s tissue and there was a limited encapsulation seen after 1 week of implantation ( 
Figure 6-3, A and D).  After 2 weeks of implantation ( 
Figure 6-3, B and E), there is a substantial amount of cellular infiltration from the host and 
tissue is seen being deposited into the leaf scaffold from the host.  By 4 weeks of implantation ( 
Figure 6-3, C and F), there was a large amount of tissue remodeling seen and the leaf was 
seen to be fully integrated into the host tissue with no negative response.  The host tissue has 
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grown to the edges of the phloem and xylem, whose structures remain present and appear to be 
left open and intact.    
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Figure 6-3 
Histological Analysis of Implantation of RGD-Functionalized Leaf Scaffolds. (A, D) H&E staining showed large scale 
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integration of the functionalized leaf scaffold into the host tissue after one week of implantation.  Black arrows 
indicate leaf vasculature location.  (B, E) RGD-functionalized leaf integration improves after 2 weeks of implantion 
where there is large amounts of host tissue being deposited within the leaf scaffold.  (C, F) Native host tissue 
depositon almost entirely overtakes the leaf scaffold and completely surrounds the leaf vasculature within the leaf 
scaffold after 4 weeks of implantation.  Scale bars: (A, B, C)- 0.5 mm, (D, E, F)- 100 µm. 
 
Masson’s trichrome staining (Figure 6-4) was performed to visualize any collagen 
encapsulation and deposition associated with the RGD-functionalized leaf implants.  After 1 week 
of implantation (Figure 6-4, A and D), there was visible collagen deposition seen within the leaf 
scaffold with a very thin collagen layer encapsulating the leaf scaffold.  The collagen 
encapsulation grew slightly and there was a visible greater amount of collagen being deposited 
into the scaffold within 2 weeks of implantation (Figure 6-4, B and E).  There was substantial 
collagen deposited within the leaf scaffold 4 weeks (Figure 6-4, C and F) after implantation and 
the collagen encapsulation seemed to not grow any larger between weeks 2 and 4.   
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Figure 6-4 Masson's Trichrome Staining of RGD-Functiolizaed Leaf Scaffold Implants. (A, D) Staining showed 
collagen deposition within the leaf scaffold after just one week of implantation.  There was also a small 
collagenous encapsulation that had formed.  There was an increase in the amount of collagen being deposited 
within the leaf scaffold after both two (B, E) and four (C, F) weeks of implantation.  Scale bars: (A, B, C)- 0.5 mm, (D, 
E, F)- 100 µm. 
 
6.3.3. Comparison of Non-Functionalized and RGD-Functionalized Leaf Scaffold 
Integration into the Host Tissue 
The thickness of the collagen encapsulation and the amount of collagen deposited within the 
leaf scaffold were quantified in order to compare the host response to the leaf scaffolds that did 
and did not undergo RGD functionalization prior to implantation.  Encapsulation thickness was 
measured in 7 different random regions across each sample and averaged to account for the 
irregularity seen within the collagen capsule.  Non-functionalized leaf implant encapsulation 
increased from 1 week to 2 weeks when the capsule was at its thickest before subsiding in size 
by 4 weeks of implantation.  The 2-week encapsulation thickness for the non-functionalized leaf 
implants was significantly thicker (p<0.001) than at both the 1-week and 4-week time points.  
RGD-functionalized leaf implant encapsulation increased over the course of the study from 1-
week to 2-week to 4-week implant time points; 4-week (p<0.001) and 2-week (p=0.037) 
encapsulation thickness were both found to be significantly thicker than the encapsulation seen 
at 1-week.  Encapsulation around the non-functionalized leaf implants was found to be 
significantly thicker (p<0.001) than the RGD-functionalized leaf implants at 1 and 2 weeks but no 
significant difference was measured at 4 weeks.   
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Figure 6-5 Comparison of Integration of Non-Functionalized and RGD-Functionalized Leaf Scaffold Implants.      
(A) The thickness of the collagenous encapsulation surrounding the leaf implant was measured for both non-
functionalized and RGD-functionalized leaf scaffolds over the time-course of the study. Collagen encapsulation was 
significantly greater in the non-functionalized leaf implants when compared to the RGD-functionalized leaves at 1 
and 2 weeks.  RGD-functionalized leaves at 2 and 4 weeks had significantly greater encapsulations than at 1 week.  
(B) The percentage of the total area of the implant that was overtaken by collagen deposition was measured.  At all 
time points, the RGD-functionalized leaves had significantly greater deposition than non-functionalized leaves at 
the same time point.  The amount of collagen deposited within the RGD-functionalized leaves at 4 weeks was 
significantly greater than at 1 week.  (*,$ denotes p<0.05). 
 
 Collagen deposition within the leaf scaffold was measured to investigate active 
remodeling of the leaf scaffold being performed by the host tissue.  Deposition was measured 
and compared as a total percentage of the leaf scaffold area within which it was occurring.  There 
was an increase in the percentage of collagen being deposited over time within both non-
functionalized and RGD-functionalized leaf scaffold implants.  RGD-functionalized leaf implants 
had significantly greater (p<0.001) collagen deposition percentages when compared to non-
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functionalized leaf scaffolds at all three time points.  The percentage of collagen deposition of 
RGD-functionalized leaves at 4 weeks was significantly greater (p=0.028) that the deposition seen 
at 1 week within RGD-functionalized leaves.   
 
6.4. Discussion 
It is imperative to investigate a body’s gross biologic and immunological response to a new 
biomaterial. The body’s natural response to an implanted foreign body is a complex cascade 
involving multiple cell types over an extended period of time.    No matter the material that is 
implanted, there is a native host due to injury caused by the implantation.  Over the course of 
days to weeks to months, this injury will cede to neutrophils that will in turn signal macrophages 
to migrate to the area and, depending upon the injury, the macrophages could in turn fuse 
together in order to form foreign body giant cells 158,170.  The properties of the biomaterial can 
illicit different levels of response from the host.  For example, surface porosity 169, roughness 171, 
or binding of cellular adhesion peptide motifs such as RGD 172 can modulate the host response 
from unfavorable to a favorable one depending upon the ultimate application of the biomaterial. 
At the same time, if the body determines that the implant is unsuitable, it would begin to 
encapsulate the material in order to wall it off from the rest of the body 163.  Encapsulation can 
lead to fibrosis and ultimately, rejection of a material 157.   
The host response to implantation of cellulose, the major extracellular component of the leaf 
scaffold, has been extensively studied and found to be very biocompatible 96,173.  Cellulose has 
also promoted wound healing 97, another indication that the body positively interacts with 
material.  Those previous studies focused mostly on bacterial-derived cellulose 165, which is a 
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highly purified form of the polysaccharide.  More recently, there has been some work on plant-
based cellulose similar to what I have been investigating.  Modulevsky et al., generated cellulose 
based scaffolds from the decellularized hypanthium tissue of an apple slice 98, which was found 
to be biocompatible and promote angiogenesis when implanted in mice 99.  The success of the 
plant derived cellulose from the apple tissue provide insight into a possible reaction to our 
decellularized leaf scaffolds, but it is not a perfect analog.  The apple hypanthium tissue is 
comprised of just the plant cells with mainly cellulosic cell walls and is void of the more complex 
structures, such as the vascular system, seen in our leaf scaffolds. Considering that these more 
complex structures are mainly composed of various different plant-derived polymers including 
hemicellulose, lignin and pectin 95, it is important to study decellularized leaf scaffolds.  
 To fully elucidate the biocompatibility of the decellularized leaf scaffold, decellularized leaf 
scaffolds were implanted subcutaneously in the abdomen of Sprague Dawley rats.  The host’s 
response to the implanted leaf scaffold was analyzed through histological analysis over three 
distinct time points (1, 2, and 4 weeks post-implantation).  Histologic analysis suggested there 
was at most a weak immunological and inflammatory response to the decellularized leaf.  There 
was a thin collagen capsule that formed along the outer border of the leaf but this shrank in size 
by the fourth week after implantation.  Even with this capsule, there was still cellular infiltration 
seen with visible collagen deposition within the cellulosic leaf scaffold, all positive indications of 
the leaf being a biocompatible material.   Capsule formation is still not an ideal response 
depending upon the application.  However, if the decellularized leaf were to be used as the 
scaffolding for a tissue engineered graft, there would be cells that could be seeded into the leaf.  
Objective 2b: In Vivo Response to Subcutaneously Implanted Leaf Scaffold 91 
Those cells could help modulate the host response to the leaf and could limit capsule formation 
170.   
Alteration of the leaf itself should improve its integration into the host.  To test this, and the 
versatility of the leaf scaffold, a separate set of leaves were functionalized with an RGD peptide 
prior to implantation.  Through functionalizing the surface of the leaf, the body should better 
identify the material as something compatible and promote cellular ingrowth.  Previously, a RGD-
dopamine peptide was created by our collaborators 166.  The RGD peptide sequence is the major 
cellular binding motif found within the amino acid structure of fibronectin 174.  Dopamine plays a 
role in generating adhesive coatings on the outside of inert materials so an RGD peptide was 
combined with dopamine 175,176.  This peptide was designed to allow for the dopamine to be 
bound to the surface of the leaf while having the RGD peptide sticking out acting as a binding 
side for cells.  By functionalizing the leaf with this binding motif prior to implantation, there was 
an increase in cellular infiltration and ultimately better integration into the host tissue.  After one 
week of implantation of these functionalized leaves, there was high levels of integration into the 
host where the leaf was almost completely overtaken by the native host’s tissue.  The leaf’s 
vasculature was still visible and was completely surrounded by the native tissue.  Furthermore, 
at this short amount of time, there was visible collagen deposition and positive remodeling.  This 
positive response was seen over the course of 2 and 4 weeks where there were large amounts of 
collagen being deposited within the implant with encapsulation.  These functionalized leaves 
highlight the fact that the leaf platform can be altered and modified very easily depending upon 
the ultimate application.  Considering that leaves can be easily modified to express different 
human proteins or therapeutic biomolecules 177-179, it is potentially possible to engineer plants to 
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have an inherent immunomodulatory affect.  This could be modulated by changing the proteins 
expressed as needed for the ultimate application for the scaffold.   
In objective 2b, I aimed to measure the biocompatibility of the decellularized leaf scaffold in 
vivo.  There was a limited response to the leaf over the course of 4 weeks of implantation and 
when the leaf was functionalized prior to being implanted there was complete integration.  The 
results presented within this chapter highlight that even without prior functionalization 
decellularized leaf scaffolds can be considered a biocompatible material.  Furthermore, with 
functionalization prior to implantation, the leaf scaffold could be immunomodulatory based upon 
the intended application.   
 
7. Objective 3a: Developing an Electrically Conducting Biofiber 
7.1. Introduction 
The third pitfall that is currently limiting the clinical translation of a tissue engineered cardiac 
patch is electrical integration into the host tissue.  The heart is a highly dynamic organ that acts 
to mechanically pump blood throughout the vascular system of the body.  Mechanical function 
is generated by a precisely timed electrical signal within the heart tissue, originating from the 
sinoatrial node (SA node) and propagating down to the atrioventricular node (AV node) where 
the signal is slowed in order to provide electrical regularity 180.  Electrical signal then propagates 
through the bundle of His and into the Purkinje fibers where the signal is translated into the 
mechanical function of the right and left ventricular of the heart 181.  Proper timing and 
propagation of this electric pathway is imperative for normal heart function. Electrical 
propagation can be altered by pathologic damage to the heart such as in the case of MI 182.  The 
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irreversible scar that is formed during the aftermath of MI can slow electrical conduction to a 
point where an electrical storm or ventricle tachycardia may occur 183,184.  When designing a 
potential cardiac patch to take the place of this scar, electrical integration is thereby critical for 
not only proper function post-MI but also important to limit formation of any type of residual 
arrhythmia.  The electrical activity within a cardiac patch must be tied to the native electrical 
pathway to allow for proper cardiac function 185.    
Previous attempts to electrically integrate a cardiac patch have been varied in their 
approaches and success.  Prevascularized patches 11, patches with integrated conductive 
materials 186,187, and aligned structures 13,188 among other approaches have seen electrical 
integration when implanted post-MI. Integration of these patches occurs place over long periods 
of time, which could result in an eventual electrical mismatch and arrhythmia formation.  A more 
modular system that could provide electrical signal more rapidly should allow for greater efficacy 
in both the short and long term.   
Previously, fibrin microthread sutures 17,168,189,190  have been used as a stem cell delivery 
platform into the infarcted heart.  These sutures are modular and can easily be implanted 
virtually anywhere within the cardiac tissue.  This platform has also provided cues to cells to 
induce alignment 168. By combing the fibrin microthread with a cell that allows for electrical 
propagation, a modular tissue could be engineered that would bridge electrical signals from the 
healthy host tissue into the engineered patch.  
A highly excitable cell type should allow for quick integration into the native cardiac tissue 
and provide the short term electrical propagation needed.  HEK293 cells are a non-excitable cell 
type that can be engineered to have proper sodium and potassium channels that are required to 
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carry electrical signals 18,191.  Furthermore, these cells inherently have connexin43 192, the major 
gap junction formation protein within cardiac tissue, which should allow for quick integration 193.  
In this chapter, I aim to develop a biofiber that allows for electrical conduction and bridging over 
long gaps.  Combining engineered HEK293 cells with the fibrin microthread suture platform 
should yield a conducting biofiber.  The conducting biofiber would be a modular tissue that could 
be used to integrate the electrical signals from the native host myocardium to an engineered 
cardiac patch.   
7.2. Materials and Methods 
7.2.1. Cell culture 
An engineered HEK293 cell line that had been transfected to express pCDNA3.1-SCN5A 194, 
Kir2.1 18, and GFP was generated previously 18 and will be used in the studies within this chapter.  
SCN5A corresponds to the expression of a robust inward Na+ channel, Kir2.1 corresponds to the 
expression of an inward-rectifier potassium channel and GFP was expressed to allow 
identification of fully transfected cells for selection.  Cells were grown in modified Eagle’s medium 
supplemented with 10% FBS, 1% pen-strep, and 2% l-glutamine.  Cells were selected using 100 
µg/mL hygromycin and 800 µg/mL neomycin.  Medium was changed every other day during 
maintenance of the cells prior to seeding.   
Induced pluripotent stem cell derived cardiomyocytes (iPS-CMs) were generated as 
previously described 195.  iPS-CMs were cultured in medium containing RPMI-1640, 2% B27 
supplement minus insulin (Life Technologies), 1% penicillin/streptomycin, DNAase, and Y-27632 
Rock inhibitor.  Cells were maintained in Matrigel coated well plates until used in studies and 
medium was changed every other day.   
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7.2.2. Fibrin microthread formation 
Fibrin microthreads were created as previously described 190,196.  In short, 70 mg/mL 
fibrinogen (MP Biomedical) was coextruded with 8 U/mL thrombin (Sigma Aldrich) into a 10mM 
HEPES buffered bath (pH 7.4).  Threads were coextruded through a blending applicator tip into 
0.38 mm diameter polyethylene tubing using a syringe pump set to flow at a rate of 0.23 mL/min.  
Threads were allowed to fully polymerize for 20 minutes in the HEPES bath.  After formation, 
threads are stretched and allowed to air dry.  Threads were sterilized using ethylene oxide (EtO) 
gas for 12 hours.  Sterile threads were stored in a desiccator indefinitely at room temperature.   
7.2.3. Fibrin microthread seeding 
To initiate cell seeding onto the fibrin microthreads, microthreads were attached in groups 
of three to a polydimethylsiloxane (PDMS) ring (Figure 7-1A).  PDMS rings were made with an 
inner diameter of 1.2 cm.  Microthreads were attached to the outer portion of the ring using 
medical grade silicon adhesive (Silibone MED ADH 4100 RTV, Bluestar Silicones).  Microthread 
constructs were air dried prior to being sterilized with EtO gas, then de-gassed at least 24 hours 
post EtO treatment.   
HEK293 cell seeding onto the fibrin microthreads was accomplished through modification of 
a previously reported protocol for the seeding of iPS-CMs onto fibrin microthreads 197.  Fibrin 
microthreads were hydrated for 20 minutes in 1x PBS and then stretched over a 12-mm glass 
coverslip.  Hydrated microthreads were then coated with Matrigel (StemCell Technologies) for 2 
hours at 37°C. Engineered HEK293 cells at 250,000 cells per microthread were suspended in 150 
µL of HEK293 media and pipetted over the inner portion of the suspended microthread construct 
(Figure 7-1B).  HEK293 medium was supplemented with aprotnin (50 µg/mL) to slow degradation 
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of fibrin microthreads 198.  Cells were allowed to attach for 18 hours before being moved to a 
new well in a 6-well plate, then grown for an additional 4 days to allow for gap junction formation 
and proliferation.  After the 4 days, the seeded HEK293 biofiber was then used in the different 
studies.   
 
 
7.2.4. Microthread and hPS-CM coculture 
To produce cocultures of the seeded HEK293 Biofiber and iPS-CMs, 50 µL droplets of 
Matrigel were used to coat areas on the bottom of a 6-well plate for iPS-CM attachment.   iPS-
CMs were dissociated from their maintenance culture using TrpLe Express (Thermo Fisher) for 7 
minutes.  Then 500,000 iPS-CMs were suspended in 50 µL iPS-CM culture medium and plated on 
Matrigel-coated sections of well plate bottoms to generate high density iPS-CM monolayer 
clusters.  iPS-CM monolayer clusters were incubated 24 hours to facilitate attachment to the well 
plate prior to placement of HEK293 biofiber.  A seeded HEK293 biofiber was cut from the PDMS 
ring and placed over the iPS-CM cluster.  The biofiber was held in contact with the iPS-CM 
Figure 7-1 HEK293 Cell Seeding and Co-culture System 
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monolayer by a glass bead anchor (Figure 7-1C).   Cocultures were incubated together for 4 days 
prior to immunohistochemical and optical mapping analysis.   
7.2.5. Immunohistochemical staining 
Seeded biofibers and biofiber/iPS-CM cocultures were fixed in 4% paraformaldehyde, 
permeablized in 1% TritonX-100, and were blocked in 5% horse serum. Biofibers were incubated 
in an anti-rabbit connexin43 antibody (1:100, Santa Cruz Biotechnology, Santa Cruz, CA) and an 
anti-mouse connexin45 antibody (1:100, Santa Cruz Biotechnology) overnight at 4°C.  Cocultures 
were incubated in the anti-rabbit connexin43 antibody and in an anti-mouse alpha-actinin 
antibody (1:150, Sigma Aldrich).  The preparations were incubated with secondary antibodies 
(1:100, Jackson Immuno Research Laboratories, West Grove, PA) for 1 hour at room temperature.  
Nuclei were counterstained using DAPI for 10 minutes at room temperature.  Samples were then 
coversliped and covered in mounting medium prior to being imaged using confocal microscopy 
(LSM 510, Zeiss, Jena, Germany).   
7.2.6. Optical mapping 
Electrical propagation down HEK293-seeded biofibers and biofiber/iPS-CM cocultures was 
measured through optical mapping.  Cells were loaded with a voltage sensitive Di-4 dye and 
placed in Tyrode’s solution prior to image acquisition 199.  Electrical propagation was initiated in 
biofiber-only conditions through point-stimulation (50 mA, 5 ms pulses at 1 Hz) and coculture 
electrical activity was spontaneously generated by the iPS-CMs in culture.  A high-speed CCD-
based optical mapping system (Scimedia) was used to record electrical propagation.  Acquired 
images were analyzed with a custom-made software that generates optical maps, optical action 
potentials, and measures conduction velocities.   
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7.2.7. Statistical analysis 
All results are presented as mean ± standard error.  Statistical comparisons were made 
through the use of either a t-test or a one-way ANOVA with a Tukey’s post-hoc test.  The statistical 
tests were performed within SigmaPlot (Systat Software Inc., San Jose, CA).  Statistical 
significance was p<0.05.  There was between 3 and 6 biological replicates used in statistical 
measures.   
7.3. Results 
7.3.1. HEK293-Seeded Biofibers Allow for Electrical Propagation Along Length of Thread 
HEK293 cells were engineered to express a Na+ channel (Nav1.5) and an inward rectifier K+ 
channel (Kir2.1), as previously reported 18.  These cells have the capabilities to carry electrical 
signal for short micron-sized distances.  Engineered HEK293 cells were seeded onto the outer 
surface of a Matrigel-coated fibrin microthread.  Fibrin microthreads were attached to a PDMS 
ring, in order to better facilitate seeding (Figure 7-1, A and B).  Successful attachment of HEK293 
cells to the fibrin microthreads was visible under brightfield microscopy (Figure 7-2A) after 18 
hours of seeding.  Cells were cultured for 4 days after seeding to establish gap junctions and 
increased proliferation to entirely coat the fibrin microthread.  After 4 days gap junction 
formation was measured in these “biofibers” through immunofluorescence staining.  Images 
acquired (Figure 7-2, B-F) showed a confluent layer of the engineered HEK293, which were 
subsequently transfected to express GFP (Figure 7-2D).  Staining of the gap junction proteins, 
connexin43 and connexin45, showed high inherent expression of these proteins forming along 
the gaps between cells (Figure 7-2, E and F). Seeded biofibers were then analyzed for their ability 
to propagate an electrical signal.  Point-stimulation was applied on one side of a biofiber and 
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electrical signal was measured using a high-speed image acquisition system.  Optical mapping 
analysis (Figure 7-2G) revealed electrical signal propagation along the length of the thread.  
Electrical activation propagated from the stimulation point and directionally down toward the 
other end of the thread.  Action potentials were measured using the optical mapping software at 
different points along the length of the biofiber (Figure 7-2H). Analysis of electrical induction 
from the action potential further demonstrated electrical propagation down the length of the 
thread.  The conduction velocity of the signal propagated down the biofiber was compared to a 
monolayer of the HEK293 cells (Figure 7-2I).  There was no difference in conduction velocities 
between HEK293 cells on the fibrin microthreads and in a monolayer on a well plate. 
 
Figure 7-2 Transfected HEK293 cells seeded onto fibrin microthreads form gap junctions and allow for electrical 
propagation down the length of the microthread. (A) Brightfield image of HEK293 cells seeded on surface of fibrin 
microthread.  (B-F) Immunohistochemical staining of HEK293 cells seeded on fibrin microthreads.  Nuclei are blue; 
expressed GFP is green; connexin43 is yellow; and connexin45 is red.  Transfected HEK293 cells are transfected with 
an expressed GFP tag to confirm proper transfection.  Scale bars-50 µm.  (G)  Optical activation map from HEK293 
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seeded microthread.  Electrical stimulation was applied to spot marked by lightning bolt.  Scale Bar-1mm. (H) 
Action potential traces from three different locations along the length of the seeded microthread.  Dashed lines 
mark the point of activation for the three different traces.  Scale bar-500 ms.  (I) Conduction velocities were 
calculated for HEK293 cells seeded on fibrin microthreads and for HEK293 cells seeded as a monolayer.  There was 
no statistical difference in conduction velocities between these two groups (n=3). 
7.3.2. Biofibers can carry electrical signal generated from cardiomyocytes over extended 
distances 
In the previous section, electrical propagation within the HEK293 seeded fibrin microthreads 
(Figure 7-2) was generated from an external source.  However, it is imperative to study whether 
electrical signal generated by cardiomyocytes could be transferred onto the biofiber.  If biofibers 
are able to form gap junctions with a separate cell population and propagate a cell-derived 
electrical signal it will give further credence to their translational potential.  This was assessed 
through cocultures of iPS-CMs and biofibers.  Cocultures were created by holding biofibers in 
contact with a monolayer of iPS-CMs (Figure 7-3A) with a glass bead, glass was used to act as an 
insulator to limit any outside electrical signal.  Cocultures were grown together for 4 days in order 
to stimulate gap junction formation.  Electrical propagation was measured using the same optical 
mapping setup previously described.  There was no outside electrical stimulation given to either 
the biofiber or the monolayer of iPS-CMs, any signal generated was completely spontaneous.  
Optical mapping of the coculture (Figure 7-3B) showed electrical signal propagation starting from 
the iPS-CM cluster onto the biofiber and down the length of the biofiber.  This was verified 
through measurement of the action potentials in both the iPS-CM monolayer and on the thread 
(Figure 7-3C).  There was a delay seen between the peak of the induction of the action potential 
in the middle of the iPS-CM cluster and at the very end of the biofiber, further indicating electrical 
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propagation. Gap junction formation was visualized through immunofluorescent staining of the 
connexin43 gap junction protein (Figure 7-3, D and I).  HEK293 cells were identified by their 
engineered expressed GFP signal (Figure 7-3H) and iPS-CMs were identified by alpha-actinin 
staining (Figure 7-3I).  Connexin43 staining (Figure 7-3F) showed the presence of the protein 
between cells and even more importantly was found to be present at the interface of HEK293 
and iPS-CMs (Figure 7-3E).   
 
Figure 7-3 Transfected HEK293 cell seeded fibrin microthreads form gap junctions with iPS-CM monolayers and 
allow for electrical propagation from iPS-CM monolayer down the length of the seeded thread. (A)  Diagram of 
HEK293 seeded microthread and iPS-CM monolayer coculture.  Seeded microthreads are held down in contact with 
the monolayer of iPS-CMs through use of a ceramic bead.  (B) Optical activation map of HEK293 seeded 
microthread and iPS-CM monolayer coculture.  Electrical activation in the coculture was completely spontaneous 
from the electrical activity in the iPS-CM monolayer, no outside electrical stimulation was applied.  The iPS-CM 
cluster is denoted by the red dashed line and the HEK293 seeded microthread is denoted by the white dashed line.  
Scale bar- 1mm.  (C) Action potential traces from two different locations in the coculture.  (1) is taken from the 
point in the iPS-CM monolayer where electrical activation begins and (2) is taken from the end of the seeded fibrin 
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microthread. Dashed lines mark the point of activation for the two different traces.  Scale bar-500 ms.  (D-I) 
Immunohistochemical staining of HEK293 seeded microthread and iPS-CM coculture.  Nuclei are stained blue, 
expressed GFP is shown in green, Connexin43 are stained in yellow, and alpha-actinin are stained red.  (E) Zoomed 
in view of dashed box in (D) shows gap-junction formation between the seeded thread and iPS-CM monolayer.  
Scale bars (D,F-I)- 50 µm and (E)-15 µm. 
The fibrin microthread is a modular platform and can be created in different lengths and 
thicknesses.  Engineered biofibers must be capable of carrying electrical signal along various 
different lengths depending upon the specific query being addressed.  Different lengths of fibrin 
microthreads were used in order to generate longer biofibers.  Electrical signal was propagated 
from an iPS-CM cluster and down the length of these different lengths of threads (Figure 7-4).  
There was successful electrical propagation down the length of 1 and 2 cm long thread 
protrusions outside the iPS-CM monolayers.  Three cm long threads were also used but were 
unmeasurable due to constraints of the imagining platform.     
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Figure 7-4 Different lengths of HEK293 seeded fibrin microthreads were used in coculture with iPS-CM 
monolayers to determine whether there is a length that would cause a conduction block. (A) Optical activation map 
from coculture with a HEK293 seeded microthread with a length of 1 cm outside of iPS-CM monolayer.  Scale bar- 5 
mm. (B) Zoom to the end of the seeded microthread from (A), marked by dashed rectangle.  Scale bar- 1mm.  (C) 
Optical activation map from coculture with a HEK293 seeded microthread with a length of 2 cm outside of iPS-CM 
monolayer.  This was the maximal length of thread that could be used within the culture plates and macroscope 
used.  Scaled bar- 5 mm.  (D) Action potential traces from two different locations in the coculture in (C).  (1) is the 
iPS-CM monolayer and (2) is the end of the HEK293 seeded microthread.  Dashed lines mark the point of activation 
for the two different traces.  Scale bar- 500ms 
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7.3.3. Seeded biofibers can bridge electrical propagation between multiple clusters of 
cardiomyocytes 
HEK293 seeded biofibers allow directional electrical propagation and that electrical signal can 
be passed spontaneously from a cluster of iPS-CMs down onto the biofiber.  If a biofiber system 
were to be employed clinically, it would need to bridge electrical signal from one section of the 
heart into another.  This bridged signal would need to continue its propagation from the one area 
into the next in order to provide proper electrical signal. The efficacy of using the seeded biofiber 
in such a manner was investigated by modifying the coculture system such that two distinct and 
separate monolayers of iPS-CMs were created with an average gap width of 2.5 mm.  A seeded 
biofiber was laid across the two clusters and was again held in place with the glass bead anchor 
at both ends (Figure 7-5A).  Optical mapping analysis was performed to measure the biofiber’s 
ability to bridge electrical signal.  Electrical signal was seen to be generated by one monolayer, 
propagate down the thread, and continue into the second separate iPS-CM monolayer (Figure 
7-5B).  Optical measures of the action potential (Figure 7-5C) in five different locations located 
on either iPS-CM monolayer and along the length of the thread showed continued electrical 
signal propagation with signal moving from one monolayer down the length of the biofiber and 
into the second monolayer.  Control cocultures were also established to better measure the 
biofiber system.  Control cocultures included a coculture with the engineered HEK293 cells 
seeded in a confluent cell bridge layer between iPS-CM monolayers, a fibrin microthread that 
was seeded with HEK293 cells that had been transfected to only express the Na+ channel, an 
unseeded fibrin microthread, and a coculture where no bridge was established. Biofiber bridging 
occurred spontaneously synchronized in 80% of the measured cultures (Figure 7-5D).  The only 
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control where spontaneous synchronized bridging occurred was in the engineered HEK293 cell 
bridge and this only occurred in 20% of cultures.  The number of electrical activations per minute 
of the iPS-CM monolayers in the different conditions was also measured (Figure 7-5E).  The 
biofiber bridge had similar activations per minute as the coculture that had no bridge, indicating 
that the natural conduction frequency of these cells was achieved and functionality of the iPS-
CMs did not diminish due to the bridge.  The cell bridge condition had the lowest activations per 
minute, which was likely due to a slowed repolarization from inefficient gap junction formation 
because of the large area and number of cells necessary for the cell bridge.  Another measure of 
the synchronization of the different conditions was performed by investigating the average 
difference of electrical activations of the two iPS-CMs monolayers on each well (Figure 7-5F).  
Ideally in a fully synchronized culture, there would be no difference in the number of electrical 
activations measured as one cluster would be dependent upon the electrical signal from the 
other.  This was seen in the biofiber condition with an average difference of 0.23 activations per 
minute.  The cell-only bridge also had very little difference in the activations whereas the other 
conditions were varied considerably, indicating lack of synchronization.  Conduction velocities 
were also measured and compared between the biofiber bridge and the cell bridge (Figure 7-5G).  
The cell bridge had a significantly greater conduction velocity over the biofiber bridge which was 
likely resultant of the difference in number of cells used in each condition.    
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Figure 7-5 HEK293 seeded fibrin microthreads can be used to electrically connect two separate iPS-CM 
monolayers. (A) Diagram of coculture of two separate iPS-CM monolayers and a HEK293 seeded microthread.  Both 
ends of the seeded microthread are anchored down and kept in contact with the iPS-CM monolayers through use of 
a ceramic bead.  There was an average gap width of 2.5 mm separating the two iPS-CM monolayers.  (B) Optical 
activation map of two separated iPS-CM monolayers that were electrically connected by a HEK293 seeded 
microthread.  There was no electrical stimulation on either iPS-CM monolayer, electrical signal was spontaneous 
from iPS-CM monolayers.  Scale bar- 2.5 mm.  (C)  Action potential traces from five different locations in the 
activation map in (B).  (1) is taken from the center of the iPS-CM monolayer that provides electrical signal.  (2-4) are 
taken from different locations along the length of the HEK293 seeded microthread bridge. (5) is taken from the 
center of the iPS-CM monolayer that is being activated from the electrical signal provided by the HEK293 seeded 
microthread.  Dashed lines mark the point of activation for the five different traces.  Scale bar- 500 ms.  (D) The 
percentage of spontaneous synchronization of two separate iPS-CM monolayers by different bridging techniques.  
Synchronization was only accomplished when transfected HEK293 cells were used in conjunction with a fibrin 
microthread or by themselves.  There was no synchronization seen from microthreads seeded with HEK293 cells 
that were transfected with just a sodium channel, an unseeded fibrin microthread, and when there was no bridge 
connecting the two monolayers.  The efficacy of the HEK293 seeded microthread was 4x greater than when there 
was just HEK293 cells seeded between the two monolayers.    (E) Electrical activations per minute seen in the 
different bridging techniques.  HEK293 seeded microthreads had significantly greater activations per minute when 
compared to HEK293 cells and to microthreads seeded with HEK293 cells transfected with just sodium channels.  
There was no statistical difference between the HEK293 seeded microthread and unseeded microthreads and when 
there was no bridge.  (#, *, $ denotes p<0.05) indicating that the biofiber bridge did not change the inherent 
electrical activation frequency found within the iPS-CMs.  (F)  The average difference of activations per minute 
between the linked iPS-CM monolayers when connected by the different bridge types.  (G) Conduction velocity was 
measured in the coculture when there is a HEK293 seeded microthread and in HEK293 cell only bridges.  HEK293 cell 
only bridges, without microthreads, had statistically significantly greater conduction velocities as opposed to 
cocultures using HEK293 seeded microthreads.  (* denotes p<0.05).  n=3-6.   
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Further investigation into the electrical bridging of the coculture was performed by looking at 
the response the system had to disruption of the biofiber (Figure 7 6).  The biofiber was disrupted 
by cutting it down the middle (Figure 7 6).  Optical mapping was used to measure this affect. 
Optical maps were generated prior to cutting of the biofiber and were seen to have the 
synchronized bridging that had been seen previously (Figure 7 6A).  The iPS-CM monolayer that 
was dependent on the electrical signal from the biofiber for activation was focused on before 
(Figure 7 6B), immediately after disruption (Figure 7 6C), 5 minutes (Figure 7 6D), and 10 minutes 
(Figure 7 6E) after the biofiber was cut. There was signal present immediately following the 
cutting of the middle of the biofiber.  The electrical signal was found to propagate in the same 
direction as was seen prior to the cutting of the biofiber.  This electrical propagation signal 
direction changed 5 and 10 minutes after cutting of the biofiber.  There was likely a repolarization 
of the cardiomyocytes due to the loss of the electrical pacemaking that was attributed to the 
biofiber.  This further highlights the electrical integration seen between the iPS-CMs and the 
biofiber as the electrical activation change indicates that the electrical signal delivered through 
the biofiber was strong enough to override the inherent electrical activity of the cardiomyocytes.   
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Figure 7-6 The synchronization of two separate iPS-CM monolayers that were electrically linked by HEK293 
seeded microthreads was measured by cutting the biofiber. (A) Optical activation map of synchronized iPS-CM 
monolayers that were connected via HEK293 seeded microthread prior to biofiber cutting.  Scale bar- 2.5 mm.  (B-E) 
Optical activation of the right iPS-CM monolayer from (A).  This was the monolayer that was being electrically 
paced by the other monolayer and the biofiber.  (B) The optical activation map prior to biofiber cutting.  (C) The 
optical activation map immediately following cutting of the biofiber.  (D) The optical activation map 5 minutes after 
the cutting of the biofiber.  There was visible repolarization of the iPS-CM monolayer, with different directionality 
of the electrical signal.  (E) The optical activation map 10 minutes after cutting of biofiber.  There was complete 
repolarization of the monolayer at this time.  Scale bars- 2.5 mm.   
7.4. Discussion 
When designing a potential tissue engineered cardiac patch for use after an infarction, it is 
important to consider not only end-stage mechanical function but also electrical integration of 
the patch.  Considering the precisely-timed electrical pathway of the heart 180,181, it is critical to 
allow for quick electrical integration with proper directionality.  Electrical signal is disrupted 
following different pathologies, including MI 182.  The deeply collagenous scar formed during MI 
3 acts as a highly electrically-resistive area 200 resulting in further pathologies such as an electrical 
storm 184.  Previous investigation of electrical integration of cardiac patches has proved to be 
fairly successful 11,186,187.  Further development is still needed and it is important to create a 
system that could bridge electrical signal across large distances.  In this objective, I aimed to 
generate a biofiber that could act as a modular system to conduct electrical signal in the heart.   
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 A biofiber was created by seeding engineered HEK293 cells onto fibrin microthreads. 
HEK293 cells are an unexcitable cell type and were thus engineered to express both a Na+ channel 
and an inner rectifying K+ channel.  The engineered cells carried electrical signal both when 
seeded in a monolayer and when seeded onto the fibrin microthread. Prior studies have used an 
engineered HEK293 cell as the basis for an electrical conduction within the heart.  Most 
promising, Kirkton et al. 191 were able to generate an excitable engineered tissue comprised of 
HEK293 cells and neonatal ventricular rat cardiomyocytes.  This tissue, as with ours, propagated 
a signal along a 2-centimeter length, which is considered a clinically relevant conduction gap 201.  
However, our biofiber provides a more modular design and could be better implemented 
clinically due to the advantages of using the fibrin microthread platform, which has been used as 
a suture for stem cell delivery into the heart 17,168,189.   Seeded fibrin microthreads showed 
directional electrical propagation down the length of the thread.  These biofibers were 
cocultured with iPS-CM monolayers.  The iPS-CM monolayers spontaneously generated an 
electrical signal down the length of the thread and biofibers could bridge between two different 
iPS-CM monolayers such that one monolayer could pace the second more distant monolayer.   
Using an engineered cell type has many advantages.  An engineered cell type would be able 
to express specific ionic channels that would best match the native cell population.  Using HEK293 
cells would not be the best option clinically but they act as a good cellular model due to their 
ability to easily be transfected 202.  Addition of calcium channels 203 should aid in the 
depolarization stage of the cell’s action potential and over-expression of sodium channels and 
connexin43 204 should improve the conduction velocities measured to a value more reminiscent 
of the native cell population 191,205.  By using a cell model such as HEK293, we could adapt that 
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into a more clinically relevant cell type such as a cardiac fibroblast or an induced pluripotent stem 
cell.  Both of these cells types have been shown previously to integrate well into the native 
myocardium 195,206-208.   
8. Objective 3b: In Vivo Investigation of Bridging Electrical Signal in the Heart 
8.1. Introduction 
In objective 3a, an electrically conducting biofiber was created through the combination of 
fibrin microthreads 17 and engineered conductive HEK293 cells 18.  The biofiber was able to pass 
electrical current directionally down its length from both an outside electrical stimulation and 
from the electrical signal inherently found in cultured cardiomyocytes.  When the biofiber was 
placed between two separate clusters of cardiomyocytes it was able to bridge electrical signal 
from one cluster to the second one.  These initial in vitro investigations proved to be successful 
in showing the potential of the electrically conducting biofiber.  However, in order to further 
demonstrate the biofiber’s efficacy to act as a modular system to aid in the electrical integration 
of a engineered cardiac patch, it is imperative to test the biofiber in vivo.  The in vivo myocardium 
is a much more complex environment when compared to the cultured cardiomyocyte clusters.  
The native myocardium is comprised of a variety of cell types outside of cardiomyocytes including 
endothelial cells, hematopoietic derived cells, and cardiac fibroblasts 209.  Cardiac fibroblasts have 
been shown to be important to the electrical properties of the native myocardium 207,210,211 and 
would thereby affect the electrical carrying properties of any implant made.  It is also important 
to consider that there are a variety of phenotypes of cardiomyocytes found within the native 
myocardium.  These different subcellular types of cardiomyocytes can act as a pacemaker cell, as 
an electrically conductive cell, and as a contractile cell.  The biofiber would need to integrate 
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between these different cardiomyocyte subtypes to make sure that the native electrical system 
is not interrupted.  Furthermore, any type of surgical intervention involving an implant made into 
the myocardium would illicit an injury-related wound healing response.  This response would 
likely result in the deposition of small levels of collagen, a similar response as seen when there is 
an infarction 212 but at a smaller degree.  The scarring found from a wound healing response 
would have an effect on the electrical properties of any implanted cardiac patch 183.  Because of 
these complexities of the native myocardium, it is necessary to test the electrically conductive 
biofiber in vivo.  In this objective, biofibers will be implanted into rat myocardium bridging the 
atria to the ventricle to test the electrical bridging capabilities in vivo.  To isolate the electrical 
response to the implanted biofiber, a conduction block of the AV node will be established by 
pharmacological intervention 213 and the electrical activity of the heart will be visualized with a 
voltage sensitive dye 214.   
8.2. Materials and Methods 
8.2.1. Biofiber Implantation  
All of the surgery protocols were approved by the Animal Care and Use Committee of the 
Technicon Faculty of Medicine.  Male and female Wistar rats weighing between 135-270 grams 
were used for this investigation.  Rats were anesthetized, intubated, and placed on an external-
ventilator.  A left thoracometry was performed to expose the heart.  The pericardial sack was 
removed prior to implantation surgery.  A seeded biofiber was implanted to bridge from the 
appendage of the left atria into the left ventricle.  The chest cavity was then closed and the animal 
was allowed to recover.  Animals were treated daily with the immunosuppressant drugs 
cyclosporine A (15 mg/kg/day) and methylprednisolone (2 mg/kg/day) 214.  Biofibers were given 
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1 week to be fully integrated into the heart, as this should allow for gap junction formation in 
vivo 193.   
8.2.2. Ex-Vivo Visualization of Electrical Activity in Heart Induced with Acute AV 
Conduction Block 
Following the week, the animals were euthanized, their heart was excised, and then the heart 
was transferred onto a custom built Langendorff apparatus.  The heart was maintained on the 
Langendorff with oxygenated Tyrod’s solution.  A conduction block was generated through 
perfusion of methacholine (0.5 mM, 0.1 mL).  A voltage sensitive Di-4 dye was added to the 
perfusate to allow for visualization of the electrical activity in the heart.  Electrical propagation 
was visualized using a high-speed CCD-based optical mapping system (Scimedia).  Control groups 
of a no implant sham surgery and an implant without HEK293 cells were used along with the 
biofiber implanted hearts.   
8.2.3. Histological Analysis 
Following the visualization of the electrical activity, hearts were fixed in 4% 
paraformaldehyde overnight.  After fixation, the hearts were moved to a 30% sucrose solution at 
4°C.  The hearts were then bisected approximately at the terminal end of the biofiber in the left 
ventricle; right atria and ventricle were also dissected away for clarity in imaging.  Bisected hearts 
were placed in a Peel-a-Way disposable embedding mold (Polysciences, Inc., Warrington, PA) and 
embedded in OCT compound (Electron Microscopy Sciences, Hatfield, PA) overnight in a -80°C 
freezer.  The solidified OCT block was removed from the mold and attached to a cyrosectioning 
chuck with OCT.  A Leica CM 3050 cyrostat (Leica Microsystems, Buffalo Grove, IL) was used to 
cut 10 µm thick sections.  Sections were stained with a Hematoxylin and Eosin stain (H&E) to 
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visualize the biofiber implantation.  Stained sections were imaged using a Leica Upright DMLB2 
microscope (Leica Microsystems).   
8.3. Results  
8.3.1. Verification of AV-Block Heart Model 
Prior to the biofiber implantation studies, it was important to verify that an AV block could 
be established and visualized in the Langendorff setup.  A Wistar rat was ethically sacrificed and 
its heart was excised and connected to the Langendorff apparatus.  The heart was perfused 
with the Di-4 voltage sensitive dye and its normal electrical pathway activation was visualized.  
The heart’s electrical activity was first seen in the atria propagating from the basal side towards 
the apex and then in the ventricle propagating from the apex and upwards (Error! Reference 
source not found.A).  The electrical action potential initiation was graphed from the acquired 
video.  The atrial signal was initiated first followed by the ventricle signal which followed a 
consistent delay in each cycle measured (Error! Reference source not found.C).   
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Figure 8-1 Verification of AV-Block Heart Model. Visualization of the electrical activity in a representative cycle in 
the excised heart (A) prior and (B) after methacholine injection.  The first image in both sequence denotes the 
relative locations of the left atria (marked LA) and the left ventricle (marked LV).  The initiation of electrical activity 
in both the atria and ventricle were graphed together to denote the timing and any possible delay between signals 
as a result of the conduction block both (C) prior and (D) after methacholine injection.  In this graphs, the activation 
within the atria is in black and the activation in the ventricle is in blue.   
 
 
To induce the AV conduction block, methacholine (0.5 mM, 0.1 mL) was injected directly into 
the heart’s vasculature.  The electrical activity was visualized immediately following the 
methacholine injection (Error! Reference source not found.B).  After the methacholine 
injection, there was still atrial electrical activity, propagating in the same direction as seen prior 
to the injection.  There was, however, no ventricular activation following atrial activation which 
is attributed to a successful AV conduction block.  This was further verified by graphing the 
action potential initiation (Error! Reference source not found.D), where there was only atrial 
activation measured and no ventricular activation.  The acute AV conduction block was thereby 
confirmed and was used for the rest of this chapter.   
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8.3.2. Unseeded Fibrin Microthreads Do No Affect the Electrical Pathway of the Heart 
Unseeded fibrin microthread sutures were implanted for one week; bridging the left atria to 
the left ventricle.  The unseeded sutures acted as a control to test whether the surgical procedure 
would result in confounding electrical pathways activations.  There was concern was the surgery 
resulted in the atria being sutured down tight onto the ventricular pericardium due to the 
pressure from the unseeded suture.  Rats were sacrificed, hearts were excised, placed into the 
Langendorff apparatus, and electrical activity was visualized as previously described.   
 
Figure 8-2 Electrical Activity Is Unaffected by Implanted Unseeded Fibrin Microthread. Visualization of the 
electrical activity in a representative cycle in the excised heart that had been implanted with an unseeded fibrin 
microthread (A) prior and (B) after methacholine injection and (C) after the heart recovered from the acute 
conduction block.  The first image in both sequence denotes the relative locations of the left atria (marked LA) and 
the left ventricle (marked LV).  The direction of the electrical activity (D) prior to the methacholine injection and (E) 
after the heart had recovered from the conduction block were shown with directional vectors.  Atrial activation 
direction is denoted by the black arrow and the ventricular activation direction is denoted by the blue arrow. The 
initiation of electrical activity in both the atria and ventricle were graphed together to denote the timing and any 
possible delay between signals as a result of the conduction block both (F) prior, (G) after methacholine injection 
and (H) after the heart recovered from the conduction block.  In these graphs, the activation within the atria is in 
black and the activation in the ventricle is in blue.   
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Prior to the induction of the conduction block, the electrical activity was seen to be normal (A) in 
both the directionality of the signal (D) and the timing of the initiation of the action potentials 
(F).  Methacholine was then injected into the heart to generate the AV conduction block. 
Immediately following the methacholine injection, electrical activity of an AV conduction block 
was visualized (B) and measured (G).  Hearts were given time to recover from the methacholine 
injection to investigate whether the methacholine resulted in any electrical misfiring once the AV 
node had recovered.  The recovered heart rhythm (C) followed the same directionality (E) and 
electrical activation initiation (H) as was seen prior to the methacholine injection.   
8.3.3. Implanted Conducting Biofiber Elicits Ventricular Feedback into Atria 
HEK293 seeded fibrin biofibers were implanted bridging the rat’s left atria with its left ventricle 
for one week to allow for gap junction formation between the implanted cells and the host 
myocardium.  Heart electrical activity was visualized, as previously described.  Electrical activity 
prior to the AV conduction block (A) was found to have normal atrial directionality (E).  However, 
there was an apparent electrical feedback running from the ventricle and into the atria (E).  This 
was further seen in the measured action potential initiation (H) where the feedback showed an 
almost secondary atria firing.  Methacholine injection again resulted in an acute AV block (B, I) 
and this ventricular feedback was not seen.  However, when the heart initially recovered from 
the methacholine (C), there was a visible feedback from ventricle to atria (F) that initiated a 
second atria firing (J).  Once the heart fully recovered from the methacholine injection, the 
electrical activation (D) matched what was seen prior to the conduction block in both the 
electrical directionality (G) and timing (K).  The ventricular feedback was visible in 3 out of the 5 
hearts tested.   
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After hearts were removed from the Langendorff, they were fixed and prepared for 
histological analysis.  Hearts were cyrosectioned and stained with an H&E stain to locate the 
biofiber.  Biofiber’s were found to be visible near the free wall of the left ventricle (A).  Higher 
magnification imaging of the biofiber (B) showed that the fibrin structure was still intact 1-week 
after implantation.  The same area was visualized for a GFP signal (C) as the HEK293 cells are 
transfected to fluoresce GFP.  There were visible GFP-positive cells seen within the biofiber 
location indicating that some population of the HEK239 cells survived the 1-week implantation.   
Figure 8-3 Electrical Activity in Heart Implanted with Conducting Biofiber Results in Ventricular Feedback into 
The Atria.  Visualization of the electrical activity in a representative cycle in the excised heart that had been 
implanted with a conducting biofiber (A) prior and (B) after methacholine injection, after the heart recovered (C) 
initially and (D) long-term from the acute conduction block.  The first image in both sequence denotes the 
relative locations of the left atria (marked LA) and the left ventricle (marked LV).  The direction of the electrical 
activity (E) prior to the methacholine injection, and after the heart had (F) initially and (G) long-term recovered 
from the conduction block were shown with directional vectors.  Atrial activation direction is denoted by the 
black arrow, the ventricular activation direction is denoted by the blue arrow and the ventricular feedback into 
the atria direction is denoted by the green arrow. The initiation of electrical activity in both the atria and 
ventricle were graphed together to denote the timing and any possible delay between signals as a result of the 
conduction block (H) prior, (I), after methacholine injection and after the heart recovered (J) initially and (K) long-
term from the conduction block.  In these graphs, the activation within the atria is in black and the activation in 
the ventricle is in blue.   
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Figure 8-4 Histological Analysis of Implanted Biofiber.  Hematoxylin and eosin staining was performed to 
visualize the implanted biofiber. Stains were imaged to show (A) gross location and (B) zoomed in high resolution of 
the biofiber.  (C) The seeded HEK293 cells were transfected with a GFP protein tag.  Images were taken to verify 
that the HEK293 cells were still present after the 1-week implantation.  Scale bars: (A)- 250 µm, (B&C)- 50 µm. 
 
8.4. Discussion 
The third major pitfall that is currently limiting the clinical translation of a tissue engineered 
cardiac patch is the lack of electrical integration of the patch into the host tissue.  Electrical 
integration is necessary due to the highly timed electrical system that paces the heart’s 
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function.  Without proper integration, an engineered patch’s electrical activity would not match 
that of the host which would not allow for properly tuned function between the host and the 
engineered patch.  A modular system that allows for bridging of electrical signal from the host 
myocardium into the tissue engineered patch should allow for improved electrical integration 
and ease into a clinical translation.  In objective 3a, an electrically conductive biofiber was 
engineered to be such a modular approach for electrical integration of a cardiac patch.  The 
biofiber was engineered out of a fibrin microthread 17,190 and engineered HEK293 cells 18 .  In 
vitro testing indicated that the conducting biofiber could directionally carry electrical signal and 
this electrical signal could be used to electrically connect two separate cardiomyocyte clusters.   
In vivo implantation of the conductive biofiber was performed to further test the efficacy of 
the biofiber platform.  Biofibers were implanted in Wistar rats, bridging the left atria to the left 
ventricle.  A conduction block of the AV node was pharmacologically induced to isolate the 
affects that the biofiber had on the global electrical activity within the heart.  Hearts were 
excised, placed onto a custom-built Langendorff apparatus, and perfused with a voltage 
sensitive dye to visualize the electrical activity.  First, the AV conduction block model was 
established and verified, which was based upon previous investigations into the heart’s 
electrical pathways 213,214.  AV conduction block was accomplished through injection of 
methacholine.  The first set of implants that were tested were control unseeded fibrin 
microthreads.  The bridging of the atria to the ventricle with the microthread left the atria 
tightly in contact with the epicardial surface of the ventricle.  Thusly, the unseeded control was 
tested first to investigate whether this contact would form unwanted gap junctions, eliciting 
electrical misfiring.  The unseeded implant’s electrical activity matched that of the normal heart 
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both prior to, after methacholine injection, and after the heart had recovered from the 
conduction block.  
 Implanted HEK293 seeded biofiber’s resulted in hearts that had abnormal electrical 
pathways.  There was a visible feedback from the ventricular activation back into the atria prior 
to the conduction block.  Once the block was established and there was no ventricular 
activation, this feedback was not seen.  During the initial recovery from the conduction block, 
the ventricular feedback was not only present but was also activating a second atria firing.  
There was an apparent accessory electrical pathway that was uncovered where the ventricle 
was pacing and activating the atrial firing.  The obviousness of this pathway diminished once 
the heart fully recovered from the conduction block but the small ventricular feedback seen 
prior to methacholine injection was still present.  There was a present ventricular feedback 
seen in 3 of the 5 hearts that were tested with biofiber implants.  The other two hearts did not 
have any abnormal electrical activity, probably resulting in improper electrical coupling 
between the implanted biofiber and the host myocardium.  Further analysis of the implanted 
conducting biofiber was accomplished through histological sectioning and staining.  The 
biofiber was found to be intact and there were some surviving HEK293 cells seen within the 
biofiber.   
Combining the results from the electrical pathway visualization and the histological analysis, 
indicates that the implanted conductive biofiber was electrically integrated into the host 
myocardium.  This integration, however, was not perfect.  An ideal integration would have been 
that the atrial signal was able to be passed to the ventricle through the biofiber and not the 
ventricular feedback that was seen.  This feedback is likely due to the strength of the ventricular 
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conduction in comparison to the atria.  This problem is possibly overcome through some 
changes to the engineered cell type.  Firstly, HEK293 cells 202 are not the most clinically relevant 
cell type as they are an immortalized cell line.  They act as a great model cell type due to their 
ease of being transfected.  Thereby substituting the HEK293 cell with either an engineered 
cardiac fibroblast or cardiomyocyte could prove to be helpful.  Furthermore, the HEK293 cells 
used in this study had been transfected with sodium and potassium channels only whereas the 
cardiac action potential is also dependent upon the exchange calcium ions though calcium 
channels.  HEK293 cells transfected with calcium channels would improve the cell’s action 
potential which would help to better pair to the atrium.  Even with the shortcomings, this study 
was very successful in showing electrical integration between the biofiber and the host 
myocardium.  A further test of bridging within the ventricle itself would also be useful to 
understand whether this biofiber could be used to bridge signal originating from the ventricle 
and ending in a potential tissue engineer cardiac patch.   
In this objective, the conductive biofiber was implanted into rat myocardium.  There was 
some electrical integration found between the biofiber and the myocardium which further 
demonstrates the efficacy of using the biofiber to electrically integrate a prospective cardiac 
patch.  Coupling this studied integration with the highly modular design of the biofiber, further 
demonstrates a clinically relevant platform with which could be further refined and studied.   
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9. Conclusions and Future Work 
9.1. Conclusions 
The leading cause of death within the United States is cardiovascular disease, attributing to 
approximately 25% of all fatalities 1.  The prevalence of cardiovascular disease worldwide has 
been an ever increasing epidemic over time 215 and can be attributed to many different 
underlying disease mechanisms such as atherosclerosis 216, high blood pressure 217, or coronary 
artery disease 2.  One of the most prevalent forms of cardiovascular disease is myocardial 
infarction (MI) 8, which typically occurs when there is a blockage in the coronary arteries leading 
to ischemia in the region.  The ischemia triggers cell death and tissue necrosis, ultimately leading 
to the formation of an irreversible collagenous scar on the myocardium.  This scar negatively 
affects the heart’s ability to properly pump blood to the rest of the body and could lead to further 
MI, cardiovascular disease, or end stage heart failure.  The current gold-standard treatments for 
MI include coronary artery bypass graft surgery, stenting, or whole organ transplantation.  The 
only treatment that actively recovers cardiac function is organ transplantation, but the number 
of hearts available do not meet the demand.  Thusly, research has been investigating whether 
there could be new therapies to regenerate the damaged region of the heart.  One such field of 
research is tissue engineering, where researchers are actively looking to engineer new cardiac 
tissue that could be used to replace the damaged one.   
Researchers have been investigating engineering cardiac tissues for nearly 20 years 14 and 
there have been some major strides made during that time.  Engineered cardiac patches have 
shown some efficacy towards regenerating cardiac function in animal models 130 but this has not 
been properly translated to a clinical setting.  Recently, leading investigators in the field of cardiac 
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tissue engineering wrote a prospective on the field 15.  Within which, the investigators identified 
three major pitfalls towards the clinical translation of a tissue engineered cardiac patch.  The 
three current pitfalls limiting the clinical translation of a cardiac patch are the lack of proper 
vascularization, the patch must be biocompatible and immuno-modulatory, and there must be 
electrical integration between the graft and the host tissue.  In this dissertation, I aimed to 
address all three of these challenges in order to improve clinical translation of patches made from 
engineered cardiac tissue.  The dissertation was broken down into three specific aims, each trying 
to solve one of the major challenges.   
In the first specific aim, I hypothesized that perfusion decellularization could be modified to 
decellularize leaves.  Decellularized leaves could in turn be used as a pre-vascularized scaffold for 
tissue engineering.  In objective 1a, whole organ decellularization was modified to work with 
different plant types including spinach leaves.  Spinach leaves were found to be fully 
decellularized. The leaf vasculature was found to be patent and capable of transporting particles 
at the scale of red blood cells, opening up the possibility of use as a pre-vascularized tissue 
engineering scaffold.  In objective 1b, this claim was further validated by investigation into the 
recellularization of decellularized spinach leaves with human cells.  MSCs, HUVECs, and hPS-CMs 
all attached to the leaf.  HUVECs populated the inner lumens of the leaf vasculature as would be 
seen in the human cardiovascular system.  hPS-CMs functionally contracted and carried electrical 
signal over the course of 3 weeks.   
In the second aim, I hypothesized that decellularized leaves would be biocompatible.  The 
likelihood that this claim could be validated was improved through modification of the 
decellularization in objective 2a.  To limit the cytotoxic effects of the detergent solutions, leaf 
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decellularization was modified to use lower detergent solution concentrations over shorter 
perfusion cycles.  The new process was found to decellularize the leaves to the same degree as 
the original protocol established in objective 1a.  Cytotoxicity of the decellularized leaves that 
underwent the modified process was negligible whereas leaves decellularized using the original 
process were highly cytotoxic.  Systemic biocompatibility was studied in objective 2b.  Leaf 
scaffolds were implanted subcutaneously and the host response to the implant was measured 
over the course of 4 weeks.  There was limited gross pathological response to leaves.  
Furthermore, leaves functionalized with an RGD-dopamine peptide proved to be well integrated 
into the host tissue starting one-week post-implantation and continuing through the 4-week time 
period.  This opens up the possibility that through functionalization, the leaf scaffold could be 
immunomodulatory depending upon the intended application.   
In this third aim, I hypothesized that an electrically conducting biofiber could be engineered.  
This biofiber could provide a modular platform to improve electrical integration between an 
engineered cardiac patch and the native host tissue.  The biofiber was established in objective 
3a.  Fibrin microthreads were seeded with engineered HEK293 cells, that had been transfected 
to express sodium and potassium channels in order to be an excitable cell type.  These engineered 
biofibers propagated electrical signal directionally down the length of the fiber.  Furthermore, 
there was electrical integration between iPS-CM clusters and the engineered biofibers.  This 
electrical integration was strong enough for the biofiber to act as a bridge between two separate 
and distinct monolayers of iPS-CMs.  In objective 3b, an animal study was performed to further 
test the efficacy of the engineered biofiber.  Biofibers were implanted bridging the left atria with 
the left ventricle of Wistar rats.  The animals were sacrificed, hearts were excised and placed on 
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a custom-built Langendorff apparatus.  The electrical activity of the heart was visualized with a 
voltage sensitive dye.  A conduction block of the AV node was induced pharmacologically to 
better isolate the affects that the implanted biofiber had on the electrical activity of the hearts.  
In 3 out of the 5 hearts that had an implanted biofiber, there was a visible ventricular conduction 
feedback into the atria.  This was likely due to a created accessory pathway through the biofiber 
bridging the ventricle to the atria.   
9.2. Future Work 
In this dissertation the whole organ perfusion decellularization was adapted for use with plant 
tissue, in particularly spinach leaves.  Decellularized spinach leaf scaffolds were found to be void 
of DNA and were tested to act as a pre-vascularized scaffold for tissue engineering.  
Decellularized leaves were able to support being recellularized with human cells, found to be 
non-cytotoxic and biocompatible.  There are many possible future investigations needed to fully 
explore a decellularized leaf as a potential pre-vascularized scaffold for tissue engineering.  
Firstly, an investigation into the vascular resistance of the leaves would be beneficial.  Vascular 
resistance has been shown to be a factor in thrombogenesis 218.  Further translation of the leaf 
scaffold towards an implantable perfusable tissue would require proper vascular resistances to 
limit potential thrombogenesis and to allow for proper blood flow.  Tissues within the body have 
differing vascular resistances 219 depending upon metabolic demand.  Matching the vascular 
resistance of the leaf scaffold with the resistance of the native tissue would thereby be an 
important endeavor.  Furthermore, in this dissertation, we approximated the diameters of the 
leaf vasculature through perfusion of variously-sized microparticles.  Microparticles that were on 
the size scale of red blood cells flowed fully through the leaf tissue, indicating the possibility of 
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unrestricted blood flow through the leaf’s vasculature.  Considering that the leaf vasculature has 
evolved to transport water and not blood, it is thereby imperative to further investigate whether 
blood would flow freely through the plant structures and not form a thrombosis.  It has previously 
been shown that the vascular branching of a leaf matches the same physiological law of 
branching seen within the cardiovascular system 54.  Despite this similarity there are a lot of 
differences in the architecture of the plant vasculature when compared to human vascular 
structures.  Plant vasculature is comprised of a bundle of tubes that branch off to the smaller of 
parts of the tissue 220 whereas human vasculature branches from one single point and gradually 
gets smaller.  It is not understood whether this difference would have an effect on oxygen 
carrying and ultimate diffusion properties.  It would thereby important to study whether the 
vasculature within the leaf structure could be actively used to keep the tissue being grown on its 
surface alive.  One other major difference between plant vascular structures and what is found 
within the human cardiovascular system is the venous return system.  Deoxygenated blood is 
transported back to the heart within the veins of the body and there is no such comparable 
system seen within plant tissue.  For a tissue that is engineered on a leaf scaffold to be fully 
integrated into the body, venous return must be investigated.  It is possible that a second leaf 
could act as a venous platform where the engineered tissue is “sandwiched” between two leaves.  
Negative pressure must be able to be applied to the venous leaf and allow for uptake of fluid 
through the leaf’s epidermis and into the vascular system.  It is also possible that the pre-existing 
leaf vasculature would not need to be directly anastomosed into the host’s vasculature system.  
Pre-existing vasculature could possibly help direct vasculogenesis in the implanted tissue.  This 
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would need to be tested with an animal model to fully understand the need for directly 
connecting the leaf vasculature into the host’s vasculature.   
Lastly, in objective 1b HUVECs were able to adhere to the inner portions of the leaf’s lumen 
and were found to be functional 48 hours after seeding.  HUVECs were only found on the largest 
lumen in the main vein of the leaf.  For a tissue to be fully integrated into a host, it is imperative 
that the leaf would be fully endothelialized.  To accomplish this, I hypothesize that there would 
need to be a bioreactor specially designed for perfusion of HUVECs into the leaf vasculature.  
Furthermore, investigation into luminal coating or functionalization would be required to fully 
endothelialize the leaf.    
There would need to be further investigation into further refining the engineered cardiac 
tissue grown on the leaf scaffold.  In objective 1b, small clusters of hPS-CMs were able to adhere 
and function on the outer portion of the leaf scaffold for 21 days.  There were only small isolated 
clusters of cardiomyocytes that were able to adhere and function and the leaf was not fully 
seeded with the cardiomyocytes.  For an engineered cardiac patch to be successful, the seeding 
efficiency would need to be improved.  Native cardiac tissue is highly aligned and anisotropic.  
Alignment and anisotropy of cardiomyocytes is important for their contractile properties 221,222 
and thusly engineering aligned cardiac tissue on the leaf scaffold would be important for the 
generation of physiologically relevant contractile mechanics.  Alignment could be achieved in a 
variety of different techniques.  Cardiomyocytes have shown to be aligned when seeded on fibrin 
microthreads 197, thereby combining the fibrin microthread platform with the leaf scaffold might 
yield aligned cardiac structures.  Fibrin microthreads could be laid across the leaf scaffold in the 
properly aligned manners or they could be embedded in a fibrin gel 12 to create a composite 
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material that could be used in conjunction with the leaf scaffold.  Aligned cardiac structures could 
also be generated using cell sheet technology 223.  Cell sheet technology uses highly dense cell 
cultures to generate thin tissue films.  This technology can generate thicker tissues by stacking 
multiple sheets on top of one another 224.  Cell sheets that have been stacked together have 
shown the ability to transform electrical signal 225 between sheets which propagates into larger 
scale contractile function 226.  Tissues are still subjected to the pitfall of lack of vasculature and 
there would be tissue death when the engineered sheet structures exceed the oxygen diffusion 
limit.  There is a possibility that a decellularized leaf could provide the proper vascular support to 
stacked cell sheets.  Cardiac cell sheets could be staggered in their direction to create the 
necessary anisotropy and these could be sandwiched within decellularized leaves to create a 
large-scale vascularized cardiac tissue.   
In objective 3, a conducting biofiber was engineered to bridge electrical signal which would 
allow for improved electrical integration of a potential cardiac patch.  The biofiber was created 
by seeding engineered HEK293 cells 18 on fibrin microthreads 190.  The biofibers were able to carry 
electrical signal in vitro and in vivo.  The conduction velocities measured for the currents on the 
biofibers were approximately 0.015 m/s, which is much slower than the native conduction 
velocities of the heart which range from 0.05 m/s in the AV node 227 to 2-3 m/s in the Purkinje 
fibers 228.  For improved electrical integration, the conduction velocities of the biofibers must be 
increased to more closely match the native cardiac tissue.  Conduction velocity could be 
improved in a variety of ways.  One would be through further refinement of the engineered cells 
being used in the biofiber.  Currently the HEK293 cells that are being used are engineered to have 
sodium and potassium channels.  Further transfections to include calcium channels 229 would 
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allow for a more native-esque ionic profile which should translate to improve action potential 
duration.    HEK293 cells inherently have the gap junction connexin protein expressed along their 
surface 192.  Further transfections of the HEK293 cell to overexpress connexin43 and connexin45 
protein expression would also increase the likelihood that there would be increased gap junction 
formation which would result in increased conduction velocities 191.  Further refinements in the 
biofiber to increase conduction velocity could be made by modulating the fibrin microthread 
skeleton.  More fibers included in the gross biofiber structure would allow for more cells being 
delivered which would allow for a more widespread electrical conduction.  Other refinements, 
such as using a material 230 different than fibrin could serve to increase the conduction velocities.  
The last future work that would be suggested to investigate would be the integration of the 
leaf scaffold with the biofibers.  It is important to study whether electrical signal could be 
transported from a separate cluster of cardiomyocytes onto cardiomyocytes that were being 
cultured as a part of an engineered tissue on top of the leaf scaffold.  This could be translated 
into an MI animal model and looking to recapitulate cardiac function through the combination of 
a leaf- cardiac patch with the biofibers.  It would be important to study the affect that varying 
the number of biofibers sutured and their lengths would have on electrical integration of a leaf 
cardiac patch.   
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11.2. Protocols 
11.2.1. Leaf Decellularization  
Protocol for Plant Decellularization 
Used for spinach (and other) leaves, parsley stems 
Materials: 
• 27G Needles 
• 0.38 ID 1.09 OD LDPE Medical tubing 
• Hexanes 
• PBS 1x 
• DI H2O 
• 1X SDS solution in DI H2O 
o For 2L of solution mix 200 mL of 10x SDS with 1800 mL of DIH20 
o 2L of 10x SDS Solution 
§ Mix 200 g of SDS powder in 2L DIH20 until there are no more visible SDS pellets 
§ Can be stored at room temperature until needed 
• 0.1% Triton-X with 10% bleach (or Cl tablets) in DI H2O 
o 48 mL of concentrated Clorox bleach and 20 mL of TritonX-100 Solution are added to 2L of DiH20 
and mixed until in solution 
• Tris buffer solution 
o 10 mM Tris Buffer (605.7 mg in 500 mL of DiH2O) 
o Buffered to pH 9.0 
• Same protocol applies if using Gaudette Lab decellularization apparatus or custom set-up. 
o Gaudette decellularization apparatus requires ~2-4L of each solution to function efficiently. 
Custom decellularization apparatus should use an appropriate amount of solution depending on 
size. 
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Decellularization Protocol: 
1. Cannulate leafs and parsley stems via the stem, affixing cannulas with suture.  
2. Once leaves are cannulated, (Repeat 3x times) Submerge in hexanes and wash vigorously for 2 minutes. 
Remove and rinse in 1x PBS for 2 minutes. 
3. Affix plant materials to decellularization set up. 
4. Attach 4 L of 1x SDS solution to the set up and begin flow. Monitor plant materials to ensure proper flow 
through the leaf vasculature, modifying flow rate to ensure a slow, steady drip. 
a. Rapid flow rate will deplete SDS too quickly, whereas too little flow runs the risk of dehydrating 
the plant material and damaging the plant structure. 
5. Maintain in SDS for 1 day in order to decellularize plant material, until leaves and stems become more 
transparent in appearance. Green coloration at this step is normal and not indicative of an unsuccessful 
decellularization. 
6. Remove 1x SDS and add 4L of Triton-X/Bleach solution to set up.  
7. Maintain set up in Triton-X/Bleach for 24 hours, can go longer if needed.  Watch until leaves and stems 
have become clear/transparent. This solution should purge any remaining coloration from the plant 
matter. 
8. Remove Triton-X/Bleach solution and attach DI H2O to set up. Perfuse leaves/stems in DI H2O for 24 
hours. 
9. Wash decellularized leaves on rotator in Tris buffer solution overnight.   
a. Replace the solution at least twice (usually after the first hour and then secondly in the morning) 
b. Tris buffer removes residual SDS that maybe left entrapped in the leaf 
c. Make sure the rotator moves the leaf gently 
d. Watch the stem as they become very fragile 
10. *** IF FUNCTIONALIZING LEAF WITH RGDDOPA PLEASE SEE RGDDOPA FUNCTIONALIZATION PROTOCOL 
BEFORE MOVING TO STEP 11*** 
11. Remove leaves and stems from solutions, freeze overnight in -20°C freezer 
12. Lyophilize leaf/stem for 24 hours 
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13. Store at lyophilized leaf scaffold at room temperature until needed.  
a. If functionalized with RGDDOPA, store lyophilized leaves in refrigerator 
14. Please see the rehydration protocol for next steps 
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11.2.2. Leaf Functionalization with RGD-Dopamine  
Protocol for Leaf Scaffold Functionalization with RGDDOPA 
Used when functionalizing the leaf scaffold surface with RGDDOPA peptide.  This protocol takes place after the 
leaf scaffold is washed overnight in Tris buffer following the conclusion of the decellularization protocol.  RGDDOPA 
is provided by the Murphy Lab at University of Wisconsin. 
 
Materials: 
• Decellularized leaf 
• Tris buffer solution  
o 10 mM Tris Buffer (605.7 mg in 500 mL of DiH2O) 
o Buffered to pH 9.0 
• RGDDOPA Solution 
o Received as a powder from University of Wisconsin 
o Reconstitute at 1 mg/mL RGDDOPA in Tris Buffer solution 
§ Need to weigh out the provided powder  
§ Remove as much powder from tube as possible and weigh on scale 
§ There will be a small amount left over  
• In order to measure this amount and the maximize the amount of solution: 
o Weight the conical tube that has the small residual power in it 
o Dissolve the small remnant in 1 mL of Tris Buffer Solution and remove 
to a different conical tube 
o Dry the original tube and weight, the difference between the two 
measures would be the weight of the residual peptide which is 
currently constituted in the 1 mL solution 
§ Dilute the residual solution and the weighed out powder in Tris buffer such that the final 
concentration of 1 mg/mL 
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o Stored in refrigerator 
o Mix well with vortex before use as peptide falls out of solution over time 
o Solution is reused for multiple leaves  
§ Throw out if the color starts to become a light brown as opposed to a dark brown 
solution 
 
Functionalization Protocol: 
1. Remove leaves from Tris buffer solution following overnight wash  
a. Continuation from after step #10 from “Updated_Plant_Decell_Protocol_GaudetteLab”  
b. Be careful with stem if functionalizing whole leaf as the stem is very fragile at this point 
2. Optional, if using small sections of leaf instead of whole leaf use biopsy punch and cut small circles of 
wanted size out leaf 
3. Place whole leaf or leaf sections into RGDDOPA Solution 
a. Use a 50 mL conical tube for whole leaves 
b. Use a 15 mL conical tube for leaf sections 
4. Rotate whole leaf/leaf sections in RGDDOPA Solution for 24 hours 
5. Remove leaf/leaf sections from solution  
6. Retain RGDDOPA solution and store in refrigerator until next use 
7. Take leaves and continue to step #11 from the “Updated_Plant_Decell_Protocol_GaudetteLab” protocol 
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11.2.3. Leaf Scaffold Rehydration  
Protocol for Leaf Scaffold Rehydration 
Used for spinach (and other) leaves, parsley stems 
Materials: 
• Lyophilized decellularized leaf (***See Protocol for Plant Decellularization***) 
• 10 mM Tris Buffer (605.7 mg in 500 mL of DiH2O) 
o Buffered to pH 9.0 
• 1x dPBS 
• Hexanes 
• Plate Rotator 
 
 
Decellularization Protocol: 
15. Rehydrate decellularized leaf in Tris Buffer solution overnight on rotator 
a. Replace solution every few hours 
16. Wash leaf in 1x dPBS for 10 minutes 
a. ***IF leaf have been functionalized with RGDDOPA skip until step 5*** 
17. 5-minute serial washes in Hexanes and then dPBS.  Repeat 3x 
18. Wash leaf in 1x dPBS for 3 hours  
a. Replace dPBS every hour 
19. Keep leaf in dPBS until used for cell cuture 
20. Please continue onto “Human Cell Recellularization of Leaf Scaffold” protocol 
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11.2.4. Human Cell Recellularization of Leaf Scaffold  
Human Cell Recellularization of Leaf Scaffold:  
 
 
1. Decellularize and rehydrate leaf 
2. Rehydrate with serial washes of Tris-HCl Buffer (10 mM, pH 9.0) 
3. Sterilization (if leaf is not functionalized with RGDDOPA):  
o In 10cm dish containing decelled leaf, add the following: 
§ 10mL 10% bleach 
§ 1mL 0.1% Triton-X 
o Agitate gently on shaker table for 30 minutes 
o Transfer leaf to Laminar Flow hood 
o Aspirate sterilization solution 
o Rinse 3x with sterile water 
o Rinse 3x with sterile PBS 
o Section leaf for plating with sterile tweezers and scalpel/razor 
o NOTE: Leaf should change from opaque (after the decell process), to translucent 
(after sterilization. 
4. Sterilization (if leaf IS functionalized with RGDDOPA): 
o Wash leaf in sterile PBS 3x 
o Remove PBS and place leaf under UV light in biological safety cabinet for 15 
minutes 
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5. Plating: 
o Coat well with poly D-Lysine 
§ Add enough to cover well (i.e. 0.25mL in 12 well plate) 
§ Incubate at 37°C for 30 minutes 
§ Aspirate excess  
§ Let wells dry in hood 
o Chelate leaf with sterile 2mM EDTA in PBS 
§ Add EDTA to fresh well 
§ Introduce leaf to EDTA well and gently rock back and forth by hand for 
45-60 seconds taking care to coat whole leaf section 
§ GENTLY dry leaf section on edge of Kim wipe to remove excess EDTA 
o Plate leaf 
§ Lay leaf section flat on coated well 
§ Incubate at 37°C for 30 minutes to allow for adherence to plate 
§ Let dry in hood if any excess liquid remains 
o Coat leaf with preferred attachment protein according to protein specific 
protocols 
o Add media gently to side of well 
o Add cells and gently rock 
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11.2.5. Hematoxylin and Eosin Stain (Paraffin Embedded Tissue)  
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11.2.6. Hematoxylin and Eosin Stain (Frozen Tissue)  
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11.2.7. Masson’s Trichrome Stain  
Masson’s Trichrome 
This protocol was provided courtesy of the WPI Gateway Park histology core.  
Biebrich Scarlet Acid Fuchsin stock solution (Red) Biebrich scarlet aqueous 1%  
Acid Fuchsin aqueous 1%  
90.0ml 10.0ml 1.0ml  
1.0gm 99.0ml  
1.0gm  
 
Glacial Acetic Acid Biebrich scarlet aqueous 1%  
Biebrich Scarlet  
DH2O 
Acid Fuchsin aqueous 1%  
Acid fuchsin  
100%  
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DH2O 
Phosphomolybdic-Phosphotungstic Acid Solution (Yellow)  
99.0ml  
 
Phosphomolybdic acid Phosphotungstic acid DH2O  
Aniline Blue solution (Blue) Aniline blue  
Glacial Acetic acid 100%  
DH2O 
1% Glacial Acetic Acid solution  
Glacial acetic acid 100%  
DH2O Hematoxylin Solution A  
Hematoxylin crystals  
95% Alcohol Hematoxylin Solution B  
Ferric Chloride, 29% aqueous4.0ml DH2O  
147 Appendices  
5.0gm 5.0gm  
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200.0ml  
2.5gm 2.0ml 100.0ml  
1.0ml 100.0ml  
1.0gm 100.0ml  
95.0ml  
 
Hydrochloric acid, concentrated Ferric chloride 29%  
Ferric chloride  
DH2O 
Weigerts Iron Hematoxylin solution  
Equal parts of solution A and B  
1.0ml  
29.0gm 100.0ml  
Control tissue: Heart, uterus, skin.  
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Run a control slide. 
Safety equipment: Work under a hood with lab coat, gloves, and glasses.  
1. De-paraffin slides in xylene (1)---------------------- 2 minutes (re-use)  
2. De-paraffin slides in xylene (2)---------------------- 2 minutes (re-use)  
3. Clear slides in 100% alcohol------------------------- 2 minutes  
4. Clear slides in 100% alcohol------------------------- 2 minutes  
5. Hydrate slides in 95% alcohol----------------------- 2 minutes  
6. Hydrate slides in running water--------------------- 5 minutes  
7. Bouin’s at 60 degrees Celsius----------------------- 1 hour (re-use)  
8. Wash in running water ------------------------------ 10 minutes  
9. Weigert’s Hematoxylin (make fresh) -------------- 10 minutes (dump)  
10. Wash in running water -------------------------- 10 minutes  
11. Biebrich Scarlet Acid Fuchsin----------------------- 10 minutes (re-use)  
12. Rinse in running water------------------------------ 2 minutes  
13. Phosphomolybdic / Phosphotungstic acid------ 10 minutes (re-use)  
14. No rinse, goes directly into blue  
15. Aniline Blue--------------------------------------------------- 10 minutes (re-use)  
16. Rinse in running water-------------------------------- 1-2 minutes  
17. 1% Glacial Acetic Acid--------------------------------- 5 minutes (re-use)  
18. Dehydrate in 95% alcohol----------------------------- 1 minute  
19. Dehydrate in 95% alcohol--------------------------- 1 minute  
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20. Dehydrate in 100% alcohol------------------------- 1 minute  
21. Dehydrate in 100% alcohol------------------------- 1 minute  
22. Dehydrate in 100% alcohol------------------------- 5 minutes  
23. Clear in xylene (4)------------------------------------- 2 minutes (re-use)  
24. Clear in xylene (5)------------------------------------- 5 minutes (re-use)  
Results: 
Nuclei- Black  
Cytoplasm, keratin, muscle fiber and intercellular fibers- Red  
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Collagen- Blue Weigerts Iron Hematoxylin:  
Equal parts of solutions A and B – 20ml and 20ml for tall glass staining coplin jar.  
 
 
